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Abstract 
The prevalence of obesity (severe overweight) has been increasing in western 
societies during the last decades. Epidemiological studies to the public health 
impact of obesity are therefore warranted. This thesis aimed at describing the long-
term and recent time trends of obesity in the Netherlands, and to explore the 
relations between obesity, mortality, morbidity, and disability. 
The prevalence of obesity, body mass index (BMI) >30 .O kg/m , increased steadily in 
Dutch adults between 1974 and 1997. Between 1993 and 1997, the prevalence of 
obesity was estimated at 9% among men and at 10% among men aged 20-59 years, 
based on data from the Dutch MORGEN project. Levels of waist circumference 
increased more over time and showed greater seasonal variation than BMI. 
Obesity measured by BMI was related to increased all-cause mortality in men who 
never smoked, although relative risks seemed to decrease somewhat with ageing in 
European men from the Seven Countries Study. Levels of waist circumference 
identified more men over 55 years of age who never smoked with increased risk of 
mortality than levels of BMI in the Rotterdam Study. 
Obesity was related to hospitalisation for coronary heart disease and to medication 
for chronic conditions in Finnish men and women from the Social Insurance 
Institution's Mobile Clinic study. In the Mini-Finland Health Survey, obesity was 
associated with the presence of osteoarthritis, low back pain, shoulder joint 
impairment and neck pain. In addition, obesity was associated with work disability 
during a 15 years follow-up and to the presence of difficulties in daily life activities. 
Relative risks of obesity for morbidity and disability were highest in the youngest 
Finnish adults studied, and exceeded the relative risk for mortality. 
Prevention of weight gain (<0-5 kg/year) during a period often years, could prevent 
26,000 new cases of knee osteoarthritis and 19,000 new cases of work disability in 
the Dutch working aged population. 
Although obesity was related to increased mortality, obese Finns had more 
unhealthy life years than Finns with normal weight. During a maximal follow-up 
period of 15 years until age 65 years, obese men had 0.5, 0.4 and 1.7 extra years of 
work disability, coronary heart disease and morbidity leading to chronic 
medication, respectively. Obese women suffered respectively 0.5, 0.4 and 1.3 extra 
years from these conditions. 
This thesis provides new evidence based on large epidemiological studies that 
weight gain prevention programs should get high priority on both the scientific and 
the political agenda. 
7 
Contents 
Chapter i General introduction n 
Chapter 2 Literature review 
2.1 The public health impact of obesity (Annu Rev Public Health 2001; 22: 355-75) 17 
Chapter 3 Obesity prevalence 
3.1 Long-term and recent time trends in the prevalence of obesity among Dutch 43 
men and women (submitted) 
3.2 Seasonal variation in waist circumference is larger than that in body mass index 57 
(submitted) 
Chapter 4 Obesity and mortality 
4.1 Underweight and overweight in relation to mortality among men aged 40-59 63 
and 50-69 years. The Seven Countries Study {Am J Epidemiol 2000; 151: 660-6) 
4.2 A comparison of body mass index, waist-hip ratio, and waist circumference as 75 
predictors of all-cause mortality among the elderly. The Rotterdam Study 
(IntJ Obes 2001; in press) 
Chapter 5 Obesity and unhealthy life years 
5.1 Overweight, osteoarthritis, and the risk of disability (submitted) 89 
5.2 The potential effect of weight gain prevention on the incidence of osteoarthritis 103 
and work disability (submitted) 
5.3 Overweight, obesity and unhealthy life years in adult Finns. IYJ 
An empirical approach (submitted) 
Chapter 6 General discussion 133 
Summary 155 
Samenvatting 161 
List of abbreviations 167 
Een woord van dank 169 
Curriculum vitae 173 
Chapter 1 
GENERAL INTRODUCTION 
I I 
The prevalence of obesity (severe overweight) has been increasing dramatically in 
western societies during the last decades of the xo century and in non-western 
societies recently. Currently, about 20% of adult men and 25% of adult women in 
the United States is obese,' and nearly 10% of the Dutch men and women is 
obese. ' Worldwide, over 250 million people are obese. In affluent societies, obesity 
is most common among persons with a relatively low educational level. 
Overweight and obesity are commonly defined using the body mass index (BMI), 
also known as the Quetelet Index. BMI is calculated as weight divided by height 
squared (kg/m). According to World Health Organization guidelines, normal 
weight is defined as BMI 18.5-24.9 kg/m2, overweight as BMI 25.0-29.9 kg/m and 
obesity as BMI >30.O kg/m2 for both sexes. Abdominal fatness can be measured by 
waist circumference. Action levels for abdominal overweight and obesity differ 
between men and women. Prevalence estimates of abdominal obesity are scarce. 
The public health relevance of obesity became apparent in the 1950's when actuarial 
studies showed a relation between obesity and increased mortality. This association 
is now widely accepted, and may be at least partly explained by hypertension and 
an unfavourable lipid profile, which are in the causal chain between obesity and 
mortality. Relative risks of mortality for obesity decrease with ageing.10'" These 
decreasing relative risks were established using different birth cohorts. Possibly, 
different birth years affected both body weight development and mortality risks. A 
cohort effect may influence relative risks of different age groups. BMI levels change 
with ageing, because of changes in body composition. BMI is therefore probably not 
a good indicator of increased risk of mortality in the elderly. 
Much evidence exists that obesity contributes to morbidity. Obesity is an 
important risk factor for type 2 diabetes mellitus and cardiovascular diseases, but 
also for musculoskeletal disorders such as osteoarthritis. Especially fat mass in the 
abdominal region is an important risk factor for the onset of type 2 diabetes 
mellitus, as free fatty acids from excess abdominal fat tissues are entering the liver 
through the vena porta. Free fatty acids in the liver have a restraining effect on 
insulin clearance, stimulate synthesis of triglycerides and vxDL-lipoproteins, and 
metabolic products of free fatty acids activate hepatic glyconeogenesis.1 The 
combination of obesity, hypertension, hyperlipidaemia, and hyperinsulinaemia is 
well known as cluster of risk factors for cardiovascular diseases. This cluster is 
known as the Syndrome X, the metabolic syndrome, or the Deadly Quartet. The 
relation between obesity and musculoskeletal disorders is explained by mechanical 
pressure of excess weight on the joints. 
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The total health care costs directly attributable to obesity are estimated at about 6% 
in the United States," and at i%-5% in Europe. The direct health care costs of 
overweight and obesity in the Netherlands have been estimated at around 4% in a 
study dating from 1991. ' Cost estimations might be over-estimations, because the 
relation between obesity and mortality has not been taken into account. The study 
using European figures calculated only a limited number of health consequences 
and may therefore be regarded as conservative. It is possible that obese subjects with 
for instance coronary heart disease die earlier than normal weight subjects with 
coronary heart disease. Policy makers and others who are interested in the costs of 
obesity-related health consequences would need estimations of the number of 
unhealthy life years in obese, overweight, and normal weight subjects. 
The consequences of obesity that lead to indirect health care costs are also of great 
interest in the public health context. Relatively few epidemiological studies report a 
relation between obesity and work disability. ' Approximately 10% of the 
productivity loss due to sick-leave and work disability was attributable to obesity-
related diseases, according to a study in obese Swedish women. It remains 
unknown how many years obese subjects are longer disabled than normal weight 
subjects. Another form of disability related to obesity, is impaired quality of life for 
instance due to difficulties in everyday activities. The role of musculoskeletal 
disorders, which are also important contributors to disability, in the relation 
between obesity and disability has not been systematically evaluated. 
This thesis aimed at studying the impact of obesity on public health by assessing 
the increase of the prevalence obesity over time in the Netherlands, and elucidating 
the role of obesity in mortality, morbidity, and disability. 
In the literature review in chapter 2, the state of the art on the increase in obesity 
prevalence and its role in mortality, morbidity and disability is described. 
In chapter 3, the long-term and the recent increase in the prevalence of obesity in 
the Netherlands is reported. The long-term increase in the prevalence of obesity is 
assessed between 1976 and 1997 among men and women aged 37-43 years. In 
addition, the recent increase in the prevalence of obesity between 1993 and 1997 
among men and women aged 20-59 years is reported. This recent increase is studied 
across categories of age, educational level, and smoking. In addition, increases in 
levels of BMI and waist circumference over consecutive seasons are compared. 
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In chapter 4, overweight and obesity are described in relation to increased mortality 
among men aged 40-59 and men aged 50-69 years from the European centres of the 
Seven Countries Study. Smoking has been taken into account by presenting 
analyses separately for never- ex, and current smokers. In addition, it was studied 
whether waist circumference and waist-hip ratio were better predictors of mortality 
than the BMI in men and women aged 55 years and older in the Rotterdam Study. 
In chapter 5, obesity is reported in relation to morbidity and disability. Endpoints 
of disability were work disability and having difficulties in performing everyday 
activities. Data were derived from the Mini-Finland Health Survey on Finnish men 
and women aged 30-65 years to assess the role of osteoarthritis in the relation 
between obesity and disability. The relation between obesity and osteoarthritis has 
been assessed. In addition, it has been assessed whether obesity was related to 
disability among both subjects with and without osteoarthritis. Moreover, the role 
of low-back pain, shoulder joint impairment, and chronic neck pain in the relation 
between obesity and disability was studied. The potential value of weight gain 
prevention on the avoidable incidence of osteoarthritis and work disability in the 
Dutch adult population has been calculated by mathematical modelling. Relative 
risks of obesity were studied for work disability, hospitalisation due to coronary 
heart disease and medication use for chronic diseases in comparison with the 
relation between obesity and all-cause mortality. Relative risks were calculated 
across different age groups. For this purpose data were used from another Finnish 
population based cohort study: the Social Insurance Institution's Mobile Clinic 
Study on men and women aged 20-92 years. In the last part of chapter 5 results of 
analyses on the number of unhealthy years in normal weight and obese subjects are 
described. Unhealthy life years are defined as years during which subjects had work 
disability, coronary heart disease, or morbidity leading to long-term medication. 
In chapter 6, the evidence based on this thesis is summarised and discussed in the 
context of the literature. Evidence on the role of obesity in mortality, morbidity, 
and disability is combined to conclude whether or not number of unhealthy life 
years will increase with an increasing prevalence of obesity. Finally, suggestions for 
innovative weight gain prevention programs are shortly described that should be 
implemented to stop the obesity epidemic. Recommendations are made regarding 
further research on the consequences of obesity and the implementation of new 
weight gain prevention programs. 
14 
References 
i. Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL. Overweight and obesity in the 
United States: prevalence and trends, 1960-1994. IntJ Obes 1998; 22: 39-47. 
2. Statistics Netherlands, http://www.cbs.nl/nl/nieuws/artikelen/archive/artikel.asp?jr=2000 
8dd=0573k&dt=i7-07-oo. Accessed: July 2001. (Homepage Statistics Netherlands, 
Voorburg/Heerlen, the Netherlands). 
3. Viet AL, van Gils HWV, van den Hof S, Seidell JC, van den Berg J, van Veldhuizen H. 
Risk factors and health evaluation in the Dutch population (Regenboog-project) {In 
Dutch). 2001; RIVM report 260854 OOT-
4. Seidell JC. Obesity, insulin resistance, and diabetes - a worldwide epidemic. Br J Nutr 
2000; 83: S5-S8. 
5. Seidell JC, Rissanen A. Time trends in the worldwide prevalence of obesity. In: The 
handbook of obesity. 79-91. New York, USA. 1997. M Dekker, ed. 
6. World Health Organization. Obesity - Preventing and managing the global epidemic, 
report of a WHO consultation on obesity. Geneva, Switzerland, 1997, WHO/NUT/NCD/98 1. 
7. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need 
for weight management. BMJ1995; 311: 158-61. 
8. New weight standards for men and women. Stat Bull NY Metropolitan Life Insurance Co 
1959; 40: 1-4. 
9. Manson JE, Stampfer MJ, Hennekens CH, Willett WC. Body weight and longevity: a 
reassessment. JAMA 1987; 257: 353-8. 
10. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on 
the association between body-mass index and mortality. N Engl J Med 1998; 338:1-7. 
11. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW. Body-mass index and 
mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-105. 
12. Chumlea WC, Baumgartner RN. Status of anthropometry and body composition data in 
elderly subjects. Am J Clin Nutr 1989; 50: 1158-66. 
13. Gallagher D, Visser M, Sepulveda D, Pierson RN, Harris T, Heymsfield SB. How useful 
is body mass index for comparison of body fatness across age, sex, and ethnic groups. Am 
JEpidemiol1996; 143: 228-39. 
14. Bjorntorp P. Obesity. Lancet 1997; 350: 423-6. 
15. Felson DT, Zhang Y, Hannan MT et al. Risk factors for incident radiographic knee 
osteoarthritis in the elderly: The Framingham Study. Arthritis Rheum 1997; 40: 728-33. 
16. Bjorntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 
1997; 13: 795-803. 
17. Oldenburg B, Pijl H. Abdominal obesity: metabolic complications and hepatic 
consequences {In Dutch). Ned Tijdschr Geneesk 2001; 145: 1290-4. 
18. Heliovaara M. Risk factors of low back pain - A review, pp 41-51. Wien: Blackwell-MZW, 
1993. 
15 
19- Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United 
States. Obes Res 1998; 6: 97-106. 
20. Seidell JC. The impact of obesity on health status: some implications for health care costs. 
IntJObes 1995; 19 Suppl 6: S13-6. 
21. Jansen CCM, Ament AHJA. Overgewicht ... een zware last. Gezondheidszorgkosten in 
Nederland ten gevolge van overgewicht. Report 91-4, Dept Health Economics, Maastricht 
University, the Netherlands, 1991. 
22. Allison DB, Zannolli R, Narayan KM. The direct health care costs of obesity in the 
United States. Am J Public Health 1999; 89:1194-9. 
23. Rissanen A, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Maatela J. Risk of disability 
and mortality due to overweight in a Finnish population. .BA//1990; 301: 835-7. 
24. Narbro K, Jonsson E, Larsson B, Waaler H, Wedel H, Sjostrom L. Economic 
consequences of sick-leave and early retirement in obese Swedish women. IntJ Obes 1996; 
20: 895-903. 
25. Lean ME, Han TS, Seidell JC. Impairment of health and quality of life using new US 
federal guidelines for the identification of obesity. Arch Intern Afc/1999; 159: 837-43. 
16 
Chapter 2.1 
THE PUBLIC HEALTH IMPACT OF OBESITY 
Abstract The increase in obesity worldwide will have an important impact on the global 
incidence of cardiovascular disease, type 2 diabetes mellitus, cancer, osteoarthritis, work disability, 
and sleep apnoea. Obesity has a more pronounced impact on morbidity than on mortality. 
Disability due to obesity-related cardiovascular diseases will increase particularly in industrialised 
countries, as patients survive cardiovascular diseases in these countries more often than in 
nonindustrialised countries. Disability due to obesity-related type 2 diabetes will increase 
particularly in industrialising countries, as insulin supply is usually insufficient in these countries. 
As a result, in these countries, an increase in disabling nephropathy, arteriosclerosis, neuropathy, 
and retinopathy is expected. Increases in the prevalence of obesity will potentially lead to an 
increase in the number of years that subjects suffer from obesity-related morbidity and disability. 
A 1% increase in the prevalence of obesity in such countries as India and China leads to 20 
million additional cases of obesity. Prevention programs will stem the obesity epidemic more 
efficiently than weight loss programs. Only a few prevention programs, however, have been 
developed or implemented, and the success rates reported to date have been low. Obesity 
prevention programs should be high on the scientific and political agenda in both industrialised 
and industrialising countries. 
Tommy LS Visscher and Jacob C Seidell. Annu Rev Public Health 2001; 22: 355-75. 
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Introduction 
Awareness of the association of obesity with health problems is longstanding. A 
classical example of the emergence of an obesity-disease link was the 1921 
observation by Joslin that a large proportion of diabetes patients was overweight. ' 
Another classical observation was the notation, by Hinsworth, of a decrease in the 
prevalence of diabetes in countries with food shortages in World War I. The 
Metropolitan Life Insurance Company's development of "desirable weight" tables 
with respect to greatest expected longevity is a major marker for concern about 
health effects of obesity. 
During the past few decades, the prevalence of obesity has grown to epidemic 
proportions, and this condition is now known to be a major contributor to the 
global burden of disease. Currently, more than 50% of the US population is 
overweight and approximately 20% is extremely overweight, or obese. Obesity 
prevalence is still increasing rapidly, not only in industrialised countries but also in 
nonindustrialised countries, particularly in those undergoing economic transition. 
World-wide, around 250 million people are obese, and the World Health 
Organization (WHO) has estimated that in 2025, 300 million people will be obese. 
Attitudes toward obesity differ across populations and, with economic changes, may 
change within populations over time. In industrialised countries, obesity is most 
common among those with low socio-economic status. The opposite is true in 
nonindustrialised countries, where obesity is most often seen among individuals 
with high income and may be considered a status symbol. This effect may change as 
nonindustrialised countries become more affluent and obesity is seen increasingly in 
those with low socio-economic status. 
The two most important risk factors for mortality in the industrialised countries are 
cardiovascular diseases (CVD) and cancer. CVD is a major cause of mortality, but also 
of disability.' Costs for survivors of heart disease are enormous because of blood 
pressure-lowering drugs, antithrombotics and diuretics. Stroke survivors often suffer 
from such disabilities as mood disorders and impaired neuro-musculoskeletal 
functions. In many areas of the United States and Europe, there is quick access to a 
hospital at the time a heart attack or stroke occurs. Fatalities associated with such 
events are therefore lower and cvD-related disability consequently higher in 
industrialised than in non-industrialised countries. Thus, although disability due to 
obesity-related CVD will increase in both industrialised and industrialising countries, 
the increase will be largest in industrialised countries. 
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Figure 2.1.1 The public health impact of obesity 
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Diabetes is by far the most expensive public health consequence of obesity. In 
industrialised countries, severe forms of type 2 diabetes are controlled relatively well 
by insulin therapy. The industrialising countries, however, in which a huge obesity-
linked diabetes epidemic is expected, will not be able to afford sufficient insulin 
therapy. Under such circumstances, uncontrolled glucose levels would lead to 
millions of patients developing nephropathy, arteriosclerosis, neuropathy, 
retinopathy, and related disability. The increase in disability due to obesity-induced 
diabetes will, therefore, be larger in industrialising than industrialised countries. 
The direct costs of obesity are now estimated to be around 7% of total health care 
costs in the United States and around 1-5% in Europe.'3 Narbro calculated that 
approximately 10% of the total costs of loss of productivity due to sick leave and 
work disability might be attributable to obesity-related diseases. Because of the 
increasing prevalence and costly consequences, obesity is now being recognised not 
only as a risk factor in the clinical setting but also as an important threat to public 
health. The public health impact of obesity should be measured by its combined 
effect on disability and mortality (figure 2..1.1). Obesity can act through its relation 
with other morbidities and appears to have a direct effect on disability (figure 
2.1.1). ' The current focus is also on outcomes such as quality of life and physical, 
social, and mental functioning. These obesity-related outcomes increase in 
importance as population longevity increases.'7 
This review outlines obesity as a public health problem. We first discuss definitions 
and trends of obesity and describe the role of obesity as a risk factor for all-cause 
mortality and the development of cancer. We then describe the role of obesity as a 
risk factor for CVD and type 2 diabetes mellitus. In addition, we address current 
evidence on obesity as a risk factor for such musculoskeletal disorders as 
osteoarthritis, work disability, and respiratory disorders. Finally, we discuss the use 
of body weight measurements in the elderly, who represent an increasingly 
important population with regard to the impact of obesity on the public health. 
Definitions 
OBESITY 
The WHO definitions of overweight and obesity are based not only on the risks of 
increased mortality but also on increased morbidity risks (table 2.1.1).5 A body mass 
index (BMI) below 18.5 kg/m is defined as underweight; a BMI between 18.5 and 
24.9 is normal weight. Overweight individuals, those with a BMI between 25.0 and 
2 0 
29.9 kg/m , are at increased risk of morbidity and should avoid further weight gain. 
Weight loss in overweight people is recommended when other risk factors for 
disease are present. Severely overweight or obese people, those with BMIS of 30.0 
kg/m or higher, are at highly increased risk of disease irrespective of the presence of 
other risk factors and weight loss is recommended for all. Cross-culturally, the 
implication of a certain BMI level with respect to body fatness and fat distribution 
might vary across populations. Asian populations, for instance, have a higher 
absolute risk for the onset of type 2 diabetes mellitus than do Caucasian 
populations with the same level of BMI. The International Diabetes Institute and 
the International Obesity Task Force of the WHO argue that lower BMI cut points 
should be used for Asian populations than for Caucasian populations. 
BODY FAT DISTRIBUTION 
The ratio of waist circumference divided by the hip circumference (WHR) is a 
measure of fat distribution on the body. This ratio may be misinterpreted as specific 
for abdominal fat (the numerator of the ratio), although it is also influenced by the 
amount of fat in the gluteal region (denominator). Abdominal fat can be estimated 
Table 2.1.1 Definitions of waist circumference and body mass index categories* 
Waist circumference 
Men Women 
Above action level 1 >94 cm (-37 inch) >80 cm (~32inch) 
Above action level 2 >102 cm (-40 inch) >88 cm (-35 inch) 
Body mass index (kg/m2) 
Men and women 
Underweight <18.5 
Normal weight 18.5-24.9 
Moderate overweight 25.0-29.9 
Overweight >25.0* 
In this thesis: 25.0-29.9" 
Pre-obese 25.0-29.9 
Obesity >30.0 
Obese class I 30.0-34.9 
Obese class II 35.0-39.9 
Obese class III >40.0 
a Body mass index categories are defined according to the WHO-guidelines.5 Waist circumference 
categories are suggested by Lean et al .a 
b Alternative definition for overweight, often used in the literature. 
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with greater precision by the waist circumference alone. The waist circumference 
is measured midway between the lower rib margin and the iliac crest, with the 
person in a standing position. Although the waist circumference is associated with 
stature, the correlation is sufficiently low to ignore adjustment for body height in 
persons aged 20-59 years. ' 
Lean et al. suggested that action levels based on waist circumference replace BMI and 
WHR as measures of obesity (table 2.1.1).22 These action levels seemed appropriate for 
identifying those with cardiovascular risk factors, type 2 diabetes mellitus, or 
shortness of breath when walking upstairs. ' This issue, however, is still under 
debate. For example, Molarius and Seidell have noted that criteria underlying these 
waist circumference action levels were based on arbitrary levels of the WHR and that 
the evaluations with respect to risk were based on cross-sectional data. 
POPULATION ATTRIBUTABLE FRACTION 
In measuring the impact of obesity on mortality, morbidity, or disability it is useful 
to calculate the fraction of an outcome in the population that is attributable to 
obesity (the population attributable fraction), using the proportion of obesity and 
the relative risk: 
= p(RR-l) (formula 2.1.1) 
p(RR-l) + l 
with AFp being the population attributable fraction, p the proportion of subjects in 
the BMI category, and RR the corresponding relative risk. To evaluate the different 
impact of obesity on mortality and morbidity, one can easily compare relative risks, 
as the proportion of obesity will be equal for each attributable fraction calculation. 
In this review, the relative risks of categories of BMI for all-cause mortality, coronary 
heart disease, stroke, and type 2 diabetes mellitus are illustrated using US data from 
the Health Professionals Follow-Up Study2 29 and the Nurses' Health Study.30 33 
Both studies describe age-adjusted relative risks for these outcomes. 
Prevalence and trends 
Currently, more than 30% of the US population is overweight (BMI 25.0-29.9 
kg/m2) and around 20% is obese (BMI >30 .O kg/m2).6 The US National Health and 
Nutrition Examination Surveys showed a marked increase in obesity between the 
first survey cycle in 1960-1961 and the third cycle in 1988-1994 in the United States. 
More recent data on obesity prevalence and trends in the United States are from 
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the Centres for Disease Control and Prevention telephone survey data. Among 
respondents aged 18 years and older, obesity prevalence increased by around 50 
percent between 1991 and 1998, with higher prevalence rates occurring in eastern 
states (figure 2.1.2).34 The absolute prevalence rates reported by Mokdad et al. are 
probably underestimations because they are based on self-reported height and 
weight. Obese people tend to underreport their weight more than do people with 
acceptable weight. 
Data from the Third National Health and Nutrition Examination Survey (NHANES 
HI) are based on direct measurements of height and weight. These data indicate that 
for persons aged 20-74 years, the prevalence of overweight (BMI 25.0-29.9 kg/m) 
was 39.4% in men and 24.7% in women. In the same survey, 19.9% of the men and 
24.9% of the women were obese (BMI >30.O kg/m2). In women, the prevalence of 
those who were overweight or obese was even higher in non-white populations. 
Among the non-Hispanic black and Mexican-American respondents in NHANES HI, 
20% of the men and approximately 35% of the women were obese. 
B1991 • 1998 
New England 
Mid Atlantic 
East north central ; 
West north central 
South Atlantic 
East south central 
West south central 
Mountain 
Pacific 
10 15 
prevalence of obesity (%) 
20 25 
Figure 2.1.2 The increase in obesity in the United States 
Data from Mokdad ef a/., based on self-reported body weight and height.3 
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CROSS-NATIONAL DIFFERENCES 
It is less common to be overweight (BMI 25.0-29.9 kg/m) in most European 
countries than it is in the United States, but the prevalence of overweight adults in 
Germany, Finland, and Britain is substantially more than 50%. Obesity (BMI >30 .O 
kg/m) also is generally less common in Europe than in the United States, around 
10-20% of adult men and 15-25% of women. In western European study centres 
participating in the WHO-MONICA study, the prevalence of obesity ranged from 10% 
to 24% among men and from 9% to 25% among women aged 35-64 years in 1989-
1996. Obesity was more common in eastern Europe, especially among women. In 
Polish and Russian study centres, the prevalence of obesity was around 40%. The 
increase in obesity between the initial MONICA survey in 1979-1989 and the final 
survey in 1989-1996 was less marked for the European than the US study centre in 
Stanford, California. The increase in the US study centre was nearly as large as the 
50% increase reported for the overall US population between 1991 and 1998. 
Martorell et al. reported obesity rates for women aged 15-49 years from countries in 
various levels of development. In the poorest countries, there was a strong relation 
between the gross national product and the prevalence of obesity. Prevalence was 
estimated at 0.1% in South Asia, 2.5% in sub-Saharan Africa, 9.6% in Latin 
America and the Caribbean, 15.4% in Kazakhstan, Turkey, and Uzbekistan, 17.2% 
in the Middle East and north Africa, and 20.7% in the United States.38 
WITHIN-COUNTRY DIFFERENCES 
Data from NHANES and from the Centers for Disease Control and Prevention 
Behavioral Risk Factor Surveillance System showed equivalent increases in obesity 
across different race/ethnic groups and educational categories in the United 
States.' Molarius et al. described most of the increase in obesity in the European 
MONICA study populations as being among those with the lowest socio-economic 
status. Thus, the inequality in obesity prevalence widened between categories of 
socio-economic status. In nonindustrialised countries, obesity often is a marker of 
relatively high socio-economic status. Seidell and Rissanen described the increase in 
obesity as most notable in those countries undergoing rapid economic transition 
and more notable in urban areas than in rural areas.9 Martorell et al. described 
obesity as mostly concentrated among urban and higher-educated women in very 
poor countries, such as in sub-Saharan Africa. In more developed countries, such as 
Latin American countries and Kazakhstan, Turkey, and Uzbekistan, obesity rates 
were more equal across categories of urbanisation and education. Popkin et al. 
reported a difference in the association between socio-economic status and obesity 
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in rural and urban areas in China in 1993. In urban areas, obesity was most 
common among those with low socio-economic status, whereas in rural areas, 
obesity was most common in those with relatively high socio-economic status. 
Obesity and mortality 
Although obesity has been considered a risk factor for mortality for several decades, 
not all studies confirmed the relation between obesity and mortality. Sjostrom's 
review indicated that studies showing no positive association between BMI and 
mortality had short follow-up or small sample size, or did not account for smoking 
habits. Manson et al. argued that adjustment for hypertension and unfavourable 
lipid levels could lead to underestimation of the effect of obesity on mortality. 
These authors pointed out that high BMI is related to the increased blood pressures 
and unfavourable lipid levels that predispose to increased mortality. When 
analysing the impact of obesity on increased mortality, one should therefore not 
adjust for these intermediates of the BMi-mortality relation in the statistical 
models. Manson et al. also argued that the first five years of mortality should be 
eliminated from such analyses to account for possible weight loss, as a consequence 
of subclinical disease among individuals who died early in the follow-up period. 
Furthermore, as smokers are known to be leaner and to have higher risks of obesity, 
and the risk of death for obesity may differ between smoking categories, the effect 
of obesity on mortality must be calculated across different smoking categories. 
Recent studies reaffirmed high BMI levels as risk factors for all-cause mortality. 
Mortality risk increased for BMI above 27 kg/m in both the Nurses' Health Study 
and the US Health Professionals Follow-Up Study (tables 2.1.2 and 2.1.3). I n these 
studies, the relative risks associated with high BMI are lower for all-cause mortality 
than for disease incidence, i.e., for type 2 diabetes mellitus, myocardial infarction, 
and ischaemic stroke (figures 2.1.3 a n d 2..1.4). 
Stevens et al. showed that relative risks of mortality associated with high BMI were 
lower at older ages. This finding was based on analyses of BMi-mortality relation in 
approximately 62,000 men and 262,000 women who had never smoked and who 
were followed from i960 through 1972. Calle et al. concluded that the relation 
between high BMI and increased mortality was more pronounced in white than in 
black people and was stronger among those who never smoked than among 
smokers. Their analysis was based on follow-up of more than 1 million US men and 
women aged 30 years and over (mean age: 57 years) from 1982 through 1996. 
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Figure 2.1.3 Age-adjusted relative risks by categories of body mass index for different endpoints among US 
women from the Nurses' Health Study2629 
Figure 2.1.4 
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Age-adjusted relative risks by categories of body mass index for different endpoints among US 
men from the Health Professionals Study30"33 
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Table 2.1.2 Characteristics of the Nurses' Health Study on US women as presented in figure 2.1.3 
Outcome Baseline Follow-up Subjects at baseline Cases 
All-cause mortality30 1976 1976-1984 115,195 4,726 
Coronary heart disease31 1976 
Nonfatal myocardial infarction 
Stroke32 1976 
Ischaemic stroke 
Type 2 diabetes mellitus33 1986 
Self-reported 
1976-1992 155,886 
1976-1992 116,759 
1986-1994 43,581 
306 
403 
705 
Table 2.1.3 Characteristics of the Health Professionals Follow-up Study on US men * 
Outcome Baseline Follow-up Subjects at baseline Cases 
All-cause mortality26 1986 1986-1996 39,756 1,972 
Coronary heart disease27" 1986 
Stroke28 1986 
Ischaemic/haemorrhagic 
Type 2 diabetes mellitus29 1986 
Self-reported 
1987-1996° 29,122 
1987-1992= 28,643 
1986-1991 27,983 
420 
(53 fatal) 
118 
302 
a see figure 2.1.4 
b Fatal myocardial infarction, nonfatal myocardial infarction, coronary artery bypass graft, percutaneous 
transluminal coronary angioplasty 
c Participants contributed follow-up time from 1987. 
Obesity and cancer 
The relation between obesity and several types of cancer has been relatively 
neglected in most recent monographs on obesity. The comprehensive review of diet 
and cancer by the American Institute for Cancer Research and World Cancer 
Research Fund (WCRF), however, includes extensive coverage of this topic. The 
incidence of some cancers is related to body size or to BMI. According to the WCRF 
review, evidence relating BMI and cancer is strongest for endometrial cancer (table 
2.1.4). A B M I exceeding 30.0 kg/m is associated with a one and a half to three times 
higher risk of developing endometrial cancer than a BMI between 20 and 25 kg/m . 
The WCRF review classified the relation between high BMI and breast and kidney 
cancer as "probable," with an approximately 1.8-fold higher risk for those with a 
BMI exceeding 27 kg/m2 compared with those having a BMI below 17 kg/m . 
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Table 2.1.4 Relations between obesity and several forms of cancer" 
Tumoursite Evidence 
Endometrium 
Breast (postmenopausal) 
Kidney 
Gallbladder (particularly in women) 
Colon (less consistent for women) 
Thyroid 
Pancreas 
Prostate 
Convincing 
Probable 
Possible 
Insufficient 
None 
Data were adapted from the World Cancer Research Fund and the American Institute for Cancer 
Research." 
There is evidence for a relation between high BMI and colon cancer, less consistent 
for women than for men. Gallbladder cancer is also possibly associated with high 
BMI, particularly among women. The importance of obesity-induced gallstones, 
which are themselves a risk factor for gallbladder cancer, in the association of 
obesity and gallbladder cancer is uncertain. 7 Based on a small number of case-
control studies, little evidence exists for a relation between obesity and cancer of the 
thyroid. There is also a relation between cancer and low BMI, although it is 
probably confounded by smoking and cancer-induced weight loss. Smokers tend to 
be leaner than non-smokers and are at increased risk of cancer. 
Breast cancer risks are often considered separately pre- and postmenopausally. In 
the Nurses' Health Study follow-up from 1986-1994, a relation was found between 
large waist circumference and postmenopausal breast cancer incidence except for 
current and past postmenopausal hormone users. Obesity apparently has a small 
protective effect for premenopausal breast cancer. Some studies reported a positive 
relation between obesity and premenopausal breast cancer. Such findings, however, 
might be explained by weight gain shortly after diagnosis, especially among women 
receiving chemotherapy. Tall women have a greater risk of breast cancer than 
short women, because of the larger number of potential cancer target cells.50 
The American Cancer Society's follow-up study assessed the association of obesity 
with cancer mortality among 750,000 subjects aged over 30 years followed from 
i960 to 1972. Obese men had a 1.33 obese women a 1.55 times higher mortality rate 
from cancer than their normal-weight peers. In this study, overweight was defined 
with the relative weight index, calculated as the individual's body weight divided by 
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the average weight of all respondents in that sex-age group and multiplied by ioo. 
Obesity was defined as a relative weight index over 140, normal weight was defined 
an index of 90-109 or within 10% of group average. Among men, the relative risk of 
obesity was highest for mortality due to cancer in the colon and the prostate. 
Among women, the relative risk was highest for cancer of the endometrium (5 times 
higher risk in obese than in normal-weight women), followed by cancer of the 
gallbladder (3.5 times higher risk), cervix (two times higher risk), ovary (1.6 times 
higher risk), and breast (1.5 times higher risk). Based on five-year follow-up figures 
of 42,000 women from Iowa aged 55-69 years, cancer mortality was twofold among 
those with a waist-hip ratio in the fifth quintile compared to those in the lowest 
quintile. Neoplasms accounted for 50% of deaths in that study. In a 33-year 
follow-up of 3,000 men aged 39-59 years in California, cancer mortality was highest 
in those with a high waist-to-calf obesity index. Cancer mortality accounted for 
31% of all deaths in this cohort.53 
A possible mechanism for the relation between high body weight and cancer, 
discussed in the WCRF, relates to the metabolic abnormalities (metabolic syndrome) 
that result from high BMI levels. 5 This physiological milieu promotes cell growth in 
general and especially that of tumour cells-because of their differential capacity to 
use glucose and because of their up-regulation of receptors for the insulin-like 
growth factor. Increased levels of bioavailable endogenous estrogen in abdominally 
obese women may lead to an increased risk of breast cancer. Stoll argues, in a 
review of this topic, that weight reduction combined with a program of physical 
exercise might reduce both estrogen and insulin concentrations and thereby inhibit 
the development of postmenopausal breast cancer. 
Obesity might also influence cancer detection. Obese women are more reluctant 
than normal-weight women to participate in cervical and breast cancer screening 
programs. Late identification of tumours decreases the chance of therapeutic 
success.57 Also, the presence of abundance of fat complicates mammographic 
screening. Furthermore, underlying lifestyle factors related to obesity may play a 
direct role. Physical activity may promote the access of toxins through the 
gastroenterologic system, which has a relatively protective effect. Exposure time of 
toxins in the gastrointestinal tract is shorter in physically active individuals. Dietary 
practices among obese individuals might predispose to cancer risk. The WCRF panel 
estimated that 30-40% of all cancers are attributable to inappropriate diet, lack of 
physical activity, and high body weight. 
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Obesity and cardiovascular diseases 
Kannel has stated that no risk factor has as strong an impact on the cardiovascular 
risk profile as obesity. Obesity was identified as a risk factor for CVD not long after 
it was identified as a mortality risk factor. Abdominal adiposity in particular is 
associated with CVD risk. Obesity is a risk factor for increased blood pressure and 
unfavourable lipid profile (decreased high-density lipoprotein (HDL) cholesterol 
level and increased low-density lipoprotein cholesterol and triglyceride levels) and, 
as discussed in the next section, for CVD resulting from diabetes. Weight loss has 
been shown to improve blood pressure and lipid levels, at least for the short 
term. Increased blood pressure or unfavourable lipid levels are related to CVD. 
Obesity, however, is also directly related to CVD independent from blood pressure 
and lipid levels. That is, when adjustments are made for blood pressure and 
cholesterol levels, the relation between obesity and CVD is attenuated, but relative 
risks remain high and significant. ' Manson et al. and Shaper et al. argue that it 
may be inappropriate to adjust for blood pressure and cholesterol levels when the 
question is to what extent obesity adversely affects cardiovascular risk profiles, as 
these variables are in the causal chain between obesity and CVD. ',69 The relation of 
low body weight and weight loss with CVD and the confounding effects of smoking 
are other explanations for observations of lower relative risks or absent relations 
between high body weight and CVD. 
Figure 2.1.3 shows that the age-adjusted relative risk for incident coronary heart 
disease (CHD) among men and women was higher than the relative risk of high BMI 
for mortality. US women from the Nurses' Health Study with BMI above 30.0 
kg/m had a threefold risk of developing nonfatal myocardial infarction compared 
to women with a BMI below 21 kg/m (figure 2.1.3). ' Among men in the Health 
Professionals Study, those with a BMI between 29 and 33 kg/m2 had a twofold risk 
and those with BMI higher than 33 kg/m had a threefold risk of developing CHD 
compared to men with a BMI below 23 kg/m2 (figure 2.1.4).27 Among these men and 
women, high BMI was also related to the onset of stroke.28'32 The Nurses' Health 
Study reported that high BMI levels were especially related to the onset of ischaemic 
stroke. Haemorrhagic strokes, which occurred less often than ischaemic strokes, 
seemed to be less common in those with high BMIS compared with those whose 
BMIS were low. Refer to tables 2.1.2 and 2.1.3 f° r characteristics of the Nurses' 
Health Study and Health Professionals Follow-Up Study. 
Framingham data, based on 26 years of follow-up of approximately 5,200 men and 
women aged 28-62 years, showed that high relative weights were predictive of 
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myocardial infarction, sudden death, congestive heart failure, and atherothrombic 
strokes. Myocardial infarction in women over 50 years old and stroke in men over 
50 years old were not excessive in the upper categories of relative weight. It was 
estimated from the Framingham Study that if everyone could be kept at optimal 
weight, there would be 25% less CHD and 35% fewer strokes or episodes of heart 
failure. A 20% weight reduction in the obese should confer a 40% reduced risk of a 
coronary event. The British Regional Heart Study of 7,700 men aged 40-59 years, 
followed for a mean period of 14.8 years, showed that high BMI levels were related to 
incident coronary heart events and, although to a lesser extent, to stroke. 
Obesity and type 2 diabetes mellitus 
Besides being the major risk factor for CVD, obesity, in particular abdominal 
obesity, is the most important risk factor in the onset of type 2 diabetes. In the 
Nurses' Health Study and the Health Professionals Follow-Up Study, it was 
found that compared with the lowest BMI category, risks for developing type 2 
diabetes mellitus were increased more than tenfold among women with BMIS higher 
than 29 kg/m and among men with BMIS larger than 31 kg/m (figures 2.1.3 a n d 
2.1.4). I n addition, being moderately overweight was closely related to the onset of 
type 2 diabetes mellitus. Weight loss of more than 4% during the first five years of 
follow-up showed a 1.5 times reduced risk of developing type 2 diabetes among 
British men aged 40-59 years, followed for a mean period of 16.8 years, compared 
with men with stable weight. Weight loss reduced the risk of type 2 diabetes by a 
factor of around 2.5 compared with those who gained weight more than 10%. 
The WHO has calculated that about 64% of type 2 diabetes in US men and 74% in 
US women could be avoided if there was no BMI above 25 kg/m . ' ' The WHO also 
predicted that the number of diabetics would double from 143 million in 1997 to 
about 300 million in 2025. In Asian countries, the prevalence of type 2 diabetes 
mellitus will increase more rapidly over time than the increase in obesity. King et 
al. calculated that in 2025, India and China, together with the United States, would 
be the countries with the largest numbers of diabetics. 
Concentrations of free fatty acids are excessive in individuals with abdominal 
obesity and amplify insulin resistance. In his Banting Lecture in 1988, Reaven 
suggested a direct relation between plasma insulin concentration and blood 
pressure.75 Thus, he raised the possibility that insulin- stimulated glucose uptake 
and hyperinsulinaemia are involved in the aetiology and clinical course of three 
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major related diseases: type 2 diabetes, hypertension, and coronary artery disease. 
Bjomtorp subsequently described abdominal obesity as an integral part of this 
disease cluster. Ferrannini et al. recognised hyperinsulinaemia as the key feature in 
this clustering of diseases, from their study of 2,930 Mexican-Americans and non-
Hispanic whites from San Antonio, Texas.7 From an analysis of 515 European men 
aged 38 years old, Cigolini et al. argued that obesity and abdominal fat distribution 
were even more correlated than was hyperinsulinaemia to unfavourable risk profiles 
for CVD (increased total cholesterol, decreased HDL cholesterol, decreased HDL 
cholesterol, and high blood pressure levels). 
The clustering within individuals of major cardiovascular risk factors, such as 
abnormal glucose metabolism, an unfavourable lipid profile, hypertension, and 
abdominal obesity were later described as Syndrome X, the Deadly Quartet, and 
the metabolic syndrome. 
Obesity and musculoskeletal disorders 
Obesity is one of the most important preventable risk factors of osteoarthritis in 
knee and hip joints, and osteoarthritis, in turn, is an important risk factor for 
disability. Osteoarthritis is more common among women than among men. The 
relation between being overweight and having osteoarthritis is explained, at least in 
part, by the high joint pressure in overweight individuals. There might also be a 
metabolic explanation, because obesity also seems to be related to incident 
osteoarthritis in the hands.7 A case-control study by Oliveria et al. found odds 
ratios of incident osteoarthritis between 1990 and 1993 of 3.0 and 10.5, respectively, 
for women aged 20-80 years in the highest tertiles of BMI compared to the lowest. 
Associations between obesity and herniated lumbar intervertebral disc, low back 
pain, and chronic neck pain have been suggested. The strength of these 
associations, however, is generally weaker than those for osteoarthritis. In addition, 
the associations have been derived from cross-sectional studies. " Longitudinal 
studies are needed to confirm these associations. 
Obesity and work disability 
In most European countries, in cases of work disability and sick leave, pensions are, 
at least partly, reimbursed. Therefore, data on the relation between obesity and 
work disability come mainly from European studies. In Finland, disability pensions 
were granted 2.0 and 1.5 times more often to obese men and women, respectively, 
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compared with those with low BMIS.' This study was based on a National Survey 
sample of 31,000 Finns who were followed from 1966-1972 until 1982 (figure 2.1.5). 
Of 1,300 obese Swedish women aged 30-59 years, 12% were recorded to have 
disability pensions compared with 5% of the general population, and the obese 
women reported 1.5-1.9 times more sick leave during a one-year period compared 
with the normal Swedish population. 
Obesity is also related to mobility limitations, which affect quality of life 
particularly with ageing. Limitations in daily activities requiring mobility occurred 
twice as often among US women with a mean age of 65 years who were in the 
highest BMI tertile compared to those in the lowest tertile, i.e. approximately 5% 
during the 4-year follow-up. Self-reported onset of difficulties in walking and 
climbing a flight of stairs occurred 2.3 times more often in the obese among a 
population with mainly African Americans and Mexican Americans aged 51-61 
years, with an overall incidence rate of 6% during a two year follow-up. The role 
of musculoskeletal disorders in the causal chain between being overweight and 
having a disability should be further assessed. 
<22.5 22.5-24.9 25.0-27.4 27.5-29.9 30.0-32.4 
body mass index (kg/m2) 
>32.5 
Figure 2.1.5 Relative risk of work disability per category of body mass index in a Finnish population 
Relative risks were adjusted for age, geographical region, smoking habits, and occupation. 
Data were derived from Rissanen ef a/." 
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Obesity and respiratory disorders 
During the past decade, the role of excess fat became known as an obesity-related 
public health problem because of its link with shortness of breath and sleep apnoea. 
Based on a sample of Dutch adults aged 20-59 years, the odds ratios for shortness of 
breath when walking upstairs in those with a BMI of 30 kg/m or higher compared 
with those with BMIS below 25 kg/m was 3.5 in men and 3.3 in women. 
Furthermore, obese patients are more likely to suffer from obstructive sleep apnoea 
syndrome and concurrent psychosocial morbidity. Based on their random sample of 
602 employed US men and women aged 30-60 years, Young et al. estimated that 
sleep-disordered breathing was around four times more common when BMI was 5 
kg/m higher. The role of bearing weight or body fat on different parts of the body 
on the lung function is indicated by comparing odds ratios for sleep-disordered 
breathing for smaller versus larger girths at different parts of the body. Comparing 
odds of girths of neck, waist, and hip, Young et al. found that odds ratio for sleep-
disordered breathing was lowest for a large hip girth and highest for a large neck 
girth. Hypoventilation during sleep leads to nocturnal hypoxia during sleep and 
extreme sleepiness during the day. It could well be that sleep apnoea promotes 
weight gain and prevents weight loss because of visceral fat-related hormone 
disturbances. Obesity-induced sleep apnoea is an important risk factor for 
psychosocial morbidity and seems associated with some of the components of the 
metabolic syndrome. Young et al. estimated that the sleep apnoea syndrome was 
present in 2% of women and 4% of men.8 
Obesity among the elderly 
The elderly represent a particularly important age category with respect to the 
public health. This age group is increasing in magnitude in industrialised societies 
and in nonindustrialised societies because of the increased life expectancy associated 
with improved standards of living. BMI levels increase with ageing until age 60-70 
years, after which BMI decreases. 
Changes in body composition with ageing imply a change in the relation between 
BMI and fatness and the relation between BMI and mortality may change 
concurrently. It is unclear whether the BMI is the most appropriate measurement 
of body weight for the elderly, because muscle mass usually decreases with aging. 
Molarius et al. found promising results for the use of the waist circumference alone 
in a cross-sectional study on a population aged 55 years and older from Rotterdam, 
the Netherlands. High levels of waist circumference indicated a worsened 
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cardiovascular risk profile in this population. Which measurements of obesity are 
most appropriate and informative in the elderly population needs clarification. 
Relative risks of mortality for obesity are reported to be lower in elderly populations 
than in younger populations. ' Absolute incidence rates of morbidity and 
disability, however, are higher among the elderly than in younger populations. 
Small relative increases in morbidity and disability due to obesity will thus have a 
higher impact in elderly than in younger populations. In addition, living without 
disability is highly important for functioning and quality of life in ageing. 
Discussion 
Obesity is related to all-cause mortality and cancer and, even more strongly, to the 
onset of type 2 diabetes, CVD musculoskeletal disorders, work disability, and sleep 
apnoea. Many of the preceding comparisons of relative risks for mortality, coronary 
heart disease, stroke, and diabetes were adjusted for age only, and combined never-
smokers and smokers. Such comparisons, although not appropriate for more 
specific purposes, suffice to provide a general impression of the impact of obesity 
across a spectrum of conditions. 
As noted previously, the direct and indirect costs of obesity are estimated at 7% of 
the total health care costs in the United States and at around i%-5% in Europe. 
These estimates are based on prevalence rates and relative risks. Because of its closer 
relation to morbidity and disability than mortality, obesity will increase the number 
of unhealthy life years enormously. Oster et al. calculated that weight loss of about 
10% of initial body weight would reduce the number of life years with hypertension 
by 1.2-2.9 years, and type 2 diabetes mellitus by 0.5-1.7 years. Life expectancy would 
be increased by two to seven months. Again, these estimates are based on 
calculations using relative risks for the specific outcomes. Empirical data on the 
number of years obese persons suffer more than normal weight persons from 
morbidity and disability have yet to be published. Nevertheless, it is clear that the 
public health impact of obesity is enormous and will increase rapidly with each 
percentage point increase in the prevalence of obesity. Public health programs 
should include in their targets goals for reducing the obesity epidemic. Countries 
such as China and India are of particular importance in the obesity epidemic. In 
these countries, every percentage point increase in obesity prevalence involves 20 
million more obese people. 
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The increasing obesity epidemic points to the urgent need for strategies to develop 
multifaceted global and national plans for adequate prevention and management of 
obesity. A reduction in obesity is among the National Health Promotion and 
Disease Prevention Objectives in the USA. In Europe, England has set goals for 
reducing obesity. Such targets, however, are lacking in most European countries. 
Based on a study of persons aged 20-72 years, who were followed for six years, 
Russell et al. concluded that prevention of weight gain would be more successful 
than treatment of people who are already obese. The International Task Force on 
Obesity, a work group of the WHO, points to several possibilities for implementing 
prevention programs. Unfortunately, however, the few weight gain prevention 
programs reported to date have not been very successful. Swinburn et al. describe 
the societal elements that influence food intake and physical activity as the 
"obesogenic" environment. Intervention programs should take these factors into 
account. New programs should change the prevalence of obesity during the long 
run by minimal changes in the energy balance. 
CONCLUSION 
The impact of obesity on morbidity and disability is higher than its impact on 
mortality. Therefore, each increase in obesity prevalence will increase obesity-
related disability, not only in industrialised countries but also, on a very large scale, 
in industrialising countries. Weight gain prevention programs should be high on 
the scientific and political agendas. 
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Chapter 3.1 
LONG-TERM AND RECENT TIME TRENDS IN THE 
PREVALENCE OF OBESITY AMONG DUTCH MEN AND 
WOMEN 
A b s t r a c t In this chapter the long-term and recent time trends in the prevalence of obesity by 
age and educational level are described. For this purpose data were used from repeated cross-
sectional population based monitoring studies: the Consultation Bureau Heart Project was carried 
out between 1976-1980, the Monitoring Project on Cardiovascular Diseases between 1987-1991, 
and the Monitoring project on risk factors for chronic diseases (MORGEN) project between 1993-
1997. Between 1976 and 1997, 29,141 men and women aged 37 to 43 years have been measured. 
Between 1993 and 1997, data were also available from 21,926 men and women aged 20 to 59 years. 
Body mass index was calculated as weight divided by height squared (kg/m ). Between 1976 and 
1997 the prevalence of obesity increased from 4.9 to 8.5% among men and from 6.2 to 9.3% 
among women aged 37-43 years. Between 1993 and 1997, the prevalence of obesity among men 
aged 20-59 years was 8.5% and increased with 0.54 percentage points per year (jxo.oi). The 
prevalence of obesity among women was 9.6% and increased with 0.35 percentage points per year 
(p=o.oj). The increase in the prevalence of obesity in the period 1993-1997 was strongest in men 
with a relatively low educational level and in women with a high educational level. It is concluded 
that there has been a steady increase in the prevalence of obesity in the last quarter of the 20' 
century. In addition, a recent increase in the prevalence of obesity has been seen. To stop the 
increase in the prevalence of obesity, effective strategies for the management and prevention of 
obesity need to be developed. 
Tommy LS Visscher, Daan Kromhout, and Jacob C Seidell. Submitted for publication. 
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Introduction 
Obesity is an important contributor to several chronic diseases and disabilities. ' 
Obesity-related costs have been estimated at about seven percent of the total health 
care expenditure in the US and at one to five percent in Europe. Such calculations 
are usually based on fractions of chronic diseases such as type 2 diabetes mellitus 
and cardiovascular diseases and disabilities that are attributable to obesity. These 
'population attributable fractions' estimations depend on relative risks of obesity for 
different diseases and disabilities and also on the prevalence of obesity. Therefore, 
it is important to study time trends in the prevalence of obesity. 
Time trend data on obesity prevalence rates are also needed to identify specific 
categories in which the prevalence is exceptionally high or to recognise categories in 
which strong increases in the prevalence of obesity are observed. Weight gain 
prevention programs could aim at these high-risk categories. ' In western societies 
obesity is most common among those with relatively low education. In order to 
study increases in the level of body mass index (BMI) across educational levels, 
Molarius et al. analysed data from 42,000 men and women measured in the period 
1979-1989, and from 35,000 men and women measured in the period 1989-1996. 
Data were used from 26 centres participating in the WHO-MONICA project. They 
reported that the difference in BMI levels between high and low educational 
categories generally increased, because BMI levels increased more in low than in high 
educational categories. 
In the Netherlands the long-term time trend of overweight and obesity between 
1976 and 1997 was assessed among men and women aged 37-43 years in repeated 
cross-sectional population based samples. Recent time trends in the prevalence of 
obesity in the period 1993-1997 were assessed in sex, age- and educational categories, 
among subjects aged 20-59 years. 
Methods 
STUDY POPULATIONS 
Long-term trend 
We studied long-term time trends in the prevalence of overweight and obesity 
using original data from three monitoring projects on risk factors for chronic 
diseases from the National Institute of Public Health and the Environment, 
Bilthoven, the Netherlands. To allow comparisons of prevalence rates between 
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different periods, original data were used from subjects aged 37-43 years who 
participated in one of the three monitoring studies. The Consultation Bureau 
Heart Project was carried out in the period 1976-1980. The Monitoring Project on 
Cardiovascular Diseases was carried out in 1987-1991. The subsequent Monitoring 
project on risk factors for chronic diseases (MORGEN) project was carried out in 
1993-1997. All three monitoring projects were carried out in the same three 
municipal health centres in the towns of Amsterdam, Doetinchem, and Maastricht. 
Data on the Consultation Bureau Heart Project and the Monitoring Project on 
Cardiovascular Diseases have been reported earlier by Blokstra and Kromhout and 
Seidell et al.n Data on the period 1981-1986, also described by Blokstra and 
Kromhout,10 were not used for the present study, because data were only available 
from men aged younger than 37 years. Response rates in different towns and years 
of the Consultation Bureau Heart Project varied between 70 and 80%. Response 
rate of the Monitoring Project on Cardiovascular Diseases was 50% in men and 
57% in women. Response rate of MORGEN project varied between 40 and 51% 
between 1993 and 1997. Data on 13,779 m e n an<A x5>362 women were used for the 
long-term time trend analyses. 
Recent trends 
We studied recent time trends in the prevalence of overweight and obesity using 
data of the MORGEN project on men and women aged 20-59 years who visited the 
municipal health centres between 1993 and 1997. We excluded 142 women who 
were pregnant. Data on educational level was missing in 164 subjects and 55 subjects 
had missing data regarding smoking status. Data on body weight and height were 
available from 9,981 men and 11,945 women. 
MEASUREMENTS 
Body weight and height were measured with participants wearing light indoor 
clothing without shoes, with emptied pockets, by trained staff.1 Body weight was 
measured to the nearest 100 g on calibrated scales. To adjust for the weight of 
clothing, 1 kg was subtracted from body weight. BMI was calculated as weight 
divided by height squared in kg/m2. Overweight was considered as BMI 25.0-29.9 
kg/m2, and obesity as BMI >30.o kg/m2. For the period 1993-1997 level of education 
was measured as the highest level reached and categorised in five groups: primary 
school, junior (vocational) education, secondary (vocational) education, vocational 
colleges, university. Subjects were classified as never, ex-, or current smokers. 
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STATISTICAL ANALYSIS 
Mean values and prevalence rates regarding the age-range 20 to 59 years were 
standardised to the five-years age-distribution in the Netherlands in the year 1995. 
Linear trends per year and ^-values for trend were calculated by generalised linear 
models (procedure GLM, SAS version 6.12), with and without adjustment for five-
years age-categories, educational level, and town. 
Results 
Long-term trend 
During the period 1976-1997, mean BMI and the prevalence of overweight were 
higher among men than among women aged 37-43 years. The prevalence of obesity 
was slightly higher among women (table 3.1.1). Between 1976 and 1997, mean BMI 
and the prevalence of obesity increased steadily from 4.9 to 8.5% in men and from 
6.2 to 9.3% in women aged 37-43 years. The overweight prevalence did not increase 
clearly between 1976 and 1997. Body height increased about 3-4 cm and weight by 
about 5 kg in men and over 3 kg in women. High quintiles of the BMI distribution 
increased more strongly than the lower during the long term between 1976 and 
1997 among men and women aged 37 to 43 years (figure 3.1.1). 
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Figure 3.1.1 Long-term time trend of the body mass index distribution in the Netherlands among men and 
women aged 37-43 years 
Data from the Consultation Bureau Heart Project 1976-1980,'° the Monitoring Project on 
Cardiovascular Diseases 1987-1991,"and the MORGEN project 1993-1997. 
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Table 3.1.1 Mean values of height, weight, and body mass index and prevalence of overweight and 
obesity among Dutch men and women aged 37-43 years 
Number of subjects 
Mean body height (m) 
Mean body weight (kg) 
Mean body mass index (kg/m2) 
Overweight (%); 
BMI 25.0-29.9 kg/m2 
Obesity (%); 
BMI >30.0 kg/m2 
Men 
Women 
Men 
Women 
Men 
Women 
Men 
Women 
Men 
Women 
Men 
Women 
1976-1980" 
8,086 
8,922 
1.75 
1.63 
76.1 
63.8 
24.7 
23.9 
38.3 
24.6 
4.9 
6.2 
1987-1991" 
3,588 
3,922 
1.78 
1.65 
79.7 
65.6 
25.2 
24.1 
41.5 
23.9 
7.4 
7.6 
1993-1997° 
2,105 
2,518 
1.79 
1.66 
81.0 
67.1 
25.2 
24.4 
40.2 
25.0 
8.5 
9.3 
a Original data of the Consultation Bureau Heart Project10 
b Original data of the Monitoring Project on Cardiovascular Diseases" 
c Original data of the Monitoring project on risk factors for chronic diseases (MORGEN-) project 
Recent trend 
During the period 1993-1997, mean height, weight, and BMI and the prevalence of 
overweight were higher among men than among women aged 20-59 years. Obesity 
was more common among women than among men (table 3.1.2). The increase in 
the prevalence of obesity was strongest in men between 1993 and 1997. The 
prevalence of overweight decreased among men and increased among women 
between aged 20-59 years, although these trends were not statistically significant. 
Increases in BMI levels and the prevalence of obesity were strongest if adjustment for 
educational level was made. 
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Table 3.1.3 
Age (years) 
Men 
20-29 
30-39 
40-49 
50-59 
Women 
20-29 
30-39 
40-49 
50-59 
Prevalence of obesity (body mass index >30 kg/m2) in 1993-1997 and increase in the 
prevalence of obesity during this period in percentage points per year according to age-
category 
Number 
1,581 
2,374 
3,083 
2,943 
2,191 
2,826 
3,695 
3,233 
Prevalence 
1993-1997 (%) 
4.4 
6.7 
10.5 
14.7 
5.4 
7.4 
11.1 
17.0 
Increase per year" 
(%-points per year) 
0.35 
0.48 
-0.38 
1.67 
0.33 
0.70 
0.09 
0.50 
(95%-confidence 
interval) 
(-0.40-1.09) 
(-0.23-1.19) 
(-1.14-0.38) 
(0.75-2.59) 
(-0.35-1.02) 
(0.04-1.36) 
(-0.60-0.79) 
(-0.40-1.39) 
adjusted for educational category and town 
The prevalence of obesity increased with age (table 3.1.3). A slight increase in the 
prevalence of obesity between 1993 and 1997 was seen in most age-categories. The 
increase in the prevalence of obesity was particularly strong in men aged 50-59 years 
and relatively strong in women aged 30-39 years. 
The prevalence of obesity was more than three times higher among men with a low 
educational level compared to men with a high educational level (table 3.1.4). 
Among women, the prevalence of obesity was more than five times higher among 
those with low education than among women with high education. A significant 
increase in the prevalence of obesity was observed in men with a relatively low 
educational level and in women with a high educational level. 
Obesity was more prevalent among never smokers than among current smokers 
(table 3.1.5). The increase in the prevalence of obesity was observed in all smoking-
categories and was largest among never smokers. 
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Table 3.1.4 Prevalence of obesity (body mass index >30 kg/m2) in 1993-1997 and increase in the 
prevalence of obesity during this period in percentage points per year according to 
educational category 
Educational level 
Men 
Primary school 
Junior (vocational) 
school 
Secondary 
(vocational) school 
Vocational colleges 
University 
Women 
Primary school 
Junior (vocational) 
school 
Secondary 
(vocational) school 
Vocational colleges 
University 
Number 
1,089 
2,249 
986 
2,939 
2,655 
1,446 
2,758 
1,998 
3,103 
2,539 
Prevalence" 
1993-1997 (%) 
15.4 
11.4 
9.9 
7.1 
4.7 
17.8 
13.7 
10.1 
7.1 
3.4 
Increase per year" 
(%-points per year) 
1.70 
1.29 
1.04 
0.33 
-0.48 
-0.36 
0.23 
0.08 
0.82 
0.66 
(95%-confidence 
interval) 
(0.08-3.32) 
(0.29-2.30) 
(-0.42-2.49) 
(-0.34-1.01) 
(-1.08-0.12) 
(-1.79-1.08) 
(-0.72-1.17) 
(-0.90-1.06) 
(0.21-1.43) 
(0.15-1.16) 
standardised to the five-years age-distribution in the Netherlands 
adjusted for five-years age-distribution and town 
Discussion 
The prevalence of obesity increased during the last quarter of the previous century 
in the Netherlands. Between 1976 and 1997, the prevalence of obesity increased 
from 4.9 to 8.5% among men and from 6.2 to 9.3% among women aged 37-43 
years. During the recent years 1993-1997, the prevalence of obesity continued to 
increase in the Netherlands. Between 1993 and 1997, the prevalence of obesity was 
8.5% and increased with 0.54 percentage points per year among men aged 20-59 
years. The prevalence of obesity among women aged 20-59 years was 9.6% and 
increased with 0.35 percentage points per year during the period 1993-1997. An 
increase in the prevalence of obesity was found in nearly all age-categories, and was 
exceptionally strong in men aged 50-59 years. The increase in the prevalence of 
obesity was largest in men with a relatively low educational level and in women 
with a high educational level. An increase in the prevalence of obesity was noted 
within all smoking categories and was largest among never smokers. 
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Table 3.1.5 Prevalence of obesity (body mass index >30 kg/m2) in 1993-1997 and increase in the 
prevalence of obesity during this period in percentage points per year according to 
smoking status 
Men 
Current smokers 
Ex-smokers 
Never smokers 
Women 
Current smokers 
Ex-smokers 
Never smokers 
Number 
3,662 
3,221 
3,065 
4,388 
3,113 
4,422 
Prevalence" 
1993-1997 (%) 
7.7 
9.9 
8.3 
8.4 
9.0 
11.1 
Increase 
(%-points 
0.50 
0.45 
0.74 
0.24 
0.37 
0.48 
>er 
pe 
year" 
r year) 
(95%-confidence 
interval) 
(-0.15-1.14) 
(-0.36-1.26) 
(0.04-1.44) 
(-0.36-0.84) 
(-0.39-1.13) 
(-0.16-1.13) 
standardised to the five-years age-distribution in the Netherlands 
adjusted for five-years age-distribution, educational category and town 
Relatively few countries have monitoring systems that allow comparisons of long-
term time trends based on measured body weight and height obtained from 
representative study populations. ' ' These studies also show strong increases in 
the prevalence of obesity. During the last quarter of the previous century, the 
prevalence of obesity in the Netherlands has been lower than in the United States, 
England, and Germany (table 3.1.6). " Data from the National Health and 
Nutrition Examination Survey (NHANES) I and NHANES HI1 showed a strong 
increase in the prevalence of obesity in the United States between 1971 and 1994. In 
the United Kingdom an even more rapid increase in the prevalence of obesity 
between 1980 and 1997 has been reported, although the prevalence of obesity seems 
still lower in the United Kingdom than in the United States.2 German data were 
available from the German National Health Interview and Examination Survey. 
The prevalence of obesity was higher in 1998 than in 1990-1992 in men and women 
aged 25-69 years. The WHO-MONICA project reported time trend data taken from 
surveys in towns or regions across Europe, in men and women aged 35-64 years who 
were measured in the periods 1979-1989 and 1989-1996. An increase was seen in the 
prevalence of obesity in most centres . Although the WHO-MONICA study does not 
yield national prevalences and time trends, it can be tentatively concluded that 
prevalences of obesity vary widely, especially in women, with the highest 
prevalences in women from eastern and central Europe and the Mediterranean 
region. The recent prevalence of obesity in the Netherlands seems comparable to 
that in Scandinavian countries and France.' 
Table 3.1.6 Prevalence of obesity (body mass index 230 kg/m2) in the United States, England, Germany, 
and the Netherlands 
Study population Country Period Age (years) 
Prevalence (%) 
Men Women 
NHANES f " 
NHANES II I "" 
Health Survey for England'2 
Health Survey for England12 
German National Health 
Interview and Examination 
Survey15 
German National Health 
Interview and Examination 
Survey15 
CB Heart Project" 
MORGEN* 
MORGEN0 
The United States 
The United States 
England 
England 
Germany, East 
Germany, East 
Germany, West 
Germany, West 
The Netherlands 
The Netherlands 
The Netherlands 
1971-1974 
1988-1994 
1980 
1998 
1990-1992 
1998 
1990-1992 
1998 
1976-1980 
1993-1997 
1993-1997 
20-74 
20-74 
16-64 
16-64 
25-69 
25-69 
25-69 
25-69 
37-43 
37-43 
20-59 
11.8 
20.0 
6 
17 
20.6 
21.8 
17.4 
19.4 
16.2 
24.9 
8 
22 
25.8 
24.2 
19.6 
20.9 
4.9 
8.5 
8.5 
6.2 
9.3 
9.6 
a National Health and Nutrition Examination Survey 
b Present Consultation bureau heart project 
c Present Monitoring project on risk factors for chronic diseases project 
In the present study, the centiles above the median level of the BMI distribution 
increased clearly between 1976 and 1997, while the increase in the lower centiles was 
less pronounced. Consequently, the increase in the prevalence of obesity (BMI >30 .O 
kg/m) was stronger than the increase in overweight (BMI 25.0-29.9 kg/m2). The 
observation that the skewness of the BMi-distribution shifted to the left has been 
reported earlier by Thomsen et al, who studied the increase of BMI levels among 
children, aged 7 to 13 years from Copenhagen, Denmark.18 Because the lower 
centiles of the BMI distribution also increased, although slightly, Thomsen et al. 
concluded that some environmental changes are influencing the entire population, 
but others mainly a subgroup in the population that is especially susceptible for 
obesity. We deduce from the steeper increase of high centiles that subjects who 
already gained weight, for instance those who are overweight, are at high risk to 
gain even more weight. Therefore, prevention of weight gain is important in all 
people but especially in those already overweight. 
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The prevalence of obesity increased in nearly all age-categories between 20 and 59 
years, although not statistically significant in most age-categories, and was 
exceptionally high in men aged 50-59 years. We expect that the prevalence of 
obesity will increase probably more strongly in the coming decades, because an 
increase in BMI levels among Dutch boys and girls aged 0-21 years has been reported 
during the last two decades that was stronger than that in the adults in the present 
study.1 Particular attention is warranted for the increase in BMI levels at already 
young age. Many obese children are likely to become obese adults. Moreover, 
duration of obesity is among the determinants of health consequences of obesity. 
Between 1993 and 1997, the increase in obesity was strongest among men with a 
relatively low educational level and among women with a high educational level. 
The prevalence of obesity decreased among men with a high educational level and 
among women with a low educational level, although not statistically significant. 
An increase in the prevalence of obesity among those with a high educational level 
has also been reported by Mokdad et al. based on self-reported data from the US. 
They reported that men and women with relatively high educational level showed a 
larger increase in the prevalence of obesity between 1991 and 1998 than those with a 
lower educational level, although the prevalence of obesity remained inversely 
associated with educational level. Studies that are less recent than Mokdad's study 
concluded that the increase in the prevalence of obesity has been generally strongest 
in individuals with low educational level or low socio-economic status. 
Concurrently, the difference in the prevalence of obesity increased between subjects 
with low and high socio-economic status.' Also in the Netherlands, the prevalence 
of obesity is still highest among lowly educated men and women. If the increase in 
the prevalence of obesity among highly educated individuals is confirmed in other 
studies, these subjects will also become a target for intervention programs. 
Across smoking categories, the prevalence of obesity increased most strongly among 
never smokers. We presented data for all smoking categories separately, as changing 
smoking behaviour could affect BMI levels since smoking cessation is associated with 
weight gain. Among smokers, body weight depends on the amount of cigarettes 
smoked and the time since quitting smoking. It could be questioned how much of 
quitting smoking is contributing to the increase in the prevalence of overweight and 
obesity. Williamson et al. reported from the first National Health and Nutrition 
Examination Survey (NHANES I) that quitting smoking was associated with more 
than 13 kg increase in about 10% of persons who quitted smoking and were 
followed between 1971 and 1984. The average person who quits smoking, however, 
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will gain 2-4 kilograms. At the end of their study the mean body weight of persons 
who quitted smoking had increased to average body weight as persons who never 
smoked. Flegal et al. quantified the part of the noted increase in the prevalence of 
overweight that could be due to quitting smoking. In their study weight increased 
also largely in a part of the persons who quitted smoking during the last ten years, 
but this group was small and contributed only slightly to the increase in the 
prevalence of overweight. About a quarter (2.3 of the 9.6 percentage points) in men 
and about a sixth (1.3 of the 9.6 percentage points) increase in the prevalence of 
overweight was due to quitting smoking. Boyle et al. concluded earlier that the 
increase in obesity in Australia could not be explained by decreasing rates of 
cigarette smokers, since they found similar increases in obesity among never 
smokers, ex-smokers and current smokers. 
Among the advantages of our monitoring projects are the anthropometric data 
collection by trained staff and the time-span that was covered. Self-reports on body 
weight would have lead to underestimation, especially among those who are 
obese. ' As data were collected throughout the year, seasonal variation in body 
weight could not affect the prevalence estimations. Among the disadvantages is 
that the three towns in which measurements were performed may not be nationally 
representative. Another disadvantage of the present study is the decreasing response 
rate over time. Highly educated men and women were over-represented in the 
MORGEN project 1993-1997. The higher educational level of the examined 
population in most recent years, may explain why increases in the prevalence of 
obesity became stronger after adjustment for educational level. The somehow 
selective participation did not seem to affect the adjusted time-trend estimations, as 
the Central Bureau for Statistics, with a much higher response rate, but based on 
self-reported body weight and height, estimated a similar time trend in the 
prevalence of obesity between 1993 and 1997 as the present study.3 
CONCLUSION 
The increase in the prevalence of obesity reported in western societies is also seen in 
recent years in the Netherlands. The strongest increase in the prevalence of obesity 
was noticed in men with a relatively low educational level and in women with a 
high educational level. The increasing prevalence of obesity is a threat for the public 
health as it is related to several chronic morbidity and disability. In order to stop 
this burden of disease and disability, implementation of new weight gain 
prevention programs is urgently needed. 
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Chapter 3.2 
SEASONAL VARIATION IN WAIST CIRCUMFERENCE IS 
LARGER THAN THAT IN BODY MASS INDEX 
A b s t r a c t In this chapter, the time trend and seasonal variation in body mass index and waist 
circumference are compared. Data were derived from a continuous monitoring health survey 
(spring 1993-autumn 1997) that was carried out in three towns in the Netherlands. A total of 9,571 
men and 11,382 women aged 20 to 59 years participated. The time trend in abdominal obesity, 
measured by levels of waist circumference, was stronger than the time trend in general obesity, 
measured by levels of body mass index. Moreover, the seasonal variation in waist circumference 
was larger than the seasonal variation in body mass index. It is concluded that surveys on waist 
circumference are only comparable if season is taken into account. Furthermore, the waist 
circumference may be more sensitive than the body mass index to detect changes in the energy 
balance and body composition. 
Tommy LS Visscher and Jacob C Seidell. Submitted for publication. 
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Introduction 
Increases in the prevalence of obesity are widely reported. Weight gain is the result 
of a positive energy balance. Disruptions of energy balance are often reported to 
occur during holidays or the festive season. Yanovski et al. reported that subjects 
gained weight during the December holiday between Thanksgiving and New Year's 
Eve. We hypothesise that waist circumference is more sensitive to seasonal 
variation in energy balance than is body mass index. 
Methods 
STUDY POPULATION 
Between spring 1993 and autumn 1997, the population based Monitoring Project 
on Risk Factors for Chronic Diseases was carried out to study levels of risk factors 
for chronic diseases in the Dutch population. 
A total of 9,571 men and 11,382 women aged 20-59 years from the towns of 
Amsterdam, Doetinchem and Maastricht, the Netherlands were measured. 
Participation rate was 45%. 
MEASUREMENTS 
Body weight and height were measured with participants wearing light indoor 
clothing without shoes and with empty pockets, by trained staff at a visit to the 
municipal health centre. Body weight was measured to the nearest 100 g on 
calibrated scales. To adjust for the weight of clothing, one kilogram was subtracted 
from the measured weight. Body mass index was calculated as weight divided by 
height squared (kg/m). Waist circumference was measured at the level midway 
between the lower rib margin and the iliac crest, with participants in standing 
position and breathing out gently. We defined general obesity as body mass index 
>30 kg/m according to the World Health Organization guidelines.1 Abdominal 
obesity was defined as waist circumference >IO2 cm for men and >88 cm for women 
according to the action levels as suggested by Lean et al? Winter was defined as 
December-January-February. Subsequently, spring was defined as March-April-
May, summer as June-July-August, and autumn as September-October-November. 
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Table 3.2.1 Body mass index and waist circumference" (95%-confidence interval) per season between 
March 1993 and November 1997. 
Men, n=9,571 
Spring Summer Autumn Winter p-value" 
Body mass index, kg/m2 25.4 25.2 25.3 25.4 0.02 
(25.3-25.6) (25.0-25.3) (25.2-25.4) (25.3-25.6) 
Waist circumference, cm 91.8 90.9 91.5 91.9 <0.01 
(91.4-92.2) (90.5-91.3) (91.1-91.9) (91.4-92.3) 
Prevalence of obesity (%) 10.8 9.8 9.6 10.7 0.32 
[BMI >30 kg/m2] (9.6-11.9) (8.6-11.0) (8.5-10.8) (9.4-12.1) 
Prevalence of abdominal obesity 18.5 16.1 17.6 19.3 <0.01 
(%) [waist circumference >102 cm] (17.0-20.0) (14.6-17.6) (16.1-19.1) (17.5-21.0) 
Women, n=11,382 
Body mass index, kg/m2 24.7 24.6 24.8 24.8 0.03 
(24.6-24.8) (24.4-24.7) (24.6-24.9) (24.6-25.0) 
Waist circumference, cm 80.8 80.4 81.0 81.3 <0.01 
(80.4-81.2) (80.0-80.8) (80.6-81.4) (80.8-81.7) 
Prevalence of obesity (%) 10.6 10.8 11.2 11.9 0.20 
[BMI >30 kg/m2] (9.5-11.6) (9.7-11.9) (10.1-12.3) (10.6-13.1) 
Prevalence of Abdominal obesity 23.0 22.2 24.9 25.5 <0.01 
(%) [waist circumference >88 cm] (21.5-24.4) (20.7-23.7) (23.4-26.3) (23.8-27.2) 
Figures are mean values unless otherwise specified 
a Adjustments were made for monthly changes between spring 1993 and autumn 1997, five-years age-
categories and level of education, 
b P-value for difference between summer and winter 
STATISTICAL ANALYSIS 
Mean values and prevalence rates were calculated per season, adjusting for five-years 
age-categories, level of education and for the general monthly changes between 1993 
and 1997. In addition, the prevalence of general and abdominal obesity was 
calculated across consecutive seasons, adjusting for five-years age-categories and 
level of education (proc GLM, SAS-version 6.12). 
Results 
Both mean body mass index and mean waist circumference were higher in winter 
than in summer for both men and women, and the seasonal difference in waist 
circumference was considerably larger than the seasonal difference in body mass 
index (table 3.2.1). Also, prevalence of general and abdominal obesity was higher in 
winter than in summer among men and women, and the seasonal difference was 
largest for abdominal obesity. Between 1993 and 1997, obesity prevalence increased 
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'93 '94 '95 '96 '97 
waist > action level 2 
body mass index > 30 kg/m2 
'93 '94 '95 '96 '97 
g summer 
O winter 
Figure 3.2.1 Prevalence of obesity (body mass index >30 kg/m2) and abdominal obesity (waist 
circumference Saction level 2") over seasons" 
a Action level 2 is defined as 102 cm among men and 88 cm among women 
b Adjusted for age-category and educational level 
with 0.57 percentage points per year (/KO.OO) among men and with 0.34 percentage 
points per year (/>=o.io) among women. Prevalence of abdominal obesity increased 
with 0.70 percentage points per year (p=o.oi) among men and with 1.33 percentage 
points per year (jxo.oi) among women. Moreover, increases during the winter 
seasons and decreases during summer seasons were most clearly seen for abdominal 
obesity, especially among women (figure 3.2.1). 
Discussion 
We suggest that the time trend changes in energy balance and the seasonal variation 
in energy balance be best reflected by changes in waist circumference. Both changes 
in food intake and in physical activity influence waist circumference. There is no 
evidence that changes in food intake have a different impact on waist circumference 
and body mass index. Changes in physical activity, however, may lead to changes in 
body composition (increase in muscle mass, decrease in fat mass), and thus to a 
decreasing waist circumference, but stable body weight, and thus stable body mass 
index. 
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Measuring waist circumference has been recommended earlier as a useful tool for 
health promotion since the measurement of waist circumference is informative, 
easy, cheap, and reliable. Han et al. showed that a large waist circumference was 
clearly predictive of unfavourable levels of cardiovascular disease risk factors based 
on the same study population as used for the present study. 
CONCLUSION 
The strong seasonal variation in waist circumference should be taken into account 
in the case of planning epidemiological surveys or time trend analyses. In addition, 
the more pronounced seasonal changes in waist circumference compared to body 
mass index changes suggest that waist circumference is a more sensitive indicator of 
variations in lifestyle and body composition. Therefore, in reaction to Little's and 
Byrne's editorial, we suggest that it is now time to implement measuring of waist 
circumference in the routine screening of changes in lifestyle and body 
composition. 
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Chapter 4.1 
UNDERWEIGHT AND OVERWEIGHT IN RELATION TO 
MORTALITY AMONG MEN AGED 40-59 AND 50-69 YEARS. 
THE SEVEN COUNTRIES STUDY 
A b s t r a c t This study investigated the relation between body mass index (BMI) and the all-cause 
mortality rate among 7,985 European men. Starting around i960, when all men were aged 40-59 
years, mortality was followed for 15 years (1960-1975); starting around 1970, the survivors were 
followed for an additional 15 years (1970-1985). For the first and second follow-up periods, a BMI 
of 18.5-24.9 kg/m around i960 and 1970, respectively, was considered the reference category. The 
authors found that the hazard ratio (HR) of mortality for a BMI of <i8.5 kg/m was 2.1 (95% 
confidence interval (ci): 1.5-2.8) for the first follow-up period and 1.7 (95% ci: 1.3-2.2) for the 
second. A BMI 25.0-29.9 kg/m2 was not related to increased mortality. Among never smokers, the 
HRS for a BMI >30.O kg/m was 1.8 (95% ci: 1.2-2.8) for the 1960-1975 follow-up period and 1.4 
(95% ci: 1.0-1.9) f° r the 1970-1985 follow-up period. A BMI of >30.o kg/m was not related to 
increased mortality among current smokers. When mortality was followed for more than 15 years, 
the HR for a BMI <I8.5 kg/m2 declined and the HR for a BMI of >30.o kg/m did not change. 
Underweight among those in all smoking categories and severe overweight in never smokers 
remained predictors of increased mortality when middle-aged men became older. 
Tommy LS Visscher, Jacob C Seidell, Allesandro Menotti, Henry Blackburn, Aulikki Nissinen, 
Edith JM Feskens, and Daan Kromhout for the Seven Countries Study Research Group. Am J 
Epidemiol 2000; 151: 660-6. 
63 
Introduction 
The effect of both high and low body mass index (BMI) on the mortality rate has 
been assessed in several large prospective cohort studies." The U- or J-shaped 
relation between BMI and the all-cause mortality rate among adult men is well 
established,' although its interpretation is still under debate. 
Average BMI increases until age 65 years and then declines. Changes in BMI are 
explained by the decrease in stature and by changes in body composition that occur 
with ageing. Most studies also report a decline in the risk ratio of all-cause 
mortality for overweight with ageing and conclude that overweight is less important 
as a risk factor for mortality in the elderly than in younger populations. 
Lower risk ratios have been explained by selective survival and a higher mortality 
rate among older people. Declines in risk ratios, however, may also be explained by 
confounding due to a cohort effect. When compared with cohorts of younger 
people, cohorts of older people may have different levels of potential confounders of 
the BMi-mortality relation because of a different historic risk profile. These cohorts 
are from different generations. They grew up during different time periods, which 
may affect both body weight and mortality. 
To avoid confounding by a cohort effect, the present study investigated the BMI-
mortality relation in one cohort of men born in similar years and started the second 
follow-up period ten years after the first. The men were aged 40-59 years around 
i960. Categories of BMI were defined according to the World Health Organization 
guidelines to enable us to determine whether these categories were still useful 
when the men were ten years older. Furthermore, different lengths of follow-up 
were assessed for their effects on the BMi-mortality relation among the elderly. 
Methods 
STUDY POPULATION 
Around i960, that is, between 1958 and 1964, 12,761 men aged 40-59 years were 
enrolled in the Seven Countries Study.7'17'18 The study sample consisted of men 
from Finland (east and west), the former Yugoslavia (Croatia (Slavonia and 
Dalmatia) and Serbia (Velika Krsna, Zrenjanin, and Belgrade)), Italy (Crevalcore, 
Montegiorgio and Rome), Greece (Corfu and Crete), the Netherlands (Zutphen), 
Japan (Ushibuka and Tanushimaru), and the United States. Most of the men lived 
in rural areas. In the town of Zutphen, four of every nine men were invited to 
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participate in the study. In Serbia, workers from a large co-operative in Zrenjanin 
and professors from the University of Belgrade were invited. In Rome and the 
United States, railroad workers were recruited. Overall, the participation rate was 
higher than 90 percent. Studies on the BMi-mortality relation in the Seven 
Countries Study have already been published. ' To our knowledge, however, our 
study is the first to present results based on analyses of the same cohort, defining 
categories of BMI at the beginning of follow-up, presenting results separately for 
men in different smoking categories, not adjusting for intermediate factors, and 
starting the follow-up periods at different ages. 
For the present study, we used data from the 13 European centres of the Seven 
Countries Study. The US railroad cohort was excluded because BMI was not 
measured around 1970 at this centre. At the two Japanese centres, the relation 
between BMI and mortality differed from the relation found at the other centres, 
although it was not statistically significant, probably because of small numbers. We 
excluded Japan to improve the homogeneity and representativeness of the present 
study for European countries. The reason that we included centres from Japan, the 
United States, and Europe at the beginning of the Seven Countries Study was to 
assess different levels of diet-related risk factors throughout the world and their 
effects on cardiovascular diseases. To be able to compare BMi-mortality 
associations between regions of Europe, we pooled centres into four regions on the 
basis of their cultural similarities: 1) Northern Europe (east and west Finland and 
Zutphen), 2) inland Southern Europe (Rome, Crevalcore, Slavonia, and Belgrade), 
3) Mediterranean Southern Europe (Crete, Corfu, Montegiorgio, and Dalmatia), 
and 4) Serbia (Velika Krsna and Zrenjanin).1 Men for whom data on BMI, age, and 
smoking were available around i960 and 1970 were included in the analyses. The 
analyses were restricted to subjects with full data to improve the comparability of 
different analyses applied to the same cohort. Of the 12,761 men who were enrolled 
in the Seven Countries Study, 9,180 were European and 7,985 had complete data. 
MEASUREMENTS 
Body weight and height were measured around i960 and again for the same men 
around 1970 while they were wearing light underwear without shoes. BMI was 
calculated as body weight to the nearest 0.1 kg divided by height in meters squared 
(kg/m2). Four categories of BMI were defined by using the World Health 
Organization guidelines,1 which consider less than 18.5 kg/m as underweight, 18.5-
24.9 kg/m as normal weight, 25.0-29.9 kg/m as grade 1 overweight, and 30.0-39.9 
kg/m2 as grade 11 overweight (also called obesity or severe overweight). Six men 
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whose BMI was more than 40 kg/m (grade m overweight) were added to the grade 
11 overweight category. Age was rounded to the nearest birthday. Information about 
cigarette smoking was obtained from a standardised questionnaire around i960 and 
again around 1970. ' Subjects were classified as never, ex-, or current smokers. 
MORTALITY FOLLOW-UP 
Vital status was checked by visiting the local register offices periodically. Two main 
periods of follow-up were defined. One 15-year follow-up period began around i960 
and ended around 1975. For the survivors, a second 15-year follow-up period started 
around 1970 and ended around 1985. In addition, the influence of follow-up length 
on the BMi-mortality relation was assessed by following the men for 15-, 20-, and 25-
year periods, all starting around i960 when the men were aged 40-59 years. During 
25 years of follow-up, 3,777 men died. One man from a total of 7,985 was lost to 
follow-up. Six men were censored between i960 and 1965, two between 1965 and 
1970, six between 1970 and 1975, and 13 between 1975 and 1985. 
STATISTICAL ANALYSIS 
A hazard ratios (HR) was calculated for each category of BMI at the beginning of 
follow-up by using Cox's proportional hazards model (proc PHREG, SAS-version 
6.12). For the analyses based on follow-up starting around i960 and 1970, a BMI of 
18.5-24.9 kg/m around i960 and 1970, respectively, was the reference category. 
The baseline categories of BMI around i960 and 1970 did not comprise exactly the 
same men; for 28 percent, their BMI category changed between i960 and 1970. To 
assess whether these changes affected the results, we also calculated HRS for 15 years 
of mortality from 1970 onward for those men who were in the same BMI category in 
both i960 and 1970 and for those who changed categories between i960 and 1970. 
For this analysis only, men whose BMI was 18.5-24.9 kg/m2 around both i960 and 
1970 were considered the reference group. 
HRS were adjusted for age at baseline as a continuous variable and for centres by 
using dummy variables. Because cardiovascular diseases and their risk factors are 
acknowledged to be intermediates in the causal chain linking overweight to 
increased mortality, " adjustments were not made for blood pressure and 
cholesterol levels. HRS were calculated for different categories of smoking separately, 
because smoking has been shown to confound or modify the relation between body 
weight and mortality. 
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The effect of early mortality, which may be attributable to lower weight because of 
clinical or subclinical disease, was studied by carrying out analyses excluding and 
not excluding the men who died or were censored within five years after baseline. 
The results presented are based on analyses in which early mortality was excluded. 
Results 
For all men combined, the mean BMI was 24.2 kg/m2 around i960 and 25.3 kg/m2 
for the survivors around 1970. As shown in tables 4.1.1 and 4.1.2, a BMI less than 18.5 
kg/m was rare around both i960 and 1970 and was most prevalent among current 
smokers. A BMI 25.0-29.9 kg/m and a BMI >30 .O kg/m were more prevalent among 
never and ex-smokers than among current smokers. A total of 405 men died 
between i960 and 1965, 648 men died between 1965 and 1970, 699 men died 
between 1970 and 1975, and 2,025 m e n died between 1975 and 1985. 
Table 4.1.1 Prevalence of body mass index categories around 1960" and follow-up characteristics of 
European men in the Seven Countries Study, by category of body mass index, 1960-1975' 
Smoking category and 
characteristics 
Never smokers 
Subjects at baseline (%) 
Total person-years 
Number of deaths 
Deaths per 1,000 person-years 
Ex-smokers 
Subjects at baseline (%) 
Total person-years 
Number of deaths 
Deaths per 1,000 person-years 
Current smokers 
Subjects at baseline (%) 
Total person-years 
Number of deaths 
Deaths per 1,000 person-years 
<18.5 
15(0.8) 
205 
4 
19.6 
8 (0.7) 
104 
2 
29.3 
111 (2.4) 
1,405 
42 
29.9 
Body mass 
18.5-24.9 
984 (52.6) 
14,275 
102 
7.1 
573 (49.7) 
8,072 
96 
11.9 
3,037 (66.7) 
42,562 
636 
14.9 
index (kg/m2) 
25.0-29.9 
708 (37.9) 
10,216 
87 
8.5 
467 (40.5) 
6,698 
68 
10.2 
1,203 (26.4) 
17,000 
214 
12.6 
>30.0 
163(8.7) 
2,318 
29 
12.5 
105(9.1) 
1,473 
23 
15.6 
199(4.4) 
2,789 
44 
15.8 
Age around 1960, 40-59 years 
Mortality during the first five years of follow-up was excluded 
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Table 4.1.2 Prevalence of body mass index categories around 1970" and follow-up characteristics of 
European men in the Seven Countries Study, by category of body mass index, 1970-1985" 
Smoking category and 
characteristics 
Body mass index (kg/nf) and number (%) 
<18.5 18.5-24.9 25.0-29.9 >30.0 
Never smokers 
Subjects at baseline 
total person-years 
Number of deaths 
Deaths per 1,000 person-years 
Ex-smokers 
Subjects at baseline 
total person-years 
Number of deaths 
Deaths per 1,000 person-years 
Current smokers 
Subjects at baseline 
total person-years 
Number of deaths 
Deaths per 1,000 person-years 
11(0.7) 
133 
6 
45.1 
15(1.0) 
168 
10 
59.6 
614(39.2) 
8,491 
156 
18.4 
587 (37.5) 
7,826 
196 
25.0 
723 (46.2) 
10,111 
167 
16.5 
759 (48.4) 
10,191 
245 
24.0 
217(13.9) 
2,928 
67 
22.9 
206(13.1) 
2,710 
79 
29.2 
85(2.8) 1,733(56.2) 1,022(33.1) 246(8.0) 
1,005 22,985 13,836 3,283 
46 631 335 87 
45.8 27.4 24.2 26.5 
Age around 1970, 50-69 years 
Mortality during the first five years of follow-up was excluded 
Table 4.1.3 Hazard ratios (95% confidence intervals) of all-cause 15-year mortality* among European 
men in the Seven Countries Study, by category of body mass index" 
Follow-up period and 
smoking category <18.5 
Body mass index (kg/m2) 
18.5-24.9 25.0-29.9 >30.0 
1960-1975 
Never smokers 
Ex-smokers 
Current smokers 
1970-1985 
Never smokers 
Ex-smokers 
Current smokers 
2.1 (0.8-5.7) 
2.0 (0.5-8.2) 
2.1 (1.5-2.8) 
2.3(1.0-5.3) 
2.5(1.3-4.8) 
1.5(1.1-2.1) 
1 
1 
1 
1 
1 
1 
1.3(0.9-1.7) 1.8(1.2-2.8) 
1.0(0.7-1.3) 1.3(0.8-2.1) 
0.9(0.8-1.1) 1.0(0.7-1.4) 
1.0(0.8-1.2) 1.4(1.0-1.9) 
1.1(0.9-1.4) 1.4(1.0-1.8) 
1.0 (0.9-1.1) 1.0(0.8-1.3) 
Mortality during the first five years of follow-up was excluded. 
Adjustments were made for age and study centre 
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Table 4.1.4 Fifteen-year mortality" from 1970 onward, by different categories of body mass index, among 
European men in the Seven Countries Studyb 
Body mass index (kg/m*) Hazard ratio (95% confidence interval) 
Smoking category 1960 1970 
All men" 
Never smokers 
Ex-smokers 
Current smokers 
18.5-24.9 
>18.5 
<18.5 
18.5-24.9 
<30.0 
>30.0 
18.5-24.9 
<30.0 
>30.0 
18.5-24.9 
<30.0 
>30.0 
18.5-24.9 
<18.5 
<18.5 
18.5-24.9 
>30.0 
>30.0 
18.5-24.9 
>30.0 
>30.0 
18.5-24.9 
>30.0 
>30.0 
1 
1.8 (1.3-2.5) 
1.5(0.9-2.4) 
1 
1.4(1.0-2.1) 
1.5(1.0-2.2) 
1 
1.3(0.9-1.8) 
1.5(1.0-2.2) 
1 
1.0(0.7-1.3) 
1.2(0.8-1.7) 
a Mortality during first five years of follow-up was excluded. 
b Adjustments were made for age and study centre. 
c Adjustment was also made for smoking at baseline for the analysis on all men. 
The 15-year all-cause mortality rate (actually, 15 year mortality minus the first five 
years of mortality) was clearly higher among those with a BMI <I8-5 kg/m than 
among those whose BMI was 18.5-24.9 kg/m2 (table 4.1.3). HRS for BMI <I8.5 kg/m 
were similar across all smoking categories. When the smoking categories were 
pooled, the HRS for BMI <I8.5 kg/m were 2.1 (95 percent confidence interval (ci): 
1.5-2.8) for the follow-up period starting around i960 and 1.7 (95 percent ci: 1.3-2.2) 
for the follow-up period that began around 1970. Men whose BMI was 25.0-29.9 
kg/m2 and those whose weight was normal had similar 15-year mortality rates. A 
BMI >30 .O kg/m2 was related to increased 15-year mortality among never smokers 
and ex-smokers but not among current smokers. The HR for BMI >30.O kg/m 
among never smokers was slightly higher for the follow-up period starting around 
i960 compared with that for the follow-up period that began around 1970. 
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Table 4.1.5 Hazard ratios (95%-confidence intervals) for all-cause mortality" among European men in the 
Seven Countries Study, by category of body mass index, for different lengths of follow-up 
starting around 1960" 
Smoking category and 
length of follow-up (years) <18.5 
Body mass index (kg/m2) 
18.5-24.9 25.0-29.9 >30.0 
Never smokers 
15 
20 
25 
Ex-smokers 
15 
20 
25 
Current smokers 
15 
20 
25 
2.1 (0.8-5.7) 
1.8(0.8-4.1) 
1.6(0.8-3.2) 
2.0 (0.5-8.2) 
1.0 (0.3-4.2) 
2.1 (0.8-5.1) 
2.1 (1.5-2.8) 
1.8(1.4-2.4) 
1.5(1.2-1.9) 
1.3(0.9-1.7) 1.8(1.2-2.8) 
1.1(0.9-1.4) 1.9(1.4-2.6) 
1.1(0.9-1.3) 1.8(1.4-2.4) 
1.0(0.7-1.3) 1.3(0.8-2.1) 
1.1(0.8-1.4) 1.5(1.0-2.2) 
1.3(1.0-1.5) 1.6(1.2-2.3) 
0.9(0.8-1.1) 1.0(0.7-1.4) 
0.9(0.8-1.1) 0.9(0.7-1.2) 
1.0(0.9-1.1) 1.0(0.8-1.3) 
Mortality during the first five years of follow-up was excluded. 
Adjustments were made for age and study centre. 
If mortality during the first five years after baseline was not excluded, the HRS for 
underweight were generally larger than when early mortality was excluded. HRS for 
BMI of 25.0-29.9 kg/m and for BMI >30.0 kg/m were similar when early mortality 
was excluded or included and were also similar in northern Europe, inland southern 
Europe, Mediterranean southern Europe, and Serbia (data not shown). 
As shown in table 4.1.4, the HR for BMI <I8.5 kg/m2 around both i960 and 1970 was 
1.5 (95 percent ci: 0.9-2.4) for the 15-year follow-up period starting around 1970; a 
BMI of 18.5-25.0 kg/m around both i960 and 1970 was considered the reference 
category. The HR was 1.8 (95 percent ci: 1.3-2.5) for men who reduced their BMI to 
<i8.5 kg/m between i960 and 1970. These HRS were similar to the HR for all men 
whose BMI was <i8.5 kg/m around 1970; again, the category of all men whose BMI 
was 18.5-29.9 kg/m around 1970 was used as the reference. Also shown in table 
4.1.4 are HRS, within smoking categories, for men whose BMI was >30.o kg/m2 
around i960 and 1970 and HRS for men whose BMI increased to >30.o kg/m 
between these years. These HRS were similar to those found within the smoking 
categories for all men whose BMI was >30.o kg/m around 1970; men whose BMI was 
18.5-24.9 kg/m around 1970 were considered the reference group. 
The HRS of mortality for BMI <I8.5 kg/m among never and current smokers 
declined with the length of follow-up (table 4.1.5). HRS for BMI >30 .O kg/m2 among 
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never and ex-smokers were not associated with the length of follow-up. Among 
current smokers, BMI> 30.0 kg/m was not related to increased mortality. 
Discussion 
This study showed that BMI <I8-5 kg/m was clearly related to excess all-cause 
mortality among men aged 40-59 years followed for 15 years. Similar results were 
found when the survivors were ten years older and were followed for another 15 
years. A BMI 25.0-29.9 kg/m was not associated with mortality, but BMI >30 .O 
kg/m was related to excess mortality among never and ex-smokers. The highest HR 
for BMI >30.o kg/m2 was found for never smokers aged 40-59 years. A BMI of more 
than 30.0 kg/m was not related to excess all-cause mortality in current smokers. 
For never and current smokers, the association between BMI <I8.5 kg/m and all-
cause mortality tended to decrease with an increasing follow-up period. 
Explanations for decreasing HRS with longer follow-up include a higher mortality 
rate during longer follow-up periods and confounding by the presence of 
subclinical illness. In this study, we tried to minimise the effects of underlying 
illness on mortality by excluding the first five years of follow-up, although 
excluding early mortality will not fully guarantee the absence of confounding by 
subclinical illness. No information was available regarding intentional versus 
unintentional weight loss, which made it difficult to interpret the higher mortality 
rate among those with a low BMI. Increased mortality associated with weight loss is 
reported previously.22'28 It has been hypothesised that higher mortality among those 
with a low BMI is the result of low lean body mass rather than low fat mass. 
Among men non-smokers, the finding that the HR of increased mortality for BMI 
>30.o kg/m was not associated with the length of follow-up supports the hypothesis 
that a BMI of >30.o kg/m2 is also related to excess mortality among old men. HRS 
are expected to decrease with longer follow-up periods as subjects are followed until 
old age. Thus, mortality rates are higher for a longer follow-up period. 
The finding that a BMI of 25.0-29.9 kg/m was not related to mortality concurs with 
Sjostrom's conclusion that it may well be that the BMI range associated with 
minimal mortality shifts upward with increasing age. Andres et al. found that for 
persons more than 50 years of age, the mortality rate was lower for those whose BMI 
was 25.0-27.5 kg/m2 than for those whose BMI was about 22.5 kg/m . Rissanen et 
al. observed that minimal mortality among men more than 75 years of age occurred 
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for those whose BMI was 28-31 kg/m . It cannot be concluded, however, that a BMI 
of 25.0-29.9 kg/m is an optimal range for old men. Although Shaper et al. found a 
low mortality rate among men whose BMI was 24-30 kg/m they also found an 
elevated risk for incident cardiovascular events and diabetes in this BMI range. 
BMI >30.O kg/m was not related to increased mortality among current smokers. 
Lee et al. also showed BMi-mortality associations separately for smoking categories. 
Although they found a U-shaped relation between BMI and mortality among 
current smokers, the HRS for BMI >30 .O kg/m among smokers were clearly lower 
than among non-smokers. In the present study, absolute risks of all-cause mortality 
among smokers were higher than among never smokers (tables 4.1.1 and 4.1.2). 
Smoking is such a dominant risk factor for increased mortality that overweight adds 
only a small additional risk to the already increased absolute risk among smokers. 
By using Framingham Heart Study data, Sempos et al. assessed the relation between 
metropolitan relative weight and mortality among subjects aged 28-62 years. They 
concluded that an interaction not necessarily exists between smoking and body 
weight. As smoking is often reported as a confounder and in some studies as an 
effect modifier for the relation between overweight and mortality rate, however, it 
seems sensible in further research to stratify the associations into categories of 
smoking. 
One strength of the present study was that the same cohort of men was followed 
during more than one period, and a second mortality follow-up was started ten 
years after the first. As mentioned previously, the advantage of our study design was 
that a cohort effect was impossible. BMI categories around i960 and 1970 did not 
comprise the exact same men, but a change in BMI categories did not affect the 
results. As far as we know, the present study is the first to analyse the BMi-mortality 
relation using this study design. It also included centres from many parts of Europe. 
Analyses were similar for different regions of Europe. Thus, it is appropriate to 
generalise our results to ageing European men. Note, however, that the data were 
collected years ago, when smoking was more common among men than nowadays. 
CONCLUSION 
We concluded that BMI <I8-5 kg/m was clearly associated with increased mortality. 
A BMI >30 .O kg/m was more prevalent in older men and was associated with 
increased mortality in ex- and never smokers. Underweight in all smoking 
categories and severe overweight in ex- and never smokers remain important 
predictors of increased mortality in middle-aged men when they get older. 
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Chapter 4.2 
A COMPARISON OF BODY MASS INDEX, WAIST-HIP RATIO 
AND WAIST CIRCUMFERENCE AS PREDICTORS OF ALL-
CAUSE MORTALITY AMONG THE ELDERLY. 
THE ROTTERDAM STUDY 
A b s t r a c t The aim of this study was to compare body mass index (BMI), waist-hip ratio, (WHR) 
and waist circumference as predictors of all-cause mortality among the elderly. Data were available 
from 6,296 men and women who participated in the Rotterdam Study, a population-based cohort 
study. Participants were aged 55-102 years at baseline and mean duration of follow-up was 5.4 
years. Sex-specific all-cause mortality was compared between quintiles of BMI, WHR, and waist 
circumference and between predefined categories of BMI, and waist circumference, stratified for 
smoking category. High quintiles of waist circumference, but not high quintiles of BMI and WHR 
were related to increased mortality among never smoking men, without reaching statistical 
significance. Only the highest category of BMI (BMI >30.O kg/m ) among never smoking men was 
related to increased mortality, compared to normal BMI (hazard ratio 2.6 (95% confidence 
interval: 1.3-5.3)). Waist circumference between 94 and 102 cm and waist circumference 102 cm 
and larger were related to increased mortality compared to normal waist circumference (hazard 
ratios 1.7 (95% confidence interval: 1.1-2.8) and 1.6 (95% confidence interval 1.0-2.8), 
respectively). The proportion of mortality attributable to large waist circumference among never 
smoking men was three-fold the proportion attributable to high BMI. Among never smoking 
women and ex- and current smokers, categories of large body fatness did not predict increased 
mortality. It is concluded that, among never smoking elderly men, waist circumference may have 
more potential for detecting overweight than the BMI. 
Tommy LS Visscher, Jacob C Seidell, Anu Molarius, Deirdre van der Kuip, Albert Hofman, and 
Jacqueline CM Witteman. IntJ Obes 2001525: in press. 
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Introduction 
A high body mass index (BMI) in the elderly is found to be related to increased 
mortality in some but not all studies. The BMi-mortality relation, however, seems to 
be less pronounced in elderly than in younger populations.1"1 Explanations for the 
weaker BMi-mortality relation in the elderly are selective survival and the higher 
mortality rates among older populations. Another explanation is the different 
association between BMI and body fatness in older compared to younger 
populations, as the fat-free mass declines and the body height diminishes with 
12,13 
ageing. 
Therefore, our study examined the usefulness of other measurements of body 
fatness than BMI to detect overweight in the elderly. The use of the waist 
circumference has been proposed as an index of intra-abdominal fatness and overall 
body fatness. At least in middle-aged populations a large waist circumference 
identified subjects at increased cardiovascular risk and with a high prevalence of 
other health outcomes. BMI, waist-hip ratio (WHR) and the waist circumference 
are compared as predictors of increased all-cause mortality in the elderly. 
Methods 
STUDY POPULATION 
The Rotterdam Study is a cohort study among 7,893 subjects aged 55 years and over 
from Ommoord, a suburb of Rotterdam, the Netherlands. All 10,275 eligible 
participants were invited to participate, of which 78% responded. Baseline 
examinations took place from March 1990 until July 1993. The Medical Ethical 
Committee of Erasmus University Medical Centre approved the study and written 
informed consent was obtained from all participants. The original objective of the 
Rotterdam Study was to investigate determinants of chronic and disabling 
cardiovascular, neurogeriatric, locomotor, and ophthalmologic diseases. For the 
purpose of the present study, data were used from all 6,296 subjects who had full 
data on all three body fatness measurements and smoking. 
MEASUREMENTS 
During a home visit, trained interviewers administered a questionnaire, including 
questions on smoking behaviour. Subjects were defined as never, ex- or current 
smokers at baseline. The home visit was followed by two extensive clinical 
examinations at a research centre in the suburb of Ommoord, which included 
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anthropometric measurements. Participants residing at homes for the elderly who 
were not able to visit the research centre because of a disability were examined at 
their home. Height and weight were measured with the participants standing 
without shoes and heavy outer garments. BMI was calculated as weight divided by 
height squared (kg/m). Waist circumference was measured at the level midway 
between the lower rib margin and the iliac crest with participants in standing 
position without heavy outer garments and with emptied pockets, breathing out 
gently. Hip circumference was recorded as the maximum circumference over the 
buttocks. W H R was consequently calculated as the ratio of waist circumference over 
the hip circumference. 
Sex-specific quintile cut-off points were defined for BMI, WHR, and waist 
circumference for each smoking category (table 4.2.2). Predefined categories for BMI 
were defined according to the World Health Organization guidelines.17 A BMI 
under 18.5 kg/m was considered underweight; BMI 18.5-24.9 kg/m as normal 
weight; BMI 25.0-29.9 kg/m as grade 1 overweight; and BMI 30.0-39.9 kg/m as 
grade 11 overweight, which is also referred to as obesity or severe overweight. Ranges 
include the left endpoint, not the right. One male and 22 female subjects, who had 
BMI over 40 kg/m were added to the grade 11 overweight class. For the predefined 
categories of large waist circumference the sex-specific action levels suggested by 
Lean et al. were used. Regarding men, we defined waist circumference under 79 
cm as small, and waist circumference between 79 and 94 cm as normal. Waist 
circumference between 94 and 102 cm is above action level 1; waist circumference 
above 102 cm is above action level 2. Regarding women, we defined waist 
circumference less than 68 cm as small, and waist circumference between 68 and 80 
cm as normal. Waist circumference between 80 and 88 cm is above action level 1, 
and waist circumference above 88 cm is above action level 2. Predefined categories 
of WHR were not assessed in relation to all-cause mortality. Only dichotomous 
classifications have been proposed regarding WHR and, while different cut-off points 
have been suggested for WHR, no consensus has been reached. 
MORTALITY FOLLOW-UP 
Information on vital status was acquired at regular intervals from the municipal 
authorities of Rotterdam. In addition, general practitioners in the study district of 
Ommoord provided computerised reports on the deaths of participants on a regular 
basis. General practitioners outside the study region were contacted yearly to obtain 
information on vital status. The end of follow-up was set at 1 January 1998. The 
mean duration of follow-up was 5.4 years. 
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STATISTICAL ANALYSIS 
Sex-specific hazard ratios of all-cause mortality were calculated for BMI, WHR and 
waist circumference as continuous variables to study linear trends between the body 
fatness measurements and mortality using Cox's proportional hazards model (proc 
PHREG, SAS-version 6.12). To calculate whether there was a U-shaped relation 
between the body fatness measurements and mortality, a quadratic term was 
included in the model. Hazard ratios were also calculated for quintiles of BMI, WHR, 
and waist circumference. In addition, hazard ratios were calculated per predefined 
category of BMI and waist circumference. The second quintile and second 
predefined category of body fatness measurements were taken as the reference 
because the mortality rate was expected to be elevated at the lower end of the body 
fatness measurements, as at least observed for low BMI.1" '10 The population 
attributable fractions (AF) of mortality were calculated according to 
= p(RR-l) (formula 4.2.1) 
p(RR-l) + l 
with p being the proportion of men in the body fatness category, and RR the 
corresponding hazard ratio. 
Adjustments were made for age as a continuous variable, but not for levels of 
cholesterol and blood pressure. Cholesterol and blood pressure are possible 
intermediates in the causal chain between body weight and mortality. Smoking is 
known to confound or modify the overweight-mortality relation.2,3'20 Therefore, 
analyses were performed for never, ex- and current smokers separately. 
Results 
Average BMI was higher among women than among men. Mean WHR and waist 
circumference were higher among men than among women (table 4.2.1). BMI was 
not linearly related to increased mortality among never smoking men (^=0.93) and 
never smoking women (p=o.z6) when assessed as continuous variable. W H R was 
linearly related to increased mortality in never smoking men (^=0.04), but not in 
never smoking women (^=0.98). Also waist circumference was linearly related to 
increased mortality in never smoking men ^=0.03), but not in never smoking 
women (^=0.64). In current and ex-smokers BMI, WHR and waist circumference 
were not linearly related to increased mortality. 
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Table 4.2.1 Baseline characteristics (1990-1993) and follow-up data (until 1 January 1998) on 
participants of the Rotterdam Study 
Number of subjects 
Total person-years 
Number of deaths 
Age (years) 
Body mass index (kg/m2) 
Waist hip ratio 
Waist circumference (cm) 
Men Current smokers 
631 
3,332 
127 
66.9(7.9)' 
24.9 (3.2) 
0.96 (0.07) 
92.9(10.0) 
Women 
Number of subjects 
Total person-years 
Number of deaths 
Age (years) 
Body mass index (kg/m2) 
Waist hip ratio 
Waist circumference (cm) 
678 
3,804 
83 
65.5(7.4)" 
25.9 (4.3) 
0.86 (0.09) 
85.8(11.9) 
Smoking category 
Ex-smokers 
1,547 
8,167 
262 
68.1 (7.6) 
26.0 (2.8) 
0.96 (0.07) 
95.1 (9.2) 
1,026 
5,764 
112 
68.1 (8.3) 
27.0(4.1) 
0.87 (0.09) 
88.0(11.5) 
Never smokers 
424 
2,210 
90 
69.9(10.0) 
25.5 (3.0) 
0.95 (0.07) 
93.4 (9.2) 
1,990 
10,959 
282 
71.5(9.5) 
26.9 (3.9) 
0.87 (0.09) 
88.3(11.2) 
Mean (standard deviation) 
A U-curved relation between BMI as continuous variable and mortality was observed 
in never smoking men (p for the quadratic BMI term is o.oo) and never smoking 
women (^=0.04). P-value for the quadratic WHR term was 0.06 for never smoking 
men and 0.55 for never smoking women. No U-curve was observed for the relation 
between waist circumference and mortality among never smoking men (p=o.io) 
and women (^=0.69). In the other smoking categories, statistical significance for a 
quadratic term was found for BMI and waist circumference in ex-smoking women, 
and for WHR in current smoking women. 
High quintiles of BMI and WHR were not related to increased all-cause mortality 
among never smoking men (table 4.2.2). High quintiles of waist circumference, 
however, were related to increased mortality compared to the second quintile, 
although not statistically significantly (figure 4.2.1). Among never smoking women, 
and ex- and current smokers quintiles of BMI, WHR and waist circumference were 
not related to increased mortality (tables 4.2.2 and 4.2.3). 
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Figure 4.2.1 Age-adjusted hazard ratios of all-cause mortality among men who never smoked for quintiles of 
body mass index and waist circumference; Rotterdam Study 
Ref. denotes reference category, 95% ci denotes 95% confidence interval around the hazard 
ratio 
BMI >30 .O kg/m , but not BMI 25.0-29.9 kg/m was related to increased mortality 
compared to BMI 18.5- 24.9 kg/m among never smoking men (table 4.2.4). Both 
categories of waist circumference between 94 and 102 cm and waist circumference 
above 102 cm were related to increased mortality among never smoking men. Waist 
circumference larger than 94 cm (49%) was much more common than BMI above 
30.0 kg/m2 (7%) among never smoking men. 
The proportion of mortality attributable to BMI above 30.0 kg/m was 10.1% among 
never smoking men. The proportion of mortality attributable to a waist 
circumference larger then 94 cm was 27.6% among the never smoking men. 
Among never smoking women, and among ex- and current smokers predefined 
categories of BMI and waist circumference were not related to all-cause mortality 
(data not shown). 
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Table 4.2.4 Population attributable fractions of all-cause mortality among men aged 55 years and older 
who never smoked never smoking elderly men for predefined categories of body mass index 
and waist circumference; Rotterdam Study (1990-98) 
Body mass index (kg/m2) <18.5 18.5-24.9 25.0-29.9 >30.0 
Hazard ratio (95 % CI)" 
Number of subjects 
Population attributable fraction 
4.5(1.4-14.5) Reference 0.8(0.5-1.2) 2.6(1.3-5.3) 
5 187 203 29 
3.4 Reference N.C. 10.1 
Waist circumference (cm) 
Hazard ratio (95 % CI)" 
Number of subjects 
Population attributable fraction 
<79 
1.0(0.2-4.2) 
20 
N.C. 
79- 93.9 
Reference 
198 
Reference 
94-101.9 
1.7(1.1-2.8) 
127 
17.4 
>102 
1.6(1.0-2.8) 
79 
10.2 
a Hazard ratios were adjusted for age 
NC denotes not calculated because hazard ratio was equal to or smaller than one. 
CI denotes confidence interval 
Discussion 
High quintiles of waist circumference, but not of BMI and WHR, predicted an 
increased risk of all-cause mortality among men who had never smoked. Analyses 
on predefined categories showed that waist circumference predicted increased 
mortality risk at a much lower level than BMI among these never smoking men. The 
fraction of mortality attributable to a large waist circumference (^94 cm) was 
almost three times higher than the fraction attributable to a high BMI (>30.O kg/m ) 
in never smoking men. Among never smoking women and ex- and current 
smokers, high levels of body fatness did not predict increased mortality. The use of 
waist circumference seems a promising alternative to BMI to detect overweight 
among elderly never smoking men. 
BMI is not an optimal predictor of body fatness in the elderly, because body height 
diminishes and fat-free mass decreases with ageing. ' We confirmed earlier 
findings that BMI >30.O kg/m2, but not BMI 25.0-29.9 kg/m , is related to increased 
mortality among never smoking elderly men."' Allison et at. calculated that for 
men aged 70 years and over minimal mortality occurred at a BMI between 27 and 30 
kg/m , and for women at a level between 30 and 35 kg/m . 
We found only one other study that assessed the relation between waist 
circumference and all-cause mortality among the elderly. Larsson et al. found that 
in men aged 54 years and older mean BMI and waist circumference were similar in 
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those who died and those who survived a 4.5 years period of follow-up. Seidell et 
al. showed that the sagittal waist diameter (waist depth), which is an alternative 
measurement for abdominal fatness, predicted subsequent mortality among men 
younger than 55 years, but not among men who were older than 55 years. These 
two studies, however, did not take smoking into account, and thereby probably 
underestimated the role of abdominal fatness on mortality rates. 
The relation between large waist circumference and increased mortality was found 
in never smoking men only, who constituted 16.3% of the men. It is not surprising 
that large levels of waist circumference did not predict mortality in ex- and current 
smokers. It was found earlier that relative risks of mortality for high BMI were lower 
among smokers than among never smokers.' Being overweight does not add a 
detectable risk to the high absolute risk of mortality older smokers already have, 
and controlling body weight to prevent early mortality seems thus most relevant in 
never smokers. The proportion of never smokers among the elderly in society will 
increase in the future to more than 16.3% as the participants of the Rotterdam 
Study grew up in a time period in which smoking was much more common than it 
is today. There is no reason to believe, however, that the relation between large 
waist circumference and increased mortality will be different among never smoking 
men from populations in which smoking is less common. 
An explanation for the different relation between large waist circumference and all-
cause mortality among men and women may be a relatively late onset of abdominal 
obesity among women compared to men. Among women, a redistribution of fat is 
seen after the menopause from the locations around the hips and buttocks to the 
abdominal region. Also, levels of bioavailable endogenous estrogens are relatively 
increased in postmenopausal women with abdominal obesity.2 Increased levels of 
estrogens in obese women may lead to a slightly increased risk of breast cancer, but 
may favourably affect risk of coronary heart disease. Possibly, the balance of these 
effects leads to a relatively reduced all-cause mortality rate among obese women 
who are older than menopausal age.25,2 A large waist circumference predicted future 
coronary heart disease among women from the Nurses Health Study aged 60-65 
years, but less strongly than among women aged 40-59 years. Furthermore spinal 
shrinkage at older age leading to a larger waist circumference even when amount 
of fat remains constant, could lead to different relations between waist 
circumference and body fat between men and women. 
84 
Quintiles of WHR were less clearly related to increased mortality than quintiles of 
waist circumference. In Japanese-American men aged 71-93 years, Kalmijn et al. 
found a positive association between quintiles of WHR and all-cause mortality, 
whereas quintiles of BMI were negatively related to all-cause mortality. Larsson et 
al. found that in men aged 54 years mean WHR was higher in those who died than 
in those who survived a 4.5 years period of follow-up. A large WHR, however, may 
not only reflect a large waist circumference, but also a small muscle area in the 
thigh measured, as shown by computed tomography. In elderly populations lean 
body mass is known to decline with age. The waist circumference is easier to 
interpret than the ratio between waist circumference and hip circumference (WHR), 
especially in the elderly. 
The participation rate of the Rotterdam Study was high, 78%, and included 
subjects with poor mobility as they were visited at home. Unfortunately we did not 
have complete data on life-threatening disease status at baseline and did not ask for 
weight change before baseline. Excluding subjects with a life-threatening disease 
would have made it possible to adjust for pre-mortal weight loss caused by pre-
mortal morbidity. A more commonly used method to take into account an effect of 
pre-mortal weight loss on the relation between overweight and mortality, is to 
disregard mortality within the first few years of follow-up. Obviously, our period 
of follow-up was too short to do so. Allison et al., however, concluded from a large 
meta-analysis that this may have only a minuscule impact on the relative risks, 
especially for the categories of large body weight. 
Action levels used for waist circumference are based on studies by Lean et al.. In 
their studies, which focused on middle-aged men and women, waist circumferences 
above the action levels were related to respiratory symptoms, increased levels of 
cardiovascular risk factors, increased prevalence of diabetes, low back pain and 
difficulties of physical functioning.15 Measuring waist circumference is easy and can 
be done by individuals themselves. The reliability of self-measured waist 
circumference is high, at least in the middle-aged. The action levels of 94 and 102 
cm for men and 80 and 88 cm for women are currently widely recommended but it 
should be noted that they are still under debate. To define age-specific action 
levels and to learn more about waist circumference as potential measurement of 
fatness among women, further studies are needed that assess waist circumference in 
relation to morbidity and disability. Morbidity and disability are highly important 
outcomes with regard to successful ageing. 
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CONCLUSION 
It was thought that being overweight is related to increased mortality risk among 
the elderly in a small number of individuals with extreme overweight. We conclude 
that measuring waist circumference in never smoking men detected more 
individuals that were at increased risk of mortality than did measuring BMI. The 
present study suggests that measuring waist circumference may have more potential 
for detecting overweight among elderly men than measuring BMI. 
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Chapter 5.1 
OVERWEIGHT, OSTEOARTHRITIS, AND THE RISK OF 
DISABILITY 
A b s t r a c t Overweight and osteoarthritis are related to disability. Evidence for a relation 
between overweight and osteoarthritis is often based on non-representative studies. The relation 
between overweight and disability in the presence and absence of osteoarthritis has not been 
systematically evaluated. In a Finnish representative cohort study (Mini-Finland Health Survey), 
5,625 men and women, aged 30 to 65 years, have been examined at baseline 1978/1980, and were 
followed until the end of 1995. Participation rate was higher than 90%. Categories of overweight 
were defined according to the World Health Organization guidelines. Osteoarthritis in knee and 
hip joints, chronic low back pain, shoulder joint impairment and neck pain were diagnosed at 
baseline in a clinical setting. Difficulties in everyday activities were assessed at baseline; work 
disability was evaluated during the follow-up. Overweight was associated with osteoarthritis and 
the other musculoskeletal disorders. Overweight was associated with difficulties in everyday 
activities at baseline and with risk of work disability during follow-up, among subjects both with 
and without osteoarthritis. Odds ratio of difficulties in everyday activities for subjects with both 
obesity and osteoarthritis was 7.9 (95% confidence interval: 4.4-13.9) compared to subjects with 
normal weight and no osteoarthritis. Relative risk of future work disability for subjects with both 
obesity and osteoarthritis was 2.4 (95% confidence interval: 1.3-4.3). It *s concluded that control of 
body weight has great potential in reducing musculoskeletal disorders and disability in a healthy 
population. Moreover, control of body weight should get high priority in the treatment of 
osteoarthritis. 
Tommy LS Visscher, Markku Heliovaara, Aila Rissanen, Jacob C Seidell, Paul Knekt, Matti 
Makela, Antti Reunanen, and Arpo Aromaa. Submitted for publication. 
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Introduction 
Overweight is an alleged risk factor for osteoarthritis in the knee and hip joints1" 
and may have a role in other musculoskeletal disorders. "8 The evidence, however, is 
often based on non-representative studies. Both overweight and musculoskeletal 
disorders are strong determinants of disability. The relation between overweight 
and the onset of disability in the presence and absence of osteoarthritis has not been 
systematically evaluated. 
The present study elucidates the relations between overweight and clinically defined 
osteoarthritis, low back pain, shoulder joint impairment and neck pain in a general 
population. Moreover, the relation between overweight and the development of 
disability is assessed separately among subjects with and without osteoarthritis. 
The Mini-Finland Health Survey is used for this purpose because of its unique 
combination of population based data on measured body weight, clinically 
diagnosed osteoarthritis, low back pain, shoulder joint impairment and chronic 
neck pain, comprehensive data on difficulties in everyday activities, and 
longitudinal data on work disability.1 
Methods 
STUDY POPULATION 
The Mini-Finland Health Survey was carried out in 1978-1980 by the Mobile Clinic 
of the Social Insurance Institution in 40 areas of Finland.1 A random sample was 
drawn from the population register and comprised 8,000 persons (3,637 men and 
4,363 women) aged 30 years and over from 69 municipalities. A total of 7,219 
persons, 90 percent of the sample, participated. The sample was highly 
representative for Finnish adults aged 30 years and over.1 For the present study, the 
2,714 men and 2,911 women who were aged 64 years or less were selected. Data on 
work disability is only relevant for this age-category, as 65 years is the age of 
retirement in Finland. For the longitudinal analyses on work disability, only those 
participants were included who were fit enough to work at baseline. 
MEASUREMENTS 
Body mass index (BMI) was calculated as weight in kg divided by height in meters 
squared (kg/m). Four categories of BMI were defined according to the World 
Health Organization guidelines. A BMI under 18.5 kg/m2 was considered as 
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underweight, a BMI between 18.5 and 24.9 kg/m as normal weight, a BMI between 
25.0 and 29.930 kg/m2 as grade-i overweight or moderate overweight, and a BMI 
between 30.0 and 39.9 kg/m as grade-n overweight, also called severe overweight or 
obesity. Because of small numbers of subjects with BMI of 40.0 kg/m or higher 
(grade-m overweight) these subjects were classified as grade-n overweight. Ranges 
include the lower limit, not the upper. 
To screen all participants for musculoskeletal disorders, a specific structured 
interview for the musculoskeletal system was performed. Together with the 
invitation to attend the first health examination, the subjects received a 
questionnaire eliciting information about previous diseases, hospitalisations, 
operations, and medications. They were also asked to bring along all documents 
relevant for assessment of health status, such as drug prescriptions and medical 
records. In addition, specially trained nurses who were unaware of the interview 
results carried out a standardised joint function test. Subjects with disease history, 
symptoms, or findings suggestive of musculoskeletal diseases were invited to 
participate in a second diagnostic, clinical phase, on average three and a half 
months after the screening examination. That the screening was sensitive was 
confirmed by inviting a randomly selected validation sample of 740 participants to 
the second phase, regardless of their screening status, for a validation study. Of the 
3,775 subjects who met at least one of the screening criteria, 3,434 (91.0%) 
participated in the second examination. Physical examinations were carried out by 
specially trained physicians who applied uniform diagnostic criteria, according to a 
standardised written protocol. A full medical history was taken comprising the 
development of the musculoskeletal symptoms, previous medical examinations, and 
any previous diagnosis. Immediately after the examination, the physicians made a 
final diagnosis based on medical history, symptoms, and clinical findings. 
Osteoarthritis was diagnosed if there was either a convincing disease history or 
definite findings in the physical status of one or both knee or hip joints.' 
Physicians took detailed medical histories including the development of joint 
symptoms and previous examinations and diagnoses. The physicians also 
investigated all documents (X-rays, health records and doctor's certificates) that the 
subjects had been asked to bring along. Tenderness and mobility of the knee and 
hip were tested according to standard protocols regardless of the screening results. 
Low back pain was diagnosed if the subject had a convincing symptom history of 
chronic low back pain as well as symptoms during the preceding month and one or 
9i 
more major pathologic findings upon physical examination. These included 
fingertip-floor distance of 25 cm or more at flexion, upper body rotation restricted 
to 250 or less, objective signs of back pain in motion, scoliosis of 20° or more, clearly 
straightened lumbar lordosis at inspection, Lasegue's test positive at 6o° or less, or 
other severe abnormality. If the subject had both a convincing symptom and disease 
history, then the physician diagnosed low back syndrome even in the case of only a 
minor pathologic finding in any physical test.5 
Shoulder joint impairment was defined as limited mobility in or pain from the 
joint. Active shoulder elevation was observed while standing or sitting, and was 
considered limited when less than 1600. Active shoulder rotation (combined 
internal and external rotation) was visually evaluated with the shoulder at 90° 
(passive) abduction. It was considered limited if the range of combined internal and 
external rotation was less than 120°. Any pain during passive or active movement, or 
any tenderness, was recorded. 
Chronic neck pain was diagnosed if there was a convincing history of severe, long-
standing neck pain that had manifested symptoms during the previous month, a 
documented history of a previously diagnosed neck syndrome with convincing 
observable signs on physical examination, or mild or moderate neck pain with 
observable physical signs at the time of the examination. Current neck pain of short 
(<3 months) duration was not considered a neck syndrome.8 For the purpose of the 
present study the existence of a low back pain syndrome, a shoulder joint 
impairment, or chronic neck pain was labelled as 'other musculoskeletal disorder'. 
Information on difficulties in everyday activities was elicited from the basic health 
questionnaire and the health interview. Participants were assessed for their ability to 
perform physical functions without difficulty, with minor difficulties, with major 
difficulties or not at all. Subjects were defined as experiencing a difficulty in 
everyday activities if they had at least a minor difficulty in one or more of the 
following: carrying a 5kg bag, shopping, going to bed without help, cutting 
toenails, domestic cleaning, dressing, moving without restrictions, travelling by 
public transport, climbing one flight of stairs, walking 500 meters without a rest. 
Information on work disability was obtained for all participants by a linkage with 
the nation-wide register of pensions granted to individuals by the Finnish Social 
Insurance Institution. Participants were followed from the start of the study in 
1978/1980, until the end of 1995. 
92 
STATISTICAL ANALYSIS 
Age-adjusted odds ratios of the presence of osteoarthritis and other musculoskeletal 
disorders at baseline per category of BMI were calculated using logistic regression 
(proc LOGISTIC, SAS-version 6.12). 
Odds ratios of difficulties in everyday activities were calculated per category of BMI 
adjusted for age and the presence of osteoarthritis. In addition, odds ratios were 
calculated separately among those with and without osteoarthritis. Those with BMI 
between 18.5 and 25.0 kg/m and no osteoarthritis were then taken as the reference 
category. Relative risks of future work disability, adjusted for age and the presence 
of osteoarthritis, were calculated per category of BMI using Cox's Proportional 
Hazards model (proc PHREG, SAS-version 6.12). In addition, relative risks were 
calculated separately among those with and without osteoarthritis. Those with BMI 
between 18.5 and 24.9 kg/m2 and no osteoarthritis were then the reference. 
Furthermore, odds ratios of difficulties in everyday activities and relative risks of 
work disability were adjusted for the presence of the other musculoskeletal 
disorders. When calculations were performed for those with and without 
musculoskeletal disorders separately, those with BMI between 18.5 and 24.9 kg/m 
and no other musculoskeletal disorder were taken as the reference category. The 
fraction of work disability that was attributable to overweight (BMI >25.O kg/m) 
and osteoarthritis was calculated by the use of formulas 5.1.1 and 5.1.2. 
Y pc(RRc-l) 
AFP = *%L — formula 5.1.1 l + ^pc(RRc-l) 
with AF being the attributable fraction, c the category of subjects, p the proportion 
of men in the category, and RR the corresponding relative risk. 
AF/ = ^ ~ — * -^=i (formula 5.1.2) 
with AF, being the fraction of the attributable fraction due to a specific 
(combination of) risk factors, c the category of subjects, p the proportion of men in 
the category, and RR the corresponding relative risk. 
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Results 
About half of the men and women were overweight (BMI >I$.O kg/m) , and n%-
16% of them were obese (>30.o kg/m ) (table 5.1.1). About three percent of the men 
and nearly ten percent of the women had osteoarthritis in the knee joint. About 
two percent of men and three percent of women had osteoarthritis in the hip joint. 
Osteoarthritis in hips and especially in knees was strongly associated with 
overweight. The odds ratio of knee osteoarthritis for obesity was 2.7 (95% 
confidence interval: 1.5-5.1) among men and 4.3 (95% confidence interval: 3.0-6.2) 
among women (table 5.1.2). Low back pain, shoulder joint impairment, and chronic 
neck pain were more common among men with BMI between 25.0 and 29.9 kg/m , 
but the prevalence was not increased in men with BMI >30 .O kg/m . These 
musculoskeletal disorders were more common in women with BMI between 25.0 
and 29.9 kg/m , and in women with BMI >30.0 kg/m (table 5.1.2). 
Table 5.1.1 
Sex 
Men 
Women 
Subjects (%) per category of body mass 
Finland Health Survey 
Number 
2,727 
2,946 
<18.5 
0.5 
1.2 
index among subjects aged 30 to 65 years; Mini-
Body mass index (kg/m2) 
18.5-24.9 25.0-29.9 
43.3 44.9 
50.0 32.5 
>30.0 
11.3 
16.4 
Table 5.1.2 Age-adjusted odds ratios (95% confidence intervals) of chronic musculoskeletal disorders at 
baseline; Mini-Finland Health Survey 
Men, n = 2,727 Total no. of cases (%) 
Body mass index (kg/m2) 
18.5-24.9 25.0-29.9 >30.0 
Hip osteoarthritis 
Knee osteoarthritis 
Low back pain 
Chronic neck pain 
Shoulder joint impairment 
Women, n = 2,946 
Hip osteoarthritis 
Knee osteoarthritis 
Low back pain 
Chronic neck pain 
Shoulder joint impairment 
59 (2.2) 
89 (3.3) 
471 (17.3) 
252 (9.2) 
108(4.0) 
92(3.1) 
282 (9.6) 
478(16.2) 
412(14.0) 
163(5.5) 
1.0(0.5-1.8) 2.0(1.0-4.1) 
1.6(0.9-2.7) 2.7(1.5-5.1) 
1.3(1.0-1.6) 1.1(0.8-1.6) 
1.4(1.0-1.8) 1.1(0.7-1.7) 
1.5(1.0-2.3) 1.0(0.5-1.9) 
1.8(1.0-3.0) 
2.1 (1.5-3.0) 
1.4(1.1-1.7) 
1.4(1.1-1.8) 
1.3(0.9-1.9) 
1.9(1.1-3.5) 
4.3 (3.0-6.2) 
1.3(1.0-1.7) 
1.5(1.1-2.0) 
1.2(0.8-1.9) 
Body mass index below 18.5 kg/m is not presented because of low numbers 
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DIFFICULTIES IN EVERYDAY ACTIVITIES AT BASELINE 
A total of 2,257 m e n a n d women experienced at least one minor difficulty in one of 
the everyday activities listed in table 5.1.3. Difficulties in everyday activities were 1.4 
to 3.2 times more common among obese subjects than among normal weight 
subjects (table 5.1.3). Also, osteoarthritis and the other musculoskeletal disorders 
were associated with difficulties in everyday activities at baseline in each BMI-
category (figure 5.1.1). Overweight remained associated with difficulties in everyday 
activities when adjustments were made for the presence of osteoarthritis and for the 
presence of the other musculoskeletal disorders (table 5.1.4). Among subjects 
without osteoarthritis, the odds ratio of difficulties in everyday activities for obesity 
was 1.4 (95% confidence interval: 1.2-1.7) referred to normal weight. Among 
subjects with osteoarthritis, the odds ratio of difficulties in everyday activities for 
obesity was 1.9 (7.9 divided by 4.1) referred to normal weight. Among those with 
both obesity and osteoarthritis difficulties in everyday activities were 7.9 times (95% 
confidence interval: 4.4-13.9) more common than among those with normal weight 
and no osteoarthritis. Also, overweight was associated with difficulties in everyday 
activities among subjects both with and without other musculoskeletal disorders. 
Table 5.1.3 Age- and sex adjusted odds ratios (95% confidence intervals) of difficulties in everyday 
activities at baseline; Mini-Finland Health Survey* 
Everyday activity Number of 
subjects with 
difficulty 
body mass index (kg/nf) 
18.5-24.9 25.0-29.9 >30.0 
Getting in and out of bed 
Cutting toenails 
Carrying a shop bag or some other object 
of 5 kilos or so at least 100 meters 
Heavy cleaning work (e.g. carrying and 
beating, cleaning windows) 
Dressing and undressing 
Shopping, going to a bank, office or 
similar establishment 
Travelling by train, bus or tram 
Moving 
Climbing one flight of stairs without a rest 
Walking a distance of about half a 
kilometre without a rest 
A minor difficulty in at least one of above 
mentioned everyday activities 
363 
345 
608 
1,935 
467 
536 
525 
707 
640 
740 
2,257 
a Difficulties in everyday activities defined as minor difficult 
1 1.1 (0.9-1.5) 
1 1.1 (0.9-1.5) 
1 0.9(0.7-1.1) 
1 1.2(1.0-1.3) 
1 1.2(0.9-1.5) 
1 1.0(0.8-1.2) 
1 1.0(0.8-1.3) 
1 1.2(1.0-1.5) 
1 1.2(1.0-1.5) 
1 1.2(1.0-1.4) 
1 1.1 (1.0-1.3) 
1.5(1.1-2.0) 
3.2 (2.3-4.2) 
1.4(1.1-1.7) 
1.7(1.4-2.0) 
2.0 (1.6-2.7) 
1.6(1.2-2.0) 
1.7(1.3-2.1) 
1.9(1.5-2.4) 
2.3(1.8-2.9) 
2.2(1.8-2.8) 
1.6(1.3-1.9) 
y' in at least one of the activities listed 
Body mass index below 18.5 kg/m2 is not presented because of low numbers 
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W O R K DISABILITY DURING FOLLOW-UP 
At total of 1,339 m e n a n d women were not fit enough to work at baseline. During 
the follow-up period, 490 work disability pensions were granted, and they were 
clearly related to overweight (figure 5.1.2). Osteoarthritis and the other 
musculoskeletal disorders were related to work disability in each BMi-category. 
Work disability remained associated with overweight after adjustment for the 
presence of osteoarthritis and after adjustment for the presence of other 
musculoskeletal disorders (table 5.1.5). Among subjects without osteoarthritis, the 
relative risk of developing work disability for obesity was 1.8 (95% confidence 
interval: 1.4-2.4) referred to normal weight. Among subjects with osteoarthritis, the 
relative risk of developing work disability for obesity was 1.3 (2.4 divided by 1.8) 
referred to normal weight. Among those with both obesity and osteoarthritis, work 
disability developed 2.4 times (95% confidence interval: 1.3-4.3) more often than 
among those with normal weight and no osteoarthritis. Also, overweight was 
associated with the onset of work disability among subjects both with and without 
other musculoskeletal disorders. 
Using the relative risk of work disability from figure 5.1.2A and the proportions of 
men and women per category, it can be calculated that 16.1% of the work disability 
pensions was attributable to overweight (BMI >25.O kg/m2) and osteoarthritis, of 
which 82.6% to overweight alone, 4.0% to osteoarthritis alone and 13.4% to having 
both overweight and osteoarthritis. 
Table 5.1.4 Odds ratios (95% confidence interval) of difficulties in everyday activities at baseline; 
Mini-Finland Health Survey 
Body mass index (kg/m2) 
Adjustment made for age, gender, and 18.5 - 24.9 25.0 - 29.90 > 30.0 
Baseline presence of osteoarthritis in knee or hip 1 1 . 1 (1.0-1.3) 1.4 (1.2-1.7) 
Baseline presence of other musculoskeletal disorders* 1 1.1(0.9-1.2) 1.6(1.3-1.9) 
a Other musculoskeletal disorders are low back pain, shoulder joint impairment or chronic neck pain 
Body mass index below 18.5 kg/m2 is not presented because of low numbers 
Table 5.1.5 Relative risks (95% confidence interval) of future work disability; Mini-Finland Health Survey 
Body mass index (kg/m2) 
Adjustment made for age, gender, and 18.5 - 24.9 25.0 - 29.90 > 30.0 
baseline presence of osteoarthritis in knee or hip 1 1.2 (1.0-1.5) 1.8 (1.4-2.3) 
baseline presence of other musculoskeletal disorders" 1 1.2 (1.0-1.4) 1.8 (1.4-2.3) 
a Other musculoskeletal disorders are low back pain, shoulder joint impairment or chronic neck pain 
Body mass index below 18.5 kg/m2 is not presented because of low numbers 
Subjects who were not fit enough to work at baseline were exluded 
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Discussion 
The present study shows a strong association between overweight and osteoarthritis 
of the knee and hip, and somewhat weaker associations between overweight and 
chronic low back pain, shoulder joint impairment and neck pain. Moreover, 
overweight was associated with difficulties in everyday activities at baseline and with 
increased risk of work disability during follow-up among both subjects with and 
without osteoarthritis and both with and without the other musculoskeletal 
disorders. The effects of overweight and osteoarthritis were multiplicative, resulting 
in an almost eight-fold risk of difficulties in everyday activities and a nearly 2.5-fold 
risk of work disability among subjects with both obesity and osteoarthritis. The 
relative risk of disability was higher for osteoarthritis than for overweight, but 
overweight was much more common than osteoarthritis. Therefore, more disability 
was attributable to overweight than to osteoarthritis. 
The suggestion that overweight is associated with osteoarthritis is not new, ' but 
evidence for a relation that is based on clinical data from a general population is 
scarce. In our population based study the presence of osteoarthritis was measured 
using the same objective protocol for every individual, regardless of their BMI level, 
which excludes reporting bias. We cannot, however, exclude the possibility that 
subjects became overweight as a result of suffering from osteoarthritis, but the 
available studies with longitudinal data strongly suggest that overweight predicts the 
onset of osteoarthritis during a follow-up. " The relation between overweight and 
osteoarthritis can be explained by the high pressure in overweight individuals on 
the weight bearing joints, such as knee and hip. The stronger association of 
overweight with osteoarthritis in the knee than in the hip is compatible with this 
explanation. Also, a metabolic explanation is possible, as suggested by the 
association between overweight and incident osteoarthritis in the hand. 
The findings concerning overweight and chronic low back pain, shoulder joint 
impairment and neck pain have been inconsistent in previous studies, of which 
many are beset with methodological problems."' The association between 
overweight and these musculoskeletal disorders in the present study was not 
straightforward. Among men, a BMI between 25.0 and 29.9 kg/m2 was, but a BMI > 
30.0 kg/m2 was not associated with these musculoskeletal disorders. Among women 
a BMI >30.o kg/m2 was not more associated with these musculoskeletal disorders 
than a BMI between 25.0 and 29.9 kg/m2. It is possible that subjects with a BMI > 
30.0 kg/m2 tend to avoid physically demanding tasks in general life and at work, 
and are therefore relatively protected from an onset of low back pain, shoulder joint 
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Figure 5.1.1a Age- and sex adjusted odds ratios with 95% confidence interval of difficulties in everyday 
activities at baseline, among subjects with and without osteoarthritis 
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impairment and chronic neck pain. The potentially causal relation between 
overweight and low back pain might be explained by high intradiscal pressure and 
increased stress in other spinal structures in overweight individuals.' Higher odds 
ratios of low back pain for high waist circumference than for high BMI, found by 
Han et al, suggest that an altered gait in subjects with a large waist may have a 
causal role in the onset of low back pain. Longitudinal studies should further 
assess the association between overweight and these musculoskeletal disorders. 
The present study clearly shows the strong role of overweight in the onset of 
disability. First, overweight is associated with the presence of osteoarthritis, which is 
an important cause of disability. Second, overweight determines disability during 
follow-up in a healthy population without osteoarthritis or other musculoskeletal 
disorders. Third, even among patients with osteoarthritis or other musculoskeletal 
disorders, in which the risk of disability is already increased, overweight is an 
important extra risk factor for developing disability during follow-up. 
Given the about 8-fold increased risk of difficulties in everyday activities and the 
nearly two-and-a-half-fold risk of future risk of work disability in obese 
osteoarthritis patients, a new paradigm of the treatment of osteoarthritis is 
warranted in which the control of body weight gets high priority. Lack of 
controlling body weight is a crucial risk factor for a vicious circle of gaining weight, 
developing osteoarthritis, developing disability, becoming less physically active and 
thereby gaining weight. The finding that relative risks of developing work disability 
were lower than the very high odds ratios of difficulties in everyday activities, could 
be explained by the exclusion of subjects with musculoskeletal disorders from the 
longitudinal analyses already work disabled. Also, subjects with musculoskeletal 
disorders experiencing difficulties in everyday activities could have had less 
physically demanding jobs, and could thus be protected from work disability. 
Participation rate in the Mini-Finland Health survey was high (>90%), the set up 
was representative for the Finnish population, the screening phase was effective,1 
and all definitions of disease status were based on objective and clinical definitions 
by professionals. We assumed that all given prevalence data are very close to the 
prevalence in the Finnish population aged 30 to 65 years. Linking our population 
data to the incident work disability data of the Social Insurance Institution's 
nation-wide register was easily done by using the Finnish personal identity code. 
There is no indication suggesting that our results cannot be generalised to other 
western societies. 
1 0 0 
CONCLUSION 
Overweight determines chronic musculoskeletal morbidity, especially the 
prevalence of osteoarthritis. Overweight also independently predicts the 
development of disability. Control of body weight has great potential in reducing 
musculoskeletal disorders and disability in a healthy population. Moreover, control 
of body weight should get high priority in the treatment of osteoarthritis. 
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Chapter 5.2 
THE POTENTIAL EFFECT OF WEIGHT GAIN PREVENTION 
ON THE INCIDENCE OF OSTEOARTHRITIS AND WORK 
DISABILITY 
A b s t r a c t Obesity is related to osteoarthritis and work disability. For the purpose of this study, 
the mathematical Chronic Diseases Model was used to study the potential effect of prevention of 
small weight gain on the incidence of knee osteoarthritis and work disability in the Dutch 
working aged population. Input data for the model were required on baseline distribution of body 
mass index (BMI) categories, general and BMi-specific occurrence of osteoarthritis and work 
disability, and on all-cause mortality rates. A weight gain prevention program was simulated in 
which nobody changed between BMI categories during a follow-up of ten years. BMI categories 
were defined as BMI <22.5, BMI 22.5-24.9, BMI 25.0-27.4, BMI 27.5-29.9, BMI 30.0-32.4, and BMI 
>32.5 kg/m2. If weight gain prevention was carried out during a period often years, the increase in 
the prevalence of obesity with 3.5 percentage points, which would have occurred without 
prevention, was prevented. Consequently, there were 8,000 (5%) fewer new cases of osteoarthritis 
in men and 18,000 (6%) in women, if weight gain was prevented. In addition, 6,000 (2%) cases 
of work disability in men and 13,000 (3%) in women could be prevented by weight gain 
prevention during a follow-up often years. Although results should be interpreted with caution, it 
can be concluded that prevention of small amounts of weight gain, are potentially effective in 
preventing large number of osteoarthritis and work disability. The present results are supportive to 
put effort in taking action in the field of weight gain prevention. 
Tommy LS Visscher, Rudolf T Hoogenveen, and Jacob C Seidell. Submitted for publication. 
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Introduction 
The prevalence of obesity has increased steadily during the last few decades of the 
20' century in western societies. Increasing obesity prevalence rates have 
consequences for public health, because obesity is related to excess mortality and to 
excess morbidity and disability in particular. The role of obesity in cardiovascular 
diseases and type 2 diabetes mellitus is well accepted. In addition, evidence is 
accumulating that obesity is related to musculoskeletal disorders such as 
osteoarthritis." Osteoarthritis, in turn, is an important risk factor for work 
disability. Obesity is also linked to disability independently from osteoarthritis 
(chapter 5.1). A longitudinal study in a Finnish representative population showed 
that obesity was related to the onset of work disability due to cardiovascular 
diseases, musculoskeletal disorders and accidents that occurred most often in obese 
subjects. Based on a study on obese Swedish women, it has been calculated that 
approximately 10% of the total cost of loss of productivity due to sick leave and 
work disability is attributable to morbid obesity.11 
Weight gain is the result of an imbalance between energy intake and energy 
expenditure. Small changes in energy balance may lead to relatively large yearly 
weight chances. ' For instance, a reduction in energy expenditure of 20 kcal/day is 
estimated to lead to one kg weight increase per year. If large yearly changes in body 
weight could indeed be prevented, prevention of minor changes in the energy 
balance may be important for prevention of disease and disability. 
The present study assessed the impact of partial prevention of relatively small 
positive changes in the energy balance on the incidence of knee osteoarthritis and 
work disability. For this purpose, we used mathematical modelling to assess the 
effects of a reduction in weight gain at the level of the Dutch working-aged 
population. 
Methods 
STUDY POPULATION 
The Dutch population aged 20-59 years serves as study population in our 
mathematical model. Age 60-64 years is the general age of retirement in the 
Netherlands, as in most other European countries. The five-years age distribution 
in the Netherlands in 1994 was derived from Statistics Netherlands.1 
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MATHEMATICAL SIMULATION MODEL 
The Chronic Diseases Model was used to simulate the study population's life 
course regarding changes in body mass index (BMI). The Chronic Diseases Model is 
a dynamic multistage life-table based model, which has been constructed at the 
National Institute of Public Health and the Environment. Yearly time steps are 
simulated in which subjects change between risk factor categories; BMI categories in 
the present study. By manipulating these time steps, different changes in BMI level 
can be evaluated regarding different outcomes of disease and disability. Input data 
are required regarding the baseline distribution of BMI categories in the study 
population, on the general occurrence of disease or disability in the study 
population, and on BMI specific incidence of disease and disability. For the purpose 
of the present study the occurrence of new osteoarthritis and work disability was 
evaluated after ten yearly time steps. 
BODY MASS INDEX CATEGORIES 
Distribution of BMI at baseline is derived from the Dutch Monitoring on risk 
factors for chronic diseases (MORGEN) project 1993-1997 on subjects aged 20-59 years 
(chapter 3.1). Changes in BMI for those who become older than 60 during follow-up 
is derived from the Rotterdam Study.' BMI is calculated as body weight divided by 
height squared (kg/m). BMI categories were defined as follows: BMI <22.5, 22.5-
24.9, 25.0-27.4, 27.5-29.9, 30.0-32.4, and ^32.5 kg/m . Overweight is defined as BMI 
25.0-29.9 kg/m2 and obesity as BMI >30.O kg/m2 by the World Health 
Organization. 
OSTEOARTHRITIS 
Input data on the general incidence of knee osteoarthritis, regardless of BMI, is 
estimated from the Dutch studies EPOZ and CMR-Nijmegen. In EPOZ nine cases of 
knee osteoarthritis occurred per 1,000 person-years in men and 24 cases of knee 
osteoarthritis occurred per 1,000 person-years in women. Subjects were aged 46-68 
years at baseline 1975-1978. In 1988-1989, a radiograph was taken to define the 
presence of osteoarthritis. For our population aged 20-45 years, we also used data 
from EPOZ as input data in the Chronic Diseases Model. As osteoarthritis is more 
common in older than in younger ages, however, a correction on the EPOZ data had 
to made to derive incidence rates on subjects aged younger than 45 years and 
younger. This correction factor was based on the different occurrence in 
osteoarthritis between young men and women from CMR-Nijmegen. CMR-
Nijmegen defined osteoarthritis symptomatically. Although this may lead to 
different incidence rates compared to radiographically defined cases, we assume that 
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the difference between old and young age groups may not differ with different case 
definitions. Data on the longitudinal relation between BMI and osteoarthritis in the 
knee were scarce, and most studies were not appropriate as input data in the 
Chronic Diseases Model for the purpose of the present study. One study presented 
an odds ratio for the third compared to the first tertile of BMI, one presented 
relative risks for the highest two quintiles of Metropolitan Relative Weight, two 
studies included symptomatic osteoarthritis in the case definitions,' and one study 
was based on recalled weight 35 years before the baseline. Data from the 
Framingham Study was most appropriate to use as input data for the Chronic 
Diseases Model, although the age was higher (mean: 70 years, range: 63-92 years) 
than our study population. It was assumed that relative risks of obesity for OA are 
similar across age-categories. The relative risk that was presented for men and 
women combined (1.6 per unit of BMI) was used as input data for the Chronic 
Diseases Model, under the assumption that the relation between BMI and 
osteoarthritis is similar in men and women. Although the presented relative risks 
differed between men and women, confidence intervals were widely overlapping. 
Relative risk for osteoarthritis was 1.0 (95% confidence interval: 0.5-2.2) in men and 
1.8 (95% confidence interval: 1.2-2.6) in women per unit BMI. From the relative risk 
per unit BMI presented for men and women combined, relative risks were calculated 
per BMi-category for men and women separately, according to 
RRi = 1.6 EXP((mean BMI/ - mean BMIr^/5) (formula 5.2.1) 
with RRi indicating relative risk for BMI category i, and BMlref indicating the 
reference BMI category. 
W O R K DISABILITY 
Incidence data on work disability in the Netherlands were derived from the Dutch 
National Institute of Social Insurances (LisV). Working people are eligible to 
receive a work disability pension after 52 weeks of sick leave in the Netherlands. For 
the purpose of the present study, work disability was defined as 80-100% work 
disabled, which is the most severe category according to the LisV classifications. 
Relative risks for work disability were derived from a Finnish population-based 
cohort study that presented relative risks of BMI categories <22.5, 22.5-24.9, 25.0-
27.4, 27.5-29.9, 30.0-32.4, and >32.5 kg/m2. This study derived data on work 
disability from the Finnish Social Insurance Institution. Work disability was 
defined as 100% work disability in this study. BMI categories were based on 
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measured body weight and height. Follow-up on work disability was complete 
because of the use of the unique identity code for all individuals studied.1 Only one 
other longitudinal study on the relation between BMI and work disability could be 
found, but this study comprised mainly severely overweight women. 
ALL-CAUSE MORTALITY 
Standard mortality data in the Dutch population is derived from Statistics 
Netherlands. 
W E I G H T GAIN PREVENTION SCENARIOS 
The reference scenario is the situation in which no prevention of weight gain is 
undertaken during a period of ten years. For this reference scenario, we defined the 
increase in BMI and the prevalence of obesity according to the increases that are 
associated with increasing age. Age-related differences in mean BMI and the 
prevalence of obesity in the cross-sectional MORGEN project 1993-1997 were small 
enough to assume that prevention of such weight gain is potentially reasonably 
achieved. Regarding the main scenario on weight gain prevention, we defined yearly 
time steps such that no individual could change between BMI categories. In 
addition, we modelled weight gain prevention scenarios in which changes between 
BMI categories were not possible in individuals with BMI <i'].^ kg/m and in 
individuals with BMI ^27.5 kg/m separately. 
Results 
Obesity (BMI >30 .O kg/m ) was present in 8.4% of the 4.5 million men and in 9.6% 
of the nearly 4.5 million women that comprised the study population aged 20-59 
years at baseline (table 5.2.1). 
If no prevention would be undertaken, mean BMI would rise with 0.9 kg/m in both 
men and women. The prevalence of obesity would rise with 3.5 percentage points to 
11.9% in men. In women, the prevalence of obesity would rise with 3.5 percentage 
point to 13.0% during a follow-up of ten years (table 5.2.1). Concurrently, about 
175,000 and 320.000, new cases of knee osteoarthritis would occur in men and 
women, respectively, during the ten years of follow-up (table 5.2.2). Work disability 
would occur in more than 300,000 men and 450,000 women if weight gain was not 
prevented. 
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Table 5.2.1 Mean body mass index (kg/m2) and the prevalence of obesity (%) in the Netherlands at 
baseline and ten years after baseline if no weight gain prevention would have been 
undertaken (according to the reference scenario) 
Age at baseline (years) 
20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 All 
Men (n=4.530.055) 0.14 0.15 
Women (n4.359.900) 0.14 0.15 
Men and women per age group (%) 
0.14 0.13 0.13 0.13 0.10 0.08 
0.14 0.13 0.13 0.13 0.10 0.08 
Mean body mass index (kg/m2) 
Men 
Baseline 
Ten years after baseline 
Change during follow-up 
Women 
Baseline 
Ten years after baseline 
Change during follow-up 
23.3 
24.7 
1.4 
23.2 
23.8 
0.6 
23.9 
25.1 
1.2 
23.4 
24.1 
0.7 
24.5 
25.6 
1.1 
23.7 
24.6 
0.9 
25.0 
26.0 
1.0 
24.1 
25.2 
1.1 
25.5 
26.4 
0.9 
24.6 
25.9 
1.3 
26.0 
26.8 
0.8 
25.2 
26.5 
1.3 
26.4 
27.0 
0.6 
25.9 
27.0 
1.1 
26.7 
26.9 
0.2 
26.5 
26.8 
1.3 
25.0 
25.9 
0.9 
24.4 
25.3 
0.9 
Prevalence of obesity (%); Body mass index >30 kg/m2 
Men 
Baseline 
Ten years after baseline 
Change during follow-up 
Women 
Baseline 
Ten years after baseline 
Change during follow-up 
3.2 
6.7 
3.5 
5.1 
7.5 
2.4 
4.7 
8.5 
3.8 
5.8 
8.5 
2.7 
6.2 
10.2 
4 
6.9 
10.0 
3.1 
7.8 
11.8 
4 
8.2 
12.1 
3.9 
9.6 
13.7 
4.1 
10.1 
14.8 
4.7 
11.6 
15.6 
4.0 
12.4 
18.0 
5.6 
13.7 
16.6 
2.9 
15.4 
20.3 
4.9 
15.1 
15.6 
0.5 
17.8 
19.2 
1.4 
8.4 
11.9 
3.5 
9.5 
13.0 
3.5 
If weight gain prevention would be undertaken at population level, mean BMI will 
not change in men and women. The prevalence of obesity will decrease with 0.3 
percentage points in men and with 0.2 percentage points in women due to weight 
gain prevention at population level (table 5.2.2). If weight gain would be prevented, 
8,000 (5%) and 18,000 (6%) new cases of osteoarthritis in men and women, 
respectively, could be prevented during the ten years follow-up (table 5.2.3). In 
addition, 6,000 (2%) and 13,000 (3%) new cases of work disability could be 
prevented in men and women, respectively, if weight gain was prevented in all 
individuals (table 5.2.4). 
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Table 5.2.2 Mean body mass index (kg/m2) and the prevalence of obesity (%) in the Netherlands at 
baseline and after ten years if weight gain prevention had been undertaken at population 
level 
Men 
Baseline 
Ten years after baseline 
Change during follow-up 
Women 
Baseline 
Ten years after baseline 
Change during follow-up 
Men 
Baseline 
Ten years after baseline 
Change during follow-up 
Women 
Baseline 
Ten years after baseline 
Change during follow-up 
20-24 
23.3 
23.3 
0.0 
23.2 
23.2 
0.0 
3.2 
3.2 
0.0 
5.1 
5.1 
0.0 
25-29 
23.9 
23.9 
0.0 
23.4 
23.4 
0.0 
4.7 
4.7 
0.0 
5.8 
5.8 
0.0 
30-34 
24.5 
24.5 
0.0 
23.7 
23.7 
0.0 
6.2 
6.2 
0.0 
6.9 
6.8 
-0.1 
Age at baseline (years) 
35-39 40-44 
Mean body mass 
25.0 
25.0 
0.0 
24.1 
24.1 
0.0 
25.5 
25.5 
0.0 
24.6 
24.6 
0.0 
45-49 
ndex (kg/m 
26.0 
26.0 
0.0 
25.2 
25.2 
0.0 
Prevalence of obesity (%) 
7.8 
7.7 
0.1 
8.2 
8.1 
-0.1 
9.6 
9.5 
-0.4 
10.1 
10.0 
-0.1 
11.6 
11.4 
-0.2 
12.4 
12.2 
-0.2 
50-54 
2) 
26.4 
26.4 
0.0 
25.9 
25.9 
0.0 
13.7 
13.3 
-0.4 
15.4 
15 
-0.4 
55-59 
26.7 
26.6 
-0.1 
26.5 
26.4 
-0.1 
15.1 
14.4 
-0.7 
17.8 
17.1 
-0.7 
20-59 
25.0 
25.0 
0.0 
24.4 
24.4 
0.0 
8.4 
8.1 
-0.3 
9.5 
9.3 
-0.2 
If weight gain would be prevented in men and women with a BMI <TJ.^, kg/m , the 
number of knee OA cases that could be theoretically prevented was similar as if 
weight gain would be prevented in men with BMI ^27.5 kg/m (table 5.2.3). Among 
men the number of new cases of work disability that could be prevented was 1.5 
times higher when weight gain was prevented in men with BMI <XJ.^, kg/m , 
compared to weight gain prevention in men with BMI ^27.5 kg/m . Among women, 
the opposite was reported. Nearly three times more new cases of work disability 
could be prevented if weight gain was prevented in women with BMI ^27.5 kg/m 
than if weight gain was prevented in women with BMI <27_5 kg/m (table 5.2.4). 
Discussion 
Prevention of a small amount of weight gain may prevent an increase in the obesity 
prevalence with 3.5 percentage points in both men and women from the Dutch 
population aged 20-59 years that would occur if no prevention would be performed. 
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Table 5.2.3 Number of new cases of knee osteoarthritis that could be prevented due to weight gain 
prevention in the Dutch working aged-population during a follow-up of ten years 
Category of subjects in whom weight gain prevention is carried out 
Body mass index (kg/m2) 
All subjects <27.5 >27.5 
Men 
five years after baseline 
ten year after baseline 
Women 
five years after baseline 
ten year after baseline 
2,143 
8,268 
4,776 
18,413 
1,136 
4,324 
2,471 
9,367 
1,046 
4,291 
2,414 
9,996 
Moreover, the prevalence of obesity was slightly decreased if prevention was carried 
out, e.g. if nobody changed to a higher BMI category. Consequently, 26,000 (5%) 
new cases of osteoarthritis and 19,000 (2.5%) new cases of work disability could be 
prevented among men and women, when the Dutch working-aged population was 
followed for ten years. The preventable incidence of knee osteoarthritis and work 
disability was higher in women than in men. Weight gain prevention in subjects 
with a BMI <27_5 kg/m and in subjects with a BMI ^27.5 kg/m2 leaded to similar 
proportions of prevented osteoarthritis. Weight gain prevention in men with a BMI 
<27_5 kg/m was somewhat more effective in preventing work disability then weight 
gain prevention in men with a BMI ^27.5 kg/m . In women more work disability 
could be prevented by weight gain prevention in women with a BMI ^27.5 kg/m 
compared to weight gain prevention in women with a BMI <27.5 kg/m . 
Osteoarthritis is one of the most important risk factors for disability.1 
Osteoarthritis is a non-inflammatory damage of the joint, especially of the cartilage 
tissue. The relation between obesity and osteoarthritis may be explained by 
increased pressure on weight bearing joints. The stronger relation of obesity to 
osteoarthritis of the knee than of the hips is compatible with this explanation. 
There might also be a metabolic explanation for the relation between obesity and 
osteoarthritis because obesity is also related to an increased risk of osteoarthritis in 
the hands. Other musculoskeletal disorders that are possibly related to obesity are 
low back pain, shoulder joint impairment and chronic neck pain. Longitudinal 
data on this subject, however, are scarce. Osteoarthritis is more common in elderly 
populations than in the present study population aged 20-59.years We suppose that 
weight gain prevention to avoid osteoarthritis is particularly important in elderly. 
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Table 5.2.4 Number of new cases of work disability that could be prevented due to weight gain 
prevention in the Dutch working aged-population during a follow-up of ten years 
Category of subjects in whom weight gain prevention is carried out 
Body mass index (kg/m2) 
All subjects <27.5 >27.5 
Men 
five years after baseline 
ten year after baseline 
Women 
five years after baseline 
ten year after baseline 
1,494 
5,539 
3,703 
13,050 
956 
3,526 
955 
3,333 
565 
2,245 
2,752 
9,787 
Obesity is clearly related to work disability. This relation may be, at least in part, 
explained by obesity-related osteoarthritis. Nonetheless, more work disability is 
attributable to obesity than to osteoarthritis (chapter 5.1). Other explanations for a 
relation between obesity and work disability are disabilities due to coronary heart 
disease and diseases of the back.1 In men somewhat more work disability was 
prevented if weight gain prevention was carried out in those with a BMI <vj.^ 
kg/m , whereas in women more work disability was prevented if weight gain 
prevention was carried out in those with a BMI ^27.5 kg/m . This difference 
between men and women could probably be explained by a relatively stronger 
relation between moderate overweight and work disability in men and a stronger 
relation between severe overweight do work disability in women. Since men tend to 
have more physically demanding jobs, overweight might lead to work disability 
earlier in men than in women. Obesity has large economic consequences because of 
loss of productivity. It has been calculated that 10% of productivity loss due to sick 
leave and disability was attributable to obesity, according to a Swedish population 
of obese women. It should be noted that productivity loss is estimated being 10% 
lower if all obesity could be prevented. Our estimation of a preventable 2% of work 
disability in men and 3% in women is based on prevention of a small amount of 
weight gain. 
Mathematical modelling is a powerful tool to learn about potential efficacy of 
intervention strategies, such as weight gain prevention programs, on the incidence 
of disease and disability at population level. Results of mathematical modelling, 
however, should be interpreted with caution, because several assumptions have to 
be made on uncertainties. Regarding the present study, it could be questioned 
whether input data on the BMI distribution from the MORGEN project 1993-1997 is 
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representative for the Dutch population. Data were collected in three cities only, 
Amsterdam, Doetinchem, and Maastricht. In addition, higher educational levels 
were over-represented in the MORGEN project. Body weight is generally lower in 
high educational categories compared to lower educational categories in western 
societies. It cannot be established whether selective participation by BMI was 
disproportional across age groups. Such disproportional participation could lead to 
a biased estimate of the increase in BMI due to increasing age. Furthermore, 
longitudinal increases in BMI according to the reference scenario were calculated 
from cross-sectional data on age-related increases in BMI. Different age categories 
are from different birth years and it is not clear how BMI increased within each birth 
cohort. Moreover, an extra increase in BMI due to a time-trend in mean BMI and 
prevalence of obesity has not been taken into account. The increase in BMI 
according to the reference scenario would have been somewhat larger if a time-
trend was taken into account, especially in those with high initial BMI. The secular 
increase in levels of BMI among those with low initial BMI is reported to be 
considerably low. 
Relative risks of obesity for osteoarthritis and work disability that are used in the 
Chronic Diseases Model are based on a small number of studies and could not be 
derived from Dutch studies. An advantage of the studies that were selected to derive 
input data for the Chronic Diseases Model is that internal validity of these studies 
was high. The relative risks of BMi-categories for osteoarthritis presented by Felson 
et al. were based on longitudinal data. BMI was measured and not reported, which 
might have leaded to underestimation of body weight, especially in the subjects 
with high BMI. Osteoarthritis diagnosis was based on radiographs. It would be of 
value, however, to be able to compare these relative risks, with wide confidence 
intervals, to more other longitudinal studies with similar methodology. The relative 
risks that we used in the model are relatively low compared to the few other 
longitudinal studies and the cross-sectional studies reported in table 5.2.2. A 
possible explanation is that there might be an interaction between obesity and high 
levels of physical activity levels in causing osteoarthritis. Intense physical activity in 
the Framingham Study (age: 63-93 years) of which data were used as input for the 
Chronic Diseases Model is likely less common than in our study population aged 
20-59 years. Our estimations of preventable osteoarthritis by weight gain prevention 
may therefore be conservative for the age group 20-59 years. Internal validity of the 
study on BMI and work disability by Rissanen and et al. is also high.10 Data were 
derived from a large population based cohort study. BMI was measured and follow-
up data on work disability were complete because data were linked to the national 
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register on work disability pensions. Relative risks presented by Rissanen et al. were 
lower than the relative risks for work disability pensions in the study by Narbro et 
al.,'1 but in that study relative risks were presented for severe obesity. The definition 
of work disability was somewhat different in Finland and the Netherlands. Subjects 
in Finland who received a work disability pension were 100% work disabled. 
Subjects in the Netherlands were 80-100% work disabled. It is not clear whether 
the relation between obesity and these two definitions of work disability would 
differ. 
Prevented changes in BMI in the present study were small and may seem reasonably 
to achieve. The maximum increase in mean BMI to be prevented was 1.3 kg/m over 
a follow-up of ten years, in women aged 45-49 years, which corresponds with 0.40 
kg weight change per year for a person with average height (1.70 m). A weight 
change in this order of magnitude is correlated with a crudely estimated change in 
the energy balance of 50 kcalories per week. Examples of energy intake and energy 
expenditure being associated with 50 kcalories are, respectively, half a glass of beer 
and twelve minutes of bicycling per week. ' Successful weight gain prevention 
programs with long-term success on prevention of weight gain, however, have not 
been presented. The future challenge will be to develop and implement weight gain 
prevention programs. Some authors have suggested that new prevention programs 
will have to take into account the 'obesogenic environment.' It is argued that 
weight gain is the result of a normal physiologic reaction to a pathologic 
environment, rather than a pathologic reaction to the environment. 
CONCLUSION 
The potential effects of prevention of small weight changes on the public health 
have been presented in the present study. These large potential effects on the 
preventable incidence of osteoarthritis and work disability are supportive to put 
effort in taking action in the field of weight gain prevention. 
References 
1. Seidell JC, Rissanen A. Time trends in the worldwide prevalence of obesity. In: The 
handbook of obesity. 79-91. New York, USA. 1997. M Dekker, ed. 
2. Visscher TLS, Seidell JC. The public health impact of obesity. Annu Rev Public Health 
2001; 22: 355-75. 
3. Bjorntorp P. Body fat distribution, insulin resistance, and metabolic diseases. Nutrition 
1997; 13: 795-803. 
113 
4. Felson DT, Zhang Y, Hannan MT et ai. Risk factors for incident radiographic knee 
osteoarthritis in the elderly: The Framingham Study. Arthritis Rheum 1997; 40: 728-33. 
5. Oliveria SA, Felson DT, Cirillo PA, Reed JI, Walker AM. Body weight, body mass index, 
and incident symptomatic osteoarthritis of the hand, hip, and knee. Epidemiology 1999; 
10:161-6. 
6. Felson DT, Anderson JJ, Naimark A, Walker AM, Meenan RF. Obesity and knee 
osteoarthritis. The Framingham Study. Ann Intern Med 1988; 109: 18-24. 
7. Felson DT, Zhang Y, Anthony JM, Naimark A, Anderson JJ. Weight loss reduces the risk 
for symptomatic knee osteoarthritis in women. The Framingham Study. Ann Intern Med 
1992; 116: 535-9. 
8. Seidell JC, Bakx KC, Deurenberg P, van den Hoogen HJ, Hautvast JG, Stijnen T. 
Overweight and chronic illness, a retrospective cohort study, with a follow-up of 6-17 
years, in men and women of initially 20-50 years of age. / Chronic Dis 1986; 39: 585-93. 
9. Hart DJ, Spector TD. The relationship of obesity, fat distribution and osteoarthritis in 
women in the general population: The Chingford Study. J Rheumatol 1993; 20: 331-5. 
10. Rissanen A, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Maatela J. Risk of disability 
and mortality due to overweight in a Finnish population. .BA//1990; 301: 835-7. 
11. Narbro K, Jonsson E, Larsson B, Waaler H, Wedel H, Sjostrom L. Economic 
consequences of sick-leave and early retirement in obese Swedish women. Int J Obes 1996; 
20: 895-903. 
12. World Health Organization. Obesity - Preventing and managing the global epidemic, 
report of a WHO consultation on obesity. Geneva, Switzerland, 1997, WHO/NUT/NCD/98 1. 
13. Seidell, JC. The current epidemic of obesity. In: Physical activity and obesity. 21-30. 
2000. Human Kinetics. Bouchard C. ed. 
14. Statistics Netherlands, http://www.cbs.nl/nl/nieuws/artikelen/archive/artikel.asp?jr=2000 
&id=0573k&dt=i7-07-oo. Accessed: July 2001. (Homepage Statistics Netherlands, 
Voorburg/Heerlen, the Netherlands). 
15. Hofman A, Valkenburg HA. Een epidemiologisch onderzoek naar risico-indicatoren voor 
hart- en vaatziekten (EPOZ). II. Voorkomen, opsporing en behandeling van hypertensie in 
een open bevolking (In Dutch). Ned Tijdschr Geneeskd 19S0; 124: 189-95. 
16. Makela M, Heliovaara M, Sievers K, Knekt P, Maatela J, Aromaa A. Musculoskeletal 
disorders as determinants of disability in Finns aged 30 years or more. / Clin Epidemiol 
1993; 46: 549-59-
17. Heliovaara M, Makela M, Knekt P, Impivaara O, Aromaa A. Determinants of sciatica 
and low-back pain. Spine 1991; 16: 608-14. 
18. Makela M, Heliovaara M, Sainio P, Knekt P, Impivaara O, Aromaa A. Shoulder joint 
impairment among Finns aged 30 years or over: prevalence, risk factors and co-morbidity. 
Rheumatology 1999; 38: 656-62. 
114 
19- Makela M, Heliovaara M, Sievers K, Impivaara O, Knekt P, Aromaa A. Prevalence, 
determinants, and consequences of chronic neck pain in Finland. Am J Epidemiol 1991; 
134:1356-67. 
20. Stichting NEVO. NEVO tabel. Nederlands voedingsstoffenbestand 1996 (Dutch 
Nutrient Data Base 1996). Den Haag. Voorlichtingsbureau voor de voeding (In Dutch). 
1996. 
21. Ainsworth BE, Haskell WL, Leon AS et ai. Compendium of physical activities: 
classification of energy costs of human physical activities. Med Sci Sports Exerc 1993; 25: 71-
80. 
22. Swinburn B, Egger G, Raza F. Dissecting obesogenic environments: the development and 
application of a framework for identifying and prioritizing environmental interventions 
for obesity. Prev Afe/1999; 29: 563-70. 
23. Egger G, Swinburn B. An "ecological" approach to the obesity pandemic. BA//1997; 315: 
477-80. 
"5 
Chapter 5.3 
OVERWEIGHT, OBESITY AND UNHEALTHY LIFE YEARS IN 
ADULT FINNS, AN EMPIRICAL APPROACH 
A b s t r a c t Overweight and obesity have important impact on the incidence of several chronic 
diseases and on work disability. It is presently unknown how many more unhealthy life years 
obese subjects have compared to normal weight subjects. To compare the number of unhealthy 
life years between categories of body mass index (BMI), a representative cohort of 19,518 Finnish 
men and women aged 20 to 92 years were followed for a maximum of 15 years. Participation rate 
was 83%. We measured BMI at baseline and classified subjects into World Health Organization 
categories of overweight. We linked baseline BMI to incidence of work disability, hospitalisation for 
cardiovascular diseases and use of medication due to chronic diseases by record linkage. Obese 
subjects had increased relative risks for morbidity and disability. These relative risks exceeded 
those for mortality, and were highest in the youngest age groups. During a maximum follow-up 
of 15 years, obese men (BMI >30.O kg/m) aged 20-64 years had 0.5, 0.4, and 1.7 more years of 
work disability, cardiovascular diseases, and morbidity leading to long-term medication, 
compared to men with normal weight (BMI 18.5-24.9 kg/m ). Obese women suffered respectively 
0.5, 0.4, and 1.3 more years from these conditions, compared to women with normal weight. In 
subjects aged 65 years and older, obesity increased the number of unhealthy years due to 
morbidity leading to long-term medication. From this study, it is concluded that obesity has an 
important effect on unhealthy life expectancy. 
Tommy LS Visscher, Aila Rissanen, Jacob C Seidell, Markku Heliovaara, and Paul Knekt. 
Submitted for publication. 
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Introduction 
Obesity often runs a long and disabling course with important health and economic 
consequences.' It is now well accepted that obesity contributes to the total burden 
of disease due to its role in the onset of cardiovascular diseases and type 2 diabetes 
mellitus." Furthermore, evidence is accumulating that obese subjects develop more 
often osteoarthritis, suffer more from disability and have a lower quality of life than 
normal weight individuals.7" 
The direct health care costs due to obesity have been estimated at around 6% of the 
total health care expenditure in the United States and at i to 5% in western 
European countries, where the prevalence of obesity is lower than in the United 
States. Allison et ai, however, argued that direct health care cost estimations of 
obesity are probably over-estimations, since obesity not only induces disease and 
disability, but also reduces longevity. 
Thompson and colleagues did take into account the relation between obesity and 
reduced longevity when they calculated lifetime risks and economic consequences 
of obesity. They calculated that the lifetime costs for treatment of hypertension, 
hypercholesterolaemia, type 2 diabetes mellitus, coronary heart disease, and stroke, 
among men aged 45 to 54 years, were $29,600 and $36,500 among those with body 
mass index (BMI) being 32.5 and 37.5 kg/m , respectively, compared to $19,600 
among those with BMI being 22.5 kg/m2. 
Oster et al. calculated that 10% weight loss could reduce the number of life-years 
with hypertension with 1.2 to 2.9 years and the number of life-years with type 2 
diabetes mellitus with 0.5 to 1.7 years. These calculations, however, were based on 
mathematical modelling, rather than on empirical data. 
The purpose of the present study was to calculate the number of years that obese 
subjects suffered more from disease and disability than subjects with normal weight 
did. The authors used data from The Finnish Social Insurance Institution's Mobile 
Clinic Unit following 20,000 Finns to study the impact of obesity on 
cardiovascular disease, reimbursement of medication due to chronic diseases, and 
work disability. 
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Methods 
STUDY POPULATION 
Between 1973 and 1977, the Social Insurance Institution's Mobile Clinic Unit 
carried out multiphase health examinations in twelve municipalities in four 
geographical regions of Finland. The main emphasis was on the risk factors for 
cardiovascular disorders. In each of the four regions, all inhabitants or a random 
sample of inhabitants of one rural municipality and one urban or semi-urban 
municipality as well as the employees of one factory were invited to attend the 
examination. A total of 19,518 men and women participated in the examinations. 
The mean age of participants was 45.0 years (range: 20-92 years). Participation rate 
was 83%. 
MEASUREMENTS 
A questionnaire with items concerning educational level, medical history, smoking 
and physical activity was sent to the subjects together with the invitation to the 
medical check-up, for completion before the examination. The answers to this self-
filled questionnaire were checked and completed, if necessary, by a specially trained 
nurse at the examination. 
BASELINE 
Body height and weight were measured at baseline when subjects were wearing light 
clothing. Body mass index (BMI) was calculated as weight divided by height squared 
(kg/m2). Four categories of body weight were defined according to the World 
Health Organization guidelines. BMI under 18.5 kg/m was considered 
underweight. Results are not presented for the underweight category because of too 
small numbers. BMI 18.5- 24.9 kg/m2 was considered normal weight, BMI between 
25.0-29.9 kg/m as grade-i overweight, also referred to as moderate overweight and a 
BMI between 30.0 and 39.9 kg/m as grade-11 overweight, also referred to as severe 
overweight or obesity. Subjects who had a BMI above 40.0 kg/m (grade-m 
overweight) were added to the grade-11 overweight category, because of small 
numbers in this category. Four categories of smoking habits were defined: - never 
smokers, - those who quitted smoking in the past, those who smoked fewer then 20 
cigarettes per day at baseline or cigars only, those who smoked 20 cigarettes or more 
per day at baseline. Education was classified in three categories: <9 years; 9-13 years; 
>I3 years. The questionnaire inquired about average alcohol consumption of beer, 
wine and strong alcoholic beverages during the proceeding month. The overall 
alcohol consumption was then calculated by multiplying the average intake in each 
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category by the average alcohol content of each beverage. For this study four 
categories were then defined as follows: o, < ioo, 100-500, and 500 or more grams 
of ethanol per month. The subjects were asked to classify their leisure-time activity 
during the usual week into one of three categories: 1) none or little; 2) walking, 
cycling, or related light activities, at least 4 hours per week; 3) ball games, jogging, 
or related activities at least 3 hours per week or regular vigorous activities. 
FOLLOW-UP 
Subjects aged 20-64 years were followed regarding work disability, hospitalisation 
due to coronary heart disease, morbidity leading to long-term medication, and all-
cause mortality for a maximum of 15 years, until age 65 years. Age 65 years is the 
general age of retirement in Finland. Subjects aged 65 years or older were followed 
for a maximum follow-up of 15 years for all endpoints, except work disability. 
W O R K DISABILITY 
Unhealthy life years due to work disability were calculated as the time between 
onset of work disability until death or the end of follow-up. Work disability is 
defined as having a work disability pension from the National Social Insurance 
Institution. Finns are being granted a disability pension if they are expected to be 
work disabled during the rest of their lifetimes. Subjects who were work disabled at 
baseline were excluded from the analyses on work disability. Both baseline and 
follow-up data on work disability were derived by linkage of data to the Finnish 
Social Insurance Institution. 
CORONARY HEART DISEASE 
Unhealthy life years due to coronary heart disease were classified as the time 
between hospitalisation for coronary heart disease until death or end of follow-up. 
Data on hospitalisation were derived from the Social Insurance Institution. Subjects 
with a history of cardiovascular diseases were excluded from the analyses on 
hospitalisation due to coronary heart disease. Data on cardiovascular diseases at 
baseline were obtained using specific questions: "Have you ever had, according to a 
physician's diagnosis, myocardial infarction, coronary heart disease, arterial 
hypertension, or cerebral stroke?" 
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MORBIDITY LEADING TO LONG-TERM MEDICATION 
Unhealthy life years due to morbidity leading to long-term medication is defined as 
the number of years between the onset of first reimbursement of medication due to 
chronic diseases and death or end of follow-up. In Finland, reimbursed drug 
therapy is provided for a number of chronic diseases, including common 
complications of obesity. Eligibility requires a comprehensive medical certificate 
written by the attending physician, and the evidence must be verified by an 
advisory physician of the Social Insurance Institution. Participants in the Mobile 
Clinic Health Examination Survey who later developed such chronic diseases were 
identified by linking the survey data with the Social Insurance Institution's 
population register, using the unique social security code assigned to each Finnish 
citizen. Most chronic diseases entitled to specially reimbursed medication meet 
commonly applied criteria, and the specificity of data is very high. Subjects who 
had reimbursed medication at baseline were excluded from the analyses on 
morbidity leading to long-term medication. During the follow-up most reimbursed 
medication was due to arterial hypertension (41%), cardiac failure (13%) bronchial 
asthma (9%), coronary heart disease (7%), and to diabetes (5%). The rest (25%) 
was due to 35 different less common chronic diseases other. 
STATISTICAL ANALYSIS 
Relative risks for the onset of work disability, hospitalisation due to coronary heart 
disease, morbidity leading to long-term medication, and all-cause mortality per 
category of BMI have been calculated by using the Cox proportional Hazards model 
(proc PHREG, SAS-version 6.12). Adjustments were made for age, smoking, 
education, and alcohol intake. Additional adjustments were made for leisure time, 
physical activity, diastolic blood pressure, serum cholesterol, and self-reported 
diabetes. Relative risks were calculated for all smoking categories combined as well 
as for those who never smoked separately. Relative risks were also calculated per age 
group. 
In addition, the number of unhealthy life-years years divided by the number of 
subjects at baseline per BMi-category was calculated by use of the generalised linear 
model (proc GLM, SAS-version 6.12). Adjustments were made for age, smoking, 
educational categories, and alcohol intake. Unhealthy life years were calculated for 
all smoking categories combined as well as for those who never smoked separately. 
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Table 5.3.1 Baseline characteristics in Social Insurance Mobile Clinic Unit Study; Number of subjects (%) 
<65 years >65 years 
Men Women Men Women 
Body mass index (kg/m2) 
<18.5kg/m2 86(1.0) 288(3.5) 25(2.6) 24(1.8) 
18.5-24.9 kg/m2 4,600(51.6) 4,489(53.9) 426(43.9) 379(29.0) 
25.0-29.9 kg/m2 3,467(8.9) 2,426(29.1) 402(41.4) 523(40.1) 
>30.0kg/m2 755(8.5) 1,124(13.5) 117(12.1) 379(29.0) 
Smoking category, number (%) 
Never smokers 2,599 (29.2) 6,239 (74.9) 308 (31.8) 1.251 (95.9) 
Ex,-current or cigar smokers 6.309(70.8) 2.088(25.1) 62(68.2) 54(4.1) 
Cases at baseline, number (%) 
Work disability 813(9.1) 743(8.9) a a 
Coronary heart disease 1,283(14.4) 1,380(16.6) 429(44.2) 707(54.2) 
Morbidity causing long-term medication 853(9.6) 1,194(14.3) 311(32.1) 1(53.0) 
a Work disability is relevant for <65 years only, as 65 is the general age of retirement in Finland 
Results 
In table 5.3.1 it is shown that 8.5% of the men and 13.5% of the women aged 20-64 
years were obese. Overweight and obesity were more common after age 65 years 
than in younger subjects. Work disability at baseline was more common among 
men than among women, whereas cardiovascular diseases and chronic medication 
at baseline were more common among women than among men. Smoking was 
uncommon among women at baseline between 1973 and 1977. 
In table 5.3.2 it is shown that obesity was more strongly related to the onset of work 
disability, hospitalisation due to coronary heart disease, and morbidity leading to 
long-term medication, than to all-cause mortality. The applied adjustment for 
educational level, geographical region, and alcohol intake, had negligible effect on 
relative risks. Additional adjustment for levels of physical activity did not alter 
relative risks (data not shown). Further adjustment for diastolic blood pressure, 
serum cholesterol level, and baseline presence of diabetes leaded to somewhat lower 
relative risks but relative risks were still statistically significant, except for work 
disability (data not shown). In subjects who never smoked, similar relative risks 
were found as when all smoking categories were combined. Obesity, however, was 
not related to increased mortality in women who never smoked (data not shown). 
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Table 5.3.2 Relative risks of work disability, hospitalisation due to coronary heart disease, morbidity 
leading to long-term medication, and all cause mortality during a maximal follow-up of 15 
years until age 65 years 
Endpoint 
Men 
Work disability 
Coronary heart disease 
Morbidity leading to long-
term medication 
All-cause mortality 
Women 
Coronary heart disease 
Morbidity leading to long-
term medication 
All-cause mortality 
Subjects 
8,046 
7,579 
8,008 
8,853 
6,924 
7,103 
8,291 
Events 
1,341 
905 
1,734 
580 
409 
1,470 
161 
Body mass 
18.5-24.9 
(reference) 
1 
1 
1 
1 
1 
1 
1 
index (kg/mz) 
25.0-29.9 
1.1 (1.0-1.3) 
1.2(1.1-1.4) 
1.5(1.4-1.7) 
1.0(0.8-1.1) 
1.6(1.3-2.0) 
1.5(1.4-1.7) 
0.8(0.6-1.2) 
>30.0 
1.7(1.5-2.0) 
1.6(1.3-2.0) 
2.5 (2.2-3.0) 
1.3(1.0-1.7) 
2.6 (2.0-3.4) 
2.2(1.9-2.6) 
1.2(0.8-1.9) 
Adjusted for age, smoking, educational level, geographical region, and alcohol use 
Subjects with the condition studied at baseline were excluded from the analyses 
All smoking categories are combined 
Relative risks of overweight and obesity were generally highest in the youngest men 
and women. In men aged 20-34 years relative risk of obesity for work disability was 
2.6 (95% confidence interval (ci): 1.5-4.6), and in women aged 20-34 years 1.9 (95% 
ci: 0.9-4.3), compared to men and women aged 20-34 years with normal weight. 
Relative risks of obesity for hospitalisation due to coronary heart disease were 1.8 
(95% ci: 0.9-3.4) in men and 2.9 (95% ci: 1.4-6.3) in women aged 20-34 years. 
Relative risks of obesity for morbidity due to chronic diseases were 3.3 (95% ci: 2.3-
4.8) in men and 2.3 (95% ci: 1.3-3.5) among women aged 20-34 years. 
In table 5.3.3, it is shown that overweight and obese subjects had more unhealthy 
life years than normal weight subjects during a maximum follow-up period of 15 
years. Obese men had 0.5 more unhealthy life years due to work disability, 0.4 
more years of coronary heart disease and 1.7 extra years morbidity leading to long-
term medication compared to normal weight men. Obese women had 0.5, 0.4, and 
1.3 years due to these respective conditions. Never smokers had fewer unhealthy life 
years than was observed in all smoking categories combined, but the difference in 
unhealthy life years between obese, overweight, and normal weight never smokers 
was similar to the differences observed in all smoking categories combined (figure 
5.3.1). A difference in number of unhealthy life years between normal weight and 
obese subjects was present in all age groups (data not shown). 
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Table 5.3.3 Average number of unhealthy life years" in men and women aged 20-64 years during a 
maximal follow-up of 15 years until age 65 years 
Unhealthy life years due to: 
Men 
Work disability 
Coronary heart disease 
Morbidity leading to long-term medication 
Women 
Work disability 
Coronary heart disease 
Morbidity leading to long-term medication 
Number of 
subjects 
8,046 
7,579 
8,008 
7,558 
6,924 
7,103 
Unhealthy life years 
Body 
18.5-24.9 
(reference) 
0.70 
0.48 
0.83 
0.71 
0.24 
0.99 
mass index (kg/ 
25.0-29.9 
0.80 
0.67 
1.45 
1.01 
0.45 
1.67 
m2) 
>30.0 
1.19 
0.83 
2.52 
1.24 
0.67 
2.32 
a Adjusted for age, educational level, geographical region, and alcohol intake 
Subjects with the condition at baseline were excluded from the analyses 
Table 5.3.4 Relative risks" of unhealthy life years subjects aged 65 years and older who never smoked 
during a 15-years follow-up 
Unhealthy life years due to: 
Men 
Coronary heart disease 
Morbidity leading to long-
term medication 
All-cause mortality 
Women 
Coronary heart disease 
Morbidity leading to long-
term medication 
All-cause mortality 
Subjects 
176 
203 
305 
558 
568 
1,221 
Events 
72 
78 
148 
248 
301 
583 
Body mass index 
18.5-24.9 
(reference) 
1 
1 
1 
1 
1 
1 
25-29.9 
1.3(0.8-2.1) 
2.5(1.5-4.4) 
1.3(0.9-1.8) 
0.8(0.6-1.0) 
0.7(0.6-1.0) 
0.9(0.7-1.1) 
kg/m2) 
>30.0 
1.4 (0.6-3.3) 
2.8(1.2-6.1) 
2.0(1.2-3.3) 
0.8(0.6-1.1) 
1.3(1.0-1.7) 
0.9(0.8-1.2) 
a Adjusted for age, educational level, geographical region, and alcohol intake 
Subjects with the condition at baseline were excluded from the analyses 
Among subjects aged 65 years and older who never smoked, obesity was related to 
hospitalisation due to coronary heart disease, morbidity leading to long-term 
medication, and all-cause mortality in men, not in women (table 5.3.4). The 
relations between obesity, hospitalisation for coronary heart disease and morbidity 
leading to long-term medication were less strong in men when all smoking 
categories were combined, but still statistically significant, (data not shown). 
124 
In figure 5.3.2, the number of unhealthy life years is presented for never smoking 
subjects over 65 years of age. The number of unhealthy life years due to coronary 
heart disease was not increased in obese subjects compared to their normal-weight 
counterparts. When smoking categories were combined, the number of unhealthy 
life years due to coronary heart disease was smaller than for never smokers alone. 
There was again no difference between the number of unhealthy life years due to 
coronary heart disease in obese and normal-weight elderly. The number of 
unhealthy life years due to morbidity leading to long-term medication was clearly 
elevated in never smoking obese men and women over 65 years of age compared to 
their normal weight counterparts. The number of unhealthy years due to morbidity 
leading to long-term medication was also smaller when smoking categories were 
combined, than when never smokers were analysed separately. Based on analyses for 
combined smoking categories, obese elderly men had 1.7 more years morbidity 
leading to long-term medication compared to normal weight counterparts. Obese 
elderly women had 1.4 more years morbidity leading to long-term medication then 
normal weight men and women, during a maximum follow-up of 15 years. 
Discussion 
Obesity predicted the onset of disease and disability most strongly in the youngest 
age-categories. Obesity was a stronger risk factor for disease and disability than for 
all-cause mortality. Consequently, obese subjects had more unhealthy life years 
than their normal weight counterparts. This is the first prospective study regarding 
the impact of obesity on number of unhealthy years. Comprehensive data on body 
weight, work disability, hospitalisation due to coronary heart disease, and the use of 
medication for chronic diseases were available from a representative cohort of 
Finns. This study clearly shows that obesity has great impact on relatively non-fatal 
outcomes, which is larger than the impact on mortality. 
Relative risks of obesity for disease and disability were highest in the youngest age 
group. Large relative risks in young age groups and higher proportions of obesity in 
older age groups imply a large impact of obesity on disease and disability across all 
ages between 20-64 years. The obesity-related increase in unhealthy life years due to 
morbidity leading to long-term medication was larger than the obesity-related 
increase in unhealthy life years due to coronary heart disease. Two explanations 
could be given. First, relative risks of obesity were higher for morbidity leading to 
long-term medication than for hospitalisation due to coronary heart disease. 
Second, coronary heart disease is more often fatal than the various diseases that 
were combined in our definition of morbidity leading to long-term medication. 
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Figure 5.3.1 Average number of unhealthy life years due to work disability, coronary heart disease, and 
morbidity leading to long-term medication among never smokers aged 20-64 years during a 
maximum follow-up of 15 years until age 65 years 
Subjects with the condition at baseline were excluded 
126 
coronary heart disease 
g 6 
>• 5 
CD 
S 4 
f 3 
f 1 
18.5-24.9 25.0-29.9 >30.0 18.5-24.9 25.0-29.9 >30.0 
body mass index (kg/m ) 
morbidity leading to long-term medication 
co 6 
S 4 
CO p Hi 
18.5-24.9 25.0-29.9 >30.0 18.5-24.9 25.0-29.9 
body mass index (kg/m2) 
>30.0 
Figure 5.3.2 Average number of unhealthy life years due to coronary heart disease and morbidity leading to 
long-term medication among never smokers aged >65 years during a follow-up of 15 years 
Subjects with the condition at baseline were excluded 
The latter possibly explains why obese subjects aged 65 years and older did not have 
more life years of coronary heart disease than normal weight subjects from this age, 
while the incidence of hospitalisation for coronary heart disease was clearly elevated 
in the obese. We suggest that this is explained by high mortality rates due to 
coronary heart disease in those aged 65 years and older. The absolute difference in 
years of morbidity leading to long-term medication between obese and normal 
weight subjects aged 65 years and older was much larger than the absolute 
difference in years of coronary heart disease. 
The World Health Report reported from a study on 191 countries that life 
expectancy increased during the last decade and the number of healthy life years 
increased more strongly. Fries argued earlier that postponement of death concurs 
with a stronger postponement of morbidity and labelled this phenomenon as 
'compression of morbidity.' Non-smoking alumni from the Pennsylvania State 
University had low BMI and were physically active, lived longer and reported onset 
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of disability at an older age than people with a high-risk profile. Moreover, the 
alumni with a low risk profile had less disability at any time.' From the present 
study, we hypothesise that a further increase in the prevalence of obesity will lead to 
an increase in nonfatal consequences of obesity. 
Public health consequences of obesity have often been estimated by calculating 
economic costs of obesity. It has been estimated that 6% of the direct health care 
costs in the United States were attributable to obesity.1 Allison et al. argued that 
such calculations are likely to be overestimations, because the relation between 
obesity and mortality was not taken into account. Further studies on the costs of 
obesity should take into account the number of life years suffering from obesity-
related consequences. We propose that costs due to obesity-related work disability 
highly depend on duration of work disability rather than on incidence of work 
disability. Work disability is an expensive consequence of obesity, because it is 
associated with persistent productivity loss and loss of income. Large obesity-related 
costs due to medication for chronic diseases are also mainly explained by the 
number of unhealthy life years. We conclude that increases in the prevalence of 
obesity will lead to further increase in the obesity attributable health care costs due 
to large extra number of unhealthy life years due to nonfatal conditions. For 
smoking, for instance, the opposite is true. It has been estimated that smoking is 
relatively cheap for the public health, as smokers die early and are prevented from 
long-term health care. In the present study we indeed found lower number of 
unhealthy life years in elderly smokers, then in elderly never smokers. 
This study has some important methodological strengths. We measured body 
weight in a representative sample of Finns. Participation rate was high. Follow-up 
data was complete because of the unique personal identity code, which is used in all 
health registers in Finland. Obesity is associated with other risk factors of disease 
and disability. Only the adjustment for diabetes, diastolic blood pressure and serum 
cholesterol lowered the relative risks. Adjustment for these risk factors, however, is 
not appropriate as they are in the causal chain between obesity and coronary heart 
disease and all-cause mortality. It should be noted that persons with disease or 
disability at baseline were already excluded from the analyses. Therefore, we suggest 
that most part of the difference in unhealthy life years between obese and normal 
weight subjects that are presented in this study could be directly attributed to 
obesity. 
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A drawback of the analyses on number of unhealthy life years is that it was not 
possible to calculate confidence intervals, because of their severely skewed 
distributions. Log-transformation in order to approach a normal distribution on the 
log-scale could not be done, because the majority of subjects had no unhealthy life 
year. It is unlikely, however, that the difference in unhealthy life years between 
normal weight and obese subjects was a chance finding. A dose response relation 
between BMI and number of unhealthy life years was noted, and analyses were based 
on more than 100,000 person-years for men and women separately. A second 
drawback of the present analyses may be that we defined disease and disability 
duration as time between onset and end of 15-years follow-up. Regarding work 
disability we know that Finns will be work disabled for the rest of their life, if they 
receive a disability pension by the Social Insurance Institution. Regarding coronary 
heart disease and medication for chronic diseases, one might argue that a small 
proportion of subjects may recover from coronary heart disease or stop using 
medication. If this argument is valid, however, we hypothesise that this would be 
more the case in diseased subjects with normal weight than in diseased overweight 
and obese subjects. We may have underestimated the difference in unhealthy life 
years between normal weight subjects and subjects with overweight or obesity. We 
cannot explain why obesity was relatively weakly associated with mortality in 
subjects aged 20-59 years. Some large studies reported that relative risks of obesity 
for mortality are higher in the younger than in older age groups. Obesity was 
related to mortality in men aged 65 years and older. Also, in this category obese 
subjects had more unhealthy life years due to morbidity leading to long-term 
medication than normal weight men. Obesity was not related to mortality in 
elderly women. Especially for the elderly, it would have been of value having data 
on the waist circumference. Waist circumference may be a better measure of body 
fatness and indicator of disease in the in the elderly than the body mass index. To 
indicate health risk due to body fatness in the elderly it may be valuable to link 
measures of waist circumference to disease and disability outcome. 
CONCLUSION 
The present study shows that obesity is somewhat related to increased mortality, 
but more strongly to disability and morbidity. Obese subjects have more unhealthy 
life years due to work disability, coronary heart disease, and morbidity leading to 
long-term medication. The present study provides empirical evidence that obesity is 
related to an increase in the number of unhealthy life years. We hypothesise from 
these findings that a further increase in the prevalence of overweight and obesity 
will lead to an increase in the number of unhealthy life years. 
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Chapter 6 
GENERAL DISCUSSION 
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6.i Introduction 
The prevalence of obesity (severe overweight) has increased dramatically during the 
last few decades of the 20th century.1 Therefore, an increasing attention for the 
public health impact of obesity is warranted. Large epidemiological studies have 
shown that obesity is related to mortality, morbidity, and disability. Most of these 
studies used levels of body mass index (BMI), calculated as body weight divided by 
height squared (kg/m ) to define the degree of overweight and obesity. 
The relation between obesity and mortality is less strong in elderly than in younger 
populations.3"5 One explanation is that BMI is not the best measure of body fatness 
in the elderly. An alternative explanation is that low BMI is also indicative of low 
lean body mass, which is related to health impairment. Other measures of body 
fatness than the BMI are probably better predictors of mortality in the elderly. A 
possible cohort effect and selective survival may be other explanations for a weaker 
BMi-mortality relation in older compared to younger age groups. 
It is clear that obesity is related to morbidity, such as cardiovascular diseases and 
type 2 diabetes mellitus. Relatively few studies have reported a relation between 
obesity and disability, such as work disability and difficulties in performing 
everyday activities. ' The role of musculoskeletal disorders, which are possible 
intermediates in the causal chain between obesity and disability, has not been 
systematically evaluated. 
Public health impact is not only evaluated in terms of relative risks and population 
attributable fractions, but also in terms of costs. It is estimated that direct costs of 
obesity are about 6% of the total health care expenditure in the US. In Europe, 
estimates vary between 1 and 5%. Costs due to obesity-related sick leave and work 
disability are estimated at about 10% of the total morbidity-related productivity 
loss. Weight loss could reduce the number of life years with hypertension and type 
2 diabetes mellitus. Empirical data on the number of unhealthy life years in obese, 
overweight and normal weight subjects are not available in the literature. 
This thesis aimed at studying long-term and recent increases in the prevalence of 
obesity in the Netherlands and at elucidating the role of obesity in mortality, 
morbidity, disability, and unhealthy life-years. In this general discussion, 
methodological aspects of the studies presented and other studies are considered. 
Also, implications of the results are discussed regarding future obesity research. 
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Figure 6.1 Prevalence of obesity (body mass index >30.0 kg/m2)' per category of educational level in 
Dutch men and women aged 20-59 years: 
MORGEN project 1993-1997 (see chapter 3.1.1) 
a standardised to the five years age distribution in the Netherlands in 1995 
6.2 Main findings 
The prevalence of obesity (BMI >3O.O kg/m) increased steadily in the Netherlands 
between 1976 and 1997, from 5 to 9% in men and from 6 to 9% in women aged 37-
43 years (chapter 3.1). Between 1993 and 1997, the prevalence of obesity was about 
9% in men and 10% in women aged 20-59 years. During this period, the prevalence 
of obesity increased most strongly in men with a relatively low level of education. 
In contrast, a time trend in women was most pronounced in those with a relatively 
high educational level (figure 6.1). The prevalence of abdominal obesity was about 
20% in men (waist circumference > I O 2 cm) and about 25% in women (waist 
circumference >88 cm) (chapter 3.2). The increase in the prevalence of abdominal 
obesity per year was somewhat stronger than the increase in the prevalence of 
obesity (BMI >30 .O kg/m2) between 1993 and 1997. Seasonal variation (increase in 
winter and decrease in summer) was more clearly seen for levels of waist 
circumference than for levels of BMI (chapter 3.2). 
In chapters 4.1 and 4.2, it is reported that obesity (BMI >30 .O kg/m ) was related to 
mortality in elderly men who had never smoked, but not in men who were smokers 
and not in women.5'20 A possible cohort effect did not explain the somewhat lower 
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relative risks of obesity for mortality in elderly compared to younger populations. 
Overweight (BMI 25.0-29.9 kg/m) was not related to increased mortality. Waist 
circumference was more clearly related to mortality than was BMI in elderly men 
who had never smoked (chapter 4.2). ° 
Obesity was related to the presence of knee and hip osteoarthritis at baseline, which 
are important risk factors for disability (chapter 5.1). Moreover, obesity was 
associated with difficulties in activities of daily living at baseline and to onset of 
work disability during follow-up. These associations were found in both the 
presence and absence of osteoarthritis. Obesity was also associated with chronic low 
back pain, shoulder joint impairment, and neck pain in women, although to a 
lesser extent than to osteoarthritis. In men, overweight (BMI 25.0-29.9 kg/m) was, 
but obesity (BMI >30.O kg/m) was not associated with the presence of these 
musculoskeletal disorders. 
It was estimated that prevention of little weight gain (less than 0.5 kg per year) 
could prevent about 26,000 new cases of osteoarthritis of the knee and 19,000 new 
cases of work disability in the Dutch working-aged population during a period of 
ten years (chapter 5.2). That is 5% and 2.5%, respectively, of the number of new 
cases of osteoarthritis and work disability that would occur in Dutch working-aged 
men and women, when no weight gain prevention was carried out. 
The relation between obesity and work disability, hospitalisation due to coronary 
heart disease, and morbidity leading to long-term medication was strongest in 
young adults within the age range 20-64 years (chapter 5.3). Obesity was more 
strongly related to morbidity and disability than to mortality. Obese Finns had 
more unhealthy life years than their normal weight counterparts (chapter 5.3). 
6.3 Methodological considerations 
In this thesis, the prevalence of obesity and its impact on the public health is 
studied by use of epidemiological, observational studies. In epidemiological 
research, the exposure must be clearly defined. Knowledge on potential biases is 
needed, because they may harm internal and external validity of studies. Also, 
definitions of different measures of outcome should be taken into account. 
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6.3.1 EXPOSURE ASSESSMENT 
The amount of body fat is best measured by Magnetic Resonance Imaging (MRI) 
techniques, Computer Tomography (cT)-scanning, or, more indirectly, by 
densitometry. Such techniques, however, are too expensive and time-consuming for 
large epidemiological studies. For health promotion purposes, proxy measurements 
of body fat are needed so that individuals themselves can assess their risk status. 
Body mass index 
The body mass index (BMI), which was developed by the Belgian mathematician 
Quetelet in the 19' century, is the most commonly used measure of body fatness 
independent of body height. The World Health Organization defined cut-off 
points for overweight (BMI 25.0-29.9 kg/m2) and obesity (BMI >30 .O kg/m ) as they 
reflect increased risk of morbidity and mortality. Moreover, universal 
classifications of degrees of overweight and obesity are useful for comparisons of 
prevalence of overweight and obesity within and between countries. It has been 
argued that different BMI cut-off points should be used in different ethnic groups in 
order to assess the risks of morbidity and mortality. Asian persons for instance 
have a generally higher absolute risk of type 2 diabetes mellitus than Caucasians at 
the same level of BMI.2 
16-24 25-34 35-44 45-54 55-64 
age (years) 
65-74 >75 
Figure 6.2 Prevalence of obesity (body mass index >30.0 kg/m2) by age in men and women in the United 
Kingdom 1997 (Health Survey for England 1997)46 
Figure adapted from Seidell and Visscher8 
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BMI is not an optimal indicator of body fatness in the elderly. Average body weight 
and the prevalence of BMI >30.O kg/m increase until age 60-70 years and decline 
after this age (figure 6.2). The reduced body weight, and consequently the reduced 
BMI, however, in the elderly is explained by a decrease in lean body mass and a loss 
of muscle mass, rather than a loss of fat. Thus, a certain level of BMI indicates a 
higher level of fatness in older than in younger people. Lean body mass slowly but 
progressively decreases during adulthood in men, and in women after menopause. 
Waist circumference 
Although the majority of studies report on body fatness measured by BMI, waist 
circumference may be a better measure of excess fat than the BMI, because of several 
reasons. Waist circumference is a measure for the amount of abdominal fat as well 
as the amount of total body fat. Abdominal obesity is recognised as the most 
important risk factor for type 2 diabetes and among the major determinants of 
coronary heart disease.' An advantage for health promotion is that individuals 
can easily measure the waist circumference themselves. Waist measurements are 
cheap, reliable and do not need adjustment for body height, at least for middle-
aged populations. Action levels have been proposed by Lean et al. to define cut-off 
points for large waist circumferences (table 6.1). 
In chapter 3.2 of this thesis, it is concluded that waist circumference is a better 
indicator of changes in energy balance and energy balance related behaviour than 
BMI. This conclusion is based on the observation that the time-trend and seasonal 
variation was more pronounced for waist circumference than for BMI. Greater 
changes in waist circumference than in BMI may be explained by changes in 
physical activity patterns. Physical activity is associated with smaller waist 
circumference and relatively stable BMI. Fat mass is decreased but lean mass 
(muscles) is increased because of increased physical activity. 
Table 6.1 Waist circumference action levels a suggested by Lean ef a/.34 
Men Women Clinical implication 
Action level 1 94 cm 80 cm Abdominal overweight: 
Losing weight generally not necessary 
Action level 2 102 cm 88 cm Abdominal obesity: 
Losing weight generally urged 
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Especially in the elderly, waist circumference may be a better indicator of risk than 
BMI, as it better indicates body fatness. Large waist circumference was related to 
increased cardiovascular risk factors as hypertension and hypercholesterolaemia in 
subjects aged 55 years and older from the Rotterdam Study, but age-specific waist 
action levels are not available. It is important to elucidate the relation of waist 
circumference to mortality, morbidity, and disability, especially in the elderly. 
Waist-hip ratio 
The waist-hip ratio reflects the distribution of fat, rather than the absolute amount 
of fat. Several cut-off points for waist-hip ratio have been presented in the 
literature, but classifications for categories of waist-hip ratio so far were 
dichotomous on which no consensus has been reached. ' Recently, new light has 
been shed on the discussion whether low hip circumference is associated with 
increased mortality risk.39, ° It has been suggested that a low hip circumference is an 
indicator of increased risk for morbidity and mortality. Further studies should 
measure both waist and hip circumference and analyse them separately. 
6.3.2 PREVALENCE AND TIME TRENDS 
The prevalence and time trend in obesity has been presented in chapter 3.1 of this 
thesis. External validity is of importance when study results are used to estimate the 
prevalence and trend in obesity in the Dutch population. 
Prevalence of obesity 
The prevalence of obesity in the Netherlands was assessed from data of the MORGEN 
project 1993-1997 (chapter 3.1). It could be questioned, however, whether these data 
are representative for the Dutch population. Data were derived from three cities in 
the Netherlands, Amsterdam, Doetinchem, and Maastricht, and participation rate 
was low (45%). Persons with a relatively high educational level, in which obesity is 
less common than in low educational categories, were overrepresented. An 
advantage of the MORGEN project, regarding the internal validity, is that data are 
based on measured body weight and height. The prevalence of obesity reported in 
chapter 3.1 could be compared to data from Statistics Netherlands, which had 
different methodological advantages and disadvantages compared to the MORGEN 
project. Statistics Netherlands had a higher response rate (60%) and covered all 
regions in the Netherlands. ' The main disadvantage of the data was that they were 
based on self-reported body weight and height. 
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The prevalence of obesity is likely to be underestimated when estimations are based 
on self-reports. The magnitude of underestimation could be studied by comparing 
reported body weight and measured body weight from persons who participated in 
both Statistics Netherlands and the Regenboog project. The Regenboog project is a 
recent monitoring study, carried out at the National Institute of Public Health and 
the Environment in co-operation with Statistics Netherlands. Prevalence 
estimations based on self-reported body weight underestimated the prevalence of 
obesity with 2-4 percentage points. 
Statistics Netherlands reported a somewhat lower prevalence of obesity (about 6% 
in men and 8% in women) than the MORGEN project, for the period 1993-1997. 
After comparing data from the MORGEN project and Statistics Netherlands, with 
different above described methodological advantages, it can be concluded that our 
estimated prevalence of obesity, being 9% in Dutch adult men and 10% in women, 
for the period 1993-1997 is likely to be close to the true prevalence. 
Time trends of obesity 
In chapter 3.1, it was furthermore concluded that the prevalence of obesity increased 
between 1993 and 1997. Response rates in the MORGEN project, however, decreased 
between 1993-1997 from about 50% to 40%. It could be questioned whether the 
reported increase in the prevalence of obesity is due to selective participation being 
different over time. 
Time trends have been studied within educational categories partly because 
participation rates in the MORGEN project differed across educational categories. 
The prevalence of obesity increased most strongly in men with a relatively low level 
of education. In contrast, time trends were most pronounced in women with a 
relatively high level of education (figure 6.1). Furthermore, the estimated time-trend 
in the MORGEN project can be compared with two national studies, one on adults 
(Statistics Netherlands) ' and one on children. ' 5 Both studies showed a clear 
increase in the prevalence of obesity that was of a similar magnitude as the time 
trend reported from the MORGEN project. Thus, the different designs of the study 
and methodology of body weight assessment lead to different prevalence estimates 
of obesity but still in the same order of magnitude. These methodological 
differences had less or no influence on the estimates of time trends obesity. 
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6.3.3 POTENTIAL SOURCES OF BIAS 
The relation between obesity and different health outcomes may be subject to 
various sources of biases. For example, if a factor is associated with obesity, but also 
with the studied disease occurrence, then this may lead to spurious relations 
between obesity and health. Statistical methods can account for various sources of 
bias, but are not always appropriate. Some potential sources of bias in the relation 
between obesity and disease occurrence are discussed below. 
Confounders 
A potential confounder in the relation between obesity and disease occurrence is a 
factor that is associated with obesity, causally or not causally, and also directly 
related to the disease, and which is, at least in part, responsible for an observed 
association between obesity and disease. Age is an important example of a 
confounder in the relation between obesity and most disease occurrences. Body 
weight increases until age 60-70 years after which it declines. Diseases such as 
coronary heart disease are more common in older than in younger populations. 
Adjustment for age should therefore always be made when age differs between 
individuals of the study population. Other potential confounders are behavioural 
determinants of obesity. The quantity and quality of the diet and the amount of 
physical activity for example may determine the onset of obesity and are related to 
diseases such as coronary heart disease. Adjustment for these determinants, 
however, is difficult because obese subjects tend to underestimate their food intake 
and overestimate their physical activity pattern. 
Intermediate risk factors 
If a factor is in the causal chain between obesity and health outcome, it is 
inappropriate to adjust for that factor. Relative risks of obesity for the health 
outcome will then be underestimated. Examples of intermediate risk factors are 
high blood pressure and high serum cholesterol that are in the causal chain between 
obesity and for example cardiovascular morbidity and mortality. 
Effect modifiers 
When the effect of obesity on disease occurrence is modified by a third factor, i.e. 
when the effect of obesity is different in strata of this factor, analyses have to be 
performed in each of the strata separately. A known effect modifier in the relation 
between obesity and mortality is smoking. In this thesis, for example, obesity was 
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related to mortality in men who had never smoked, but not in men who smoked in 
the Seven Countries Study and the Rotterdam Study (chapters 4.1 and 4.2). One 
explanation for this effect modification is that obesity adds little risk to smokers, 
possibly because of the high mortality risk associated with smoking. 
Cohort effect 
Relative risks of obesity for mortality seem to decline with ageing (figure 6.3). 
Different age groups often come from different birth cohorts. The people in these 
different birth cohorts grew up during different time periods and thus may have 
experienced different body weight developments. If mortality rates are also different 
between birth cohorts, different relative risks of obesity for mortality between age 
groups may be partially explained by a cohort effect. In chapter 4.1, a cohort effect 
has been avoided by following a cohort of men twice for a period of 15 years, but 
with a different age at baseline. 
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Figure 6.3 Relative risks (95% confidence intervals) of mortality from all causes among healthy women 
aged 65-74 years and >75 years. Adapted from Calle ef a/..3 
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Disease induced weight loss 
Some diseases with a relatively high fatality rate may also lead to weight loss, 
possibly giving rise to spurious associations between low BMI and such diseases. 
This bias would then be an example of reverse causation of health outcome and 
BMI. It has been suggested to take weight loss prior to mortality into account by 
excluding the first five years of mortality. Excluding the first five years of mortality 
in the Seven Countries Studies lead to somewhat lower relative risks of underweight 
for mortality. Relative risks of overweight and obesity, however, were not affected 
by the exclusion of the first five years of mortality. This effect is compatible with 
the conclusion from Allison's meta-analysis who concluded that excluding early 
mortality will lead to negligible effects on the relative risks of obesity for increased 
mortality. In a recent study it has been suggested that those who die early after the 
start of follow-up might have lost more weight than persons who died later in the 
follow-up. The authors recommended that only the first year of mortality should be 
excluded. It is unclear whether exclusion of the first year of mortality is sufficient 
when assessing the relation between obesity and other health outcomes than 
mortality. 
6.3.4 MEASURES OF EFFECT 
This thesis reports on the public health impact of obesity. The impact of obesity on 
health outcome can be expressed in different ways. Different measures of effect have 
different meaning in clinical medicine and in community medicine. In the 
following section, different measures of effect are discussed. 
Absolute risk 
The absolute risk is synonymous with incidence and means the rate of disease 
occurrence. Incidence can be expressed as incidence proportion (i.e. events per 
number of subjects), or incidence rate (i.e. events per total person years). It is the 
basic rate from which the relative risk is derived. The absolute risk is more often 
used in clinical medicine than in community medicine. The interpretation of the 
relative effect depends on the absolute effect. An intervention may not be 
warranted in an individual when the relative risk of disease occurrence for exposure 
is high, but the absolute risk is very low. The probability that the individual will 
develop the disease is then low, irrespective of exposure. Conversely, same relative 
risks for two populations could correspond with differing absolute effects. In that 
case, the absolute risk measure could be useful in community medicine to study the 
impact of exposure on disease occurrence. In chapter 5.2, for example, weight gain 
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prevention could potentially prevent 5% of new cases of osteoarthritis in men and 
6% of new cases in women. If absolute risk of osteoarthritis would be ignored, one 
might conclude that the impact of weight gain prevention on the incidence of 
osteoarthritis is similar in men and women. The absolute risk of osteoarthritis, 
however, was different in men and women. Due to the higher absolute risk in 
women more new cases of osteoarthritis were expected in women (320,000 new 
cases) than in men (175,000 new cases), during a period of ten years, if no weight 
gain prevention would be carried out. Thus, the number of new cases of 
osteoarthritis that could be prevented by weight gain prevention was 9,000 in men 
and 18,000 in women. Taking the absolute risk calculation into account, it can be 
concluded that weight gain prevention has more impact on the incidence of 
osteoarthritis in women than in men. 
Relative risk 
The relative risk is the ratio of the incidence (proportion or rate) in the exposed to 
the incidence in the non-exposed. In clinical medicine, the relative risk is used to 
indicate how much the risk is increased in a person who represents the exposed 
category, without indicating the absolute risk. In community medicine, relative 
risks can be used to indicate populations effects of exposure on disease occurrence. 
In this thesis, for example, the relative risk was used to compare the impact of 
obesity on mortality, morbidity, and disability (chapters 2.1 and 5.3). Since relative 
risks for obesity of morbidity and disability generally exceeded the relative risk of 
mortality, it was concluded that the impact of obesity on morbidity and disability is 
higher than its impact on mortality (figure 6.4). 
Population attributable fraction 
The population attributable fraction indicates the fraction of cases that would not 
have occurred if exposure had not occurred. In community medicine, the 
population attributable fraction is more informative than the relative risk alone 
when studying the impact of exposure on occurrence of different diseases, because it 
is derived from both the relative risk and the proportion of exposed subjects. It does 
not indicate an absolute number of cases that could be avoided if exposure had not 
occurred. In this thesis, the population attributable fraction was used to compare 
the impact of high BMI and large waist circumference on all-cause mortality in men 
aged 55 years and older who never smoked (chapter 4.2). 
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Figure 6.4 Hazard ratio of obesity versus normal weight for various end-points among men aged 20-92 
years in the Social Insurance Institution's Mobile Clinic Study (see chapter 5.3.3) 
Although comparison of relative risks indicated higher impact of high BMI than 
large waist circumference on all-cause mortality, comparisons of population 
attributable fractions indicated a clearly higher impact of large waist circumference 
than a high BMI on all-cause mortality. The relative risk of BMI >30.O kg/m 
(relative risk: 2.6) for mortality was higher than the relative risks of waist 
circumference above action level i (relative risk: 1.7) and waist circumference above 
action level 2 (relative risk: 1.6) for mortality. The proportion of men with waist 
circumference above action level 1 or action level 2 (0.49), however, was larger than 
the proportion of men with high BMI (0.07). From the relative risks and the 
proportions of men with large waist circumference and high BMI, it was calculated 
that the proportion of mortality attributable to a large waist circumference (0.28) 
was nearly three times higher than the proportion of mortality attributable to a high 
BMI (0.10). In chapter 5.3, it was concluded from high relative risks for obesity of 
morbidity and disability in the youngest age group (20-34 years) and higher 
proportions of obesity in older age groups (until age 65 years), that obesity has large 
impact on morbidity and disability in all age groups (figure 6.4). 
6.3.5 OUTCOME MEASURES 
The term 'public health' has to be specified when studying the 'public health' 
impact of obesity. Several public health outcome measures are discussed below. 
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Mortality 
The impact of obesity on increased mortality rates has been known since the first 
report of actuarial studies in the early 1950's. The relation between obesity, defined 
as BMI > 30.0 kg/m , and mortality in elderly populations is topic of recent debates. 
Obesity, BMI >30.O kg/m , was related to increased mortality in elderly men who 
had never smoked. Relative risk of obesity for mortality, however, is lower in elderly 
than younger populations (figure 6.3). 5' Moreover, overweight, BMI 25.0-29.9 
kg/m", was not related to mortality in elderly men who never smoked (chapters 4.1 
and 4.2). " It can be concluded that the BMI level at which minimal mortality 
occurs, increases with ageing. As discussed earlier, large waist circumference 
identified more men who never smoked aged 55 years and older from the 
Rotterdam Study with increased mortality risk than did high BMI (chapter 4.2). 
Obesity was not related to mortality in women aged 55 years and older from the 
Rotterdam Study (chapter 4.2), or in women aged 65 years and older from the 
Finnish Social Insurance Institution's Mobile Clinic Study (chapter 5.3). It was 
suggested that a redistribution of fat after menopause may be responsible for the 
absence of a relation between large waist circumference and increased mortality. 
As a consequence of the change from a gluteal to a more abdominal distribution of 
fat following menopause, duration of abdominal obesity may have been shorter in 
women than in men. Furthermore, levels of bioavailable endogenous estrogens are 
relatively increased in postmenopausal women with abdominal obesity. 
Although speculative, these levels of endogenous estrogens may favourably 
influence cardiovascular risk, and thereby all-cause mortality risk. Further studies 
with longer follow-up or more complete baseline data on disease status should 
assess whether absence of a relation between waist circumference and mortality 
among women can be confirmed. 
Morbidity and disability 
The effect of obesity on mortality can largely be explained by the relation between 
obesity and chronic diseases such as cardiovascular diseases and type 2 diabetes 
mellitus. Obesity is currently recognised as major risk factor for type 2 diabetes 
mellitus and cardiovascular diseases. Obesity is also related to some types of cancer, 
respiratory diseases, such as asthma, sleep apnoea, and shortness of breath, and to 
various musculoskeletal disorders. A large waist circumference has been shown to 
indicate impaired levels of cardiovascular risk factors, shortness of breath and 
difficulties in everyday activities.9 
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In chapter 5.1, obesity is linked to osteoarthritis, low back pain, shoulder joint 
impairment, and chronic neck pain, although based on cross-sectional analyses. It is 
not clear what came first: obesity or the musculoskeletal disorders. It may well be 
that patients with musculoskeletal disorders become less physically active and 
thereby gain weight. Some studies, however, report longitudinal relations between 
obesity and these musculoskeletal disorders, providing stronger evidence for a causal 
relation. °''' Obesity is less clearly related to low back pain, shoulder joint 
impairment and chronic neck pain, than to knee- and hip osteoarthritis. 
Longitudinal studies are needed to further explore the relation between obesity and 
these musculoskeletal disorders. 
The relation between obesity and morbidity is important from a public health 
point of view. Obesity-related morbidity is not only associated with increased 
mortality, but also with increased disability, affecting one's quality of life. Both 
morbidity and disability, in particular work disability, imply large obesity-related 
health care costs. 
Unhealthy life years 
The relation between obesity and morbidity is now widely reported. ' Evidence for 
a relation between obesity and disability is accumulating. The number of unhealthy 
life years in obese, overweight and normal weight persons, however, is unknown. 
Data on increased number of unhealthy life years in obese persons are needed to 
improve health care planning and calculating obesity-related health care costs. 
Oster et al. calculated that 10% weight loss would lead to 1.2-2.9 fewer life years 
suffering from hypertension and to 0.5-1.7 fewer years of suffering from type 2 
diabetes mellitus, depending on age-category (between 35 and 64 years) and initial 
BMI.19 These calculations are based on mathematical modelling, requiring 
assumptions regarding the relations between obesity, morbidity, and mortality. 
In this thesis, it is reported that obesity is related to both mortality and an increased 
number of unhealthy life years that were due to work disability, coronary heart 
disease, and morbidity leading to long-term medication (chapter 5.3). To our 
knowledge, this is the first attempt to make such calculations using empirical data. 
An advantage of using empirical data from one cohort of subjects is that all 
relations between obesity, morbidity and mortality and fatality rates of diseases 
studied are taken into account. Because the distribution of unhealthy life years was 
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severely skewed, confidence intervals could not be calculated, which require a 
normal distribution of the variables of interest. Log-transformation of the data was 
not possible, since the majority of subjects experienced zero unhealthy life years due 
to work disability, coronary heart disease and morbidity leading to long-term 
medication. It is unlikely, however, that our results are due to chance. Clear dose-
response relations were observed and analyses were based on more than 100,000 
person-years in men and women. It is hypothesised from these findings that a 
further increase in the prevalence of obesity will lead to an increase in the number 
of unhealthy life-years. 
6.4 Public health implications 
From this thesis, it can be concluded that an increase in the prevalence of obesity 
will lead to an increase in the number of unhealthy life-years due to increased non-
fatal morbidity and disability. Thus, the recently reported increase in the prevalence 
of obesity and the expected further increase in the prevalence of obesity in the near 
future will lead to increased health care costs due to obesity. 
An increase in body weight is due to a positive energy balance: increased energy 
intake and/or decreased energy expenditure. Small daily changes in energy intake 
and physical activity will have a large impact on the change in body weight in the 
long run. Small increases in body weight in the population will have a large impact 
on the prevalence of overweight and obesity and the number of unhealthy life-years 
attributable to weight gain. 
The prevalence of overweight and obesity has been increasing at a particular high 
rate since the last decades, while the 'gene pool' hardly changed. Consequently, 
causes of the average weight gain are largely environmental, although genes are 
potentially very important in individual cases of obesity. Gene-environment studies 
are needed to elucidate the interaction between genes and the environment. 
Changes in energy intake and in the physical activity patterns at school, work and 
during leisure time are often mentioned as causes of weight gain.7 ' Egger and 
Swinburn suggested to approach the obesity epidemic as a normal response to the 
pathologic 'obesogenic environment', in which choices are easily made to increase 
food intake and decrease physical activity.9 
It is of public health importance to develop weight gain prevention programs. It has 
been calculated that prevention of weight gain has more potency to reach public 
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health care goals than treatment of obesity. Minor changes in energy intake or 
energy expenditure (in order of magnitude of half a glass of beer or twelve minutes 
bicycling per week) had a potentially important effect on changes in the prevalence 
of obesity and consequent changes in incidence of osteoarthritis and work disability 
(chapter 5.2). Only a few prevention programs, however, have been evaluated and 
results were generally disappointing. 
A possibly important explanation for the failure of weight gain prevention programs 
is that those programs aimed too much at individual behaviour modification. The 
'obesogenic environment' could have an overriding influence on people's overall 
behaviour. Possibly, altering the 'obesogenic environment' is critical for successful 
weight gain prevention, but determinants of failure to cope with these 
environmental (social, physical, and economic) circumstances are unknown. These 
determinants of behaviour must be studied to prevent obesity effectively. 
New weight gain prevention programs should probably focus on the balance 
between food intake and physical activity. Determinants of weight gain are 
multifactorial. Hill and Peters suggested from their review on the environmental 
contributions to the obesity epidemic that traditionally neglected aspects of energy 
balance should be considered in future weight gain prevention programs. They 
suggest that food availability and portion size are important determinants of weight 
gain, in a society in which 'super sizing' of food proportions is commonplace. 
Energy density should be studied in relation to energy intake, although reductions 
in fat intake may be the most effective way to reduce energy intake. Their third 
suggestion to improve weight gain prevention is to make the environment more 
conducive to physical activity. One explanation for a relatively low prevalence of 
obesity in the Netherlands compared to the United States and England is the high 
number of people who use bicycles for transportation in the Netherlands. 
6.5 Conclusions 
Obesity is a major determinant of impaired health in all ages including the elderly. 
The results presented in this thesis confirmed that the relation of obesity with 
morbidity and disability is stronger than the relation of obesity with mortality. 
Based on empirical data, it is clearly shown that obese subjects have more unhealthy 
life years than normal weight subjects. This thesis provides evidence based on large 
cohort studies, that there is an urge for the development, implementation, and 
evaluation of new weight gain prevention programs. Recently, the World Health 
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Report showed that the healthy life expectancy increased substantially during the 
last century in 193 countries. If the prevalence of obesity will further increase, it is 
reasonable to expect that the healthy life expectancy may be unfavourably affected 
in the next decades in societies with a high prevalence of obesity. 
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Summary 
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The prevalence of obesity (severe overweight) has increased dramatically in western 
societies during the last decades of 20th century. There is therefore a need to study 
the public health consequences of obesity. The aim of this thesis is to study the 
increase in the prevalence of obesity in the Netherlands, and to elucidate different 
aspects of the relations between obesity and mortality, morbidity and disability. 
In a literature review in chapter 2, it is described that the prevalence of obesity has 
been increasing in affluent countries, and recently also in developing societies. In 
affluent countries, obesity is most prevalent among those with relatively low socio-
economic status. It is concluded that body composition is changing with ageing. 
Body mass index (BMI) might not be the best indicator of body fatness in elderly 
populations. In addition, it became clear that the relation between obesity and 
mortality is less strong than the relations between obesity, morbidity, and disability. 
The number of unhealthy years due to morbidity and disability in obese and 
normal weight subjects, however, is unknown. Based on the findings from this 
review, it is hypothesised that obese populations have higher mortality rates but also 
have more unhealthy life years. 
In chapter 3 of this thesis, the long-term and recent time trend in BMI levels in the 
Netherlands are addressed, with special reference to educational level. In addition, 
the recent time trend and seasonal changes in BMI and waist circumference are 
compared. Between 1976-1980 and 1993-1997 the prevalence of obesity (BMI >30 .O 
kg/m2) increased from 5% in to 9% among men and from 6 to 9% among women, 
aged 37 to 43 years. Analyses were based on measured body weight and height from 
29,141 men and women, who participated in one of three consecutive multicentre 
monitoring studies of the National Institute of Public Health and the 
Environment, Bilthoven, the Netherlands. These monitoring studies were carried 
out in 1976-1980, 1987-1991 and in 1993-1997. In the period 1993-1997, data were 
also collected from 21,926 men and women aged 20 to 59 years. The average 
prevalence of obesity during period 1993-1997 was estimated to be 9% among men 
and 10% among women aged 20-59 years. Within this period the prevalence of 
obesity increased with 0.54 (95% confidence interval (ci): 0.13-0.96) percentage 
points per year among men and with 0.35 (95% ci: -0.0350.73) percentage points 
per year among women, adjusted for age, town of examination and educational 
category. The recent increase in the prevalence of obesity was strongest among men 
with a relatively low educational level and, in contrast, among women with a high 
educational level. Among men, the prevalence of abdominal obesity (waist 
circumference >i02 cm) was 20% and increased with 0.70 (95% ci: 0.15-1.24) 
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percentage points per year between spring 1993 and autumn 1997. Among women, 
the prevalence of abdominal obesity (waist circumference >88 cm) was 25% and 
increased with 1.33 (95% ci: o.79;o.87) percentage points per year. Seasonal 
variation (increases in winter and decreases in summer) was most clearly present for 
abdominal obesity. 
In chapter 4, the relation between obesity and mortality is described with special 
reference to elderly populations. Data on measured BMI was used in a cohort of 
men aged 40-59 years and who were followed for 15 years regarding all-cause 
mortality. The same cohort was measured again in 1970, when the men were aged 
50-69 years, and followed again for 15 years. Analyses were based on 7,985 European 
men who took part in the Seven Countries Study. The relative risks of obesity for 
mortality was 1.8 (95% ci: 1.2-2.8) for men aged 40-59 years who never smoked, and 
1.4 (95% ci: 1.0-1.9) for men aged 50-69 years who never smoked, with normal 
weight as the reference. Among current smokers, obesity was not related to 
increased mortality, possibly because of the high mortality risk in smokers. 
Overweight (BMI 25.0-29.9 kg/m) was not related to increased mortality rates in 
any smoking category. In the Rotterdam Study, waist circumference showed a more 
continuous and steeper relation with all-cause mortality than the BMI, again in men 
who never smoked only. The Rotterdam Study comprised data regarding 6,296 
men and women aged 55 to 102 years. Mean follow-up period was 5.4 years. Waist-
hip ratio (ratio of waist circumference over hip circumference) was not clearly 
related to increased all-cause mortality. The proportion of mortality among elderly 
men who never smoked that was attributable to a large waist circumference, was 
three times higher than the proportion of mortality that was attributable to a high 
BMI. 
In chapter 5, the relation of obesity with morbidity and disability in the Mini-
Finland Health Survey is addressed. This Finnish population based cohort study 
consists of data regarding 5,625 men and women aged 30 to 64 years in 1978-1980. 
Body weight and several musculoskeletal disorders were assessed during a health 
examination. Disability was defined as being granted a work disability pension 
during a 15-year follow-up period, and as the experience of difficulties in everyday 
activities at baseline. Work disability data were obtained by linkage to the Finnish 
national pension register. Obesity was more strongly associated with knee 
osteoarthritis than with hip osteoarthritis. Osteoarthritis, in turn, was associated 
with disability. Obesity was also related to disability independently from 
osteoarthritis. The relations between obesity and disability were found among both 
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subjects with and without osteoarthritis. When both obesity and osteoarthritis were 
present, the odds ratio for difficulties in everyday activities was 7.9 (95% ci: 4.4-
13.9) compared to normal weight subjects without osteoarthritis. Relative risk of 
developing work disability during follow-up was 2.4 (95% ci: 1.3-4.3) r ° r subjects 
with both obesity and osteoarthritis compared to normal weight subjects without 
osteoarthritis. Obesity was furthermore related to chronic low back pain, shoulder 
joint impairment and neck pain at baseline in women. In men overweight (BMI 
25.0-29.9 kg/m) was associated, but obesity (BMI >30 .O kg/m) was not associated 
with the presence of these musculoskeletal disorders. 
In addition, in chapter 5, the potential effects of a weight gain prevention program 
on the incidence of osteoarthritis and work disability are described that have been 
calculated by means of the mathematical Chronic Diseases Model. It was calculated 
that partial prevention of little weight gain (less than 0.5 kg per year) would prevent 
an increase in the prevalence of obesity with 3.5 percentage-points. Concurrently, 
26,000 new cases of knee osteoarthritis and 19,000 new cases of work disability in 
the Dutch working-aged population could be prevented by weight gain prevention 
at population level during a period of ten years. 
Finally, relative risks for and unhealthy life years due to work disability, coronary 
heart disease, and morbidity leading to long-term medication are presented per 
BMi-category. For this purpose data of another Finnish population based cohort 
study, the Social Institution's Mobile Clinic Unit, were used. In this study, body 
weight was measured in about 17,000 Finnish men and women aged 20-64 years at 
baseline in 1973-1978. Subjects were followed with respect to incidence of work 
disability, hospitalisation due to coronary heart disease, and morbidity leading to 
long-term medication during a maximum follow-up period of 15 years until age 65 
years. Relative risks of obese versus normal weight subjects for morbidity and 
disability exceeded those for mortality and were highest in the youngest age 
categories. During a maximal follow-up of 15 years, obese men (BMI >30 .O kg/m) 
had 0.5, 0.4, and 1.7 extra years of work disability, coronary heart disease, and 
morbidity leading to chronic medication, respectively. Obese women suffered 
respectively 0.5, 0.4, and 1.3 extra years from these conditions, compared to normal 
weight women. 
In chapter 6, the results of this thesis are summarised and discussed in the context 
of the literature. The prevalence of obesity has increased recently in Dutch adults. 
Results of cohort studies reported in this thesis confirm that obesity is related to 
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mortality, morbidity, and disability. Relative risks of obesity for morbidity and 
disability exceeded relative risks for mortality. As hypothesised in the literature 
review in chapter 2, empirical data showed that obese persons not only live shorter, 
but also had more unhealthy life years due to work disability, coronary heart 
disease, and morbidity leading to long-term medication. 
In the last part of chapter 6, the potential importance of new, innovative weight 
gain prevention programs is discussed. Prevention programs are in theory more 
efficient than weight loss programs in stopping the increase in obesity prevalence 
rates. So far, no major effect of weight gain prevention has been reported in large 
population based prevention programs. Recently, it has been suggested that obesity 
is a result of normal behaviour to a pathogenic environment, entitled the 
'obesogenic environment.' New weight gain prevention studies should therefore 
aim at understanding the environment affecting the community's behaviour. 
Altering the 'obesogenic environment' is probably critical for successful weight gain 
prevention programs. 
Obesity, as measured by high BMI, has an impact on the public health across the 
whole age-span. The effect of obesity on health in the elderly, however, is possibly 
better captured by the waist circumference rather than the commonly used BMI. 
This thesis provides new evidence, based on both epidemiological data from large 
population based cohort studies and mathematical modelling, that the expected 
increase in the prevalence of obesity will lead to an increase in mortality, morbidity, 
and disability in the community. Weight gain prevention programs should get high 
priority on both the scientific and political agenda. 
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Samenvatting 
SUMMARY IN DUTCH 
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Obesitas (ernstig overgewicht) komt steeds vaker voor in westerse landen. Vanwege 
de enorme toename gedurende de afgelopen decennia is het belangrijk de gevolgen 
van obesitas op de volksgezondheid te bestuderen. Het doel van dit proefschrift was 
het beschrijven van de toename van obesitas in Nederland en het verder ophelderen 
van de relatie tussen obesitas, sterfte en het optreden van ziekte en lichamelijke 
beperkingen. 
In een literatuuroverzicht (hoofdstuk z) werd beschreven dat obesitas wereldwijd is 
toegenomen in de meeste landen met een hoog welvaartspeil en sinds kort ook in 
veel ontwikkelingslanden. In welvaartslanden komt obesitas het meest voor bij 
mensen met een relatief lage sociaal-economische status, in ontwikkelingslanden 
juist bij mensen met een relatief hoge sociaal-economische status. De 
lichaamsamenstelling verandert met ouder worden en de body mass index (BMI), 
waarbij het gewicht wordt gedeeld door lengte in het kwadraat (kg/m) is wellicht 
niet de beste maat om de hoeveelheid lichaamsvet te bepalen bij oudere populaties. 
Naar aanleiding van het literatuuroverzicht is de hypothese geformuleerd dat 
sterftecijfers weliswaar hoger zijn in groepen mensen met obesitas, maar dat zij ook 
meer ongezonde levensjaren doormaken dan groepen mensen met een normaal 
gewicht. 
In hoofdstuk 3 van dit proefschrift werd de lange termijn en de recente toename in 
BMI in Nederland beschreven, met speciale aandacht voor opleidingsniveau. 
Daarnaast zijn de recente tijdstrend en de seizoensvariatie in BMI en buikomvang 
met elkaar vergeleken. Tussen 1976-1980 en 1993-1997 steeg het voorkomen van 
obesitas (BMI >30,o kg/m) van 5% tot 9% bij mannen en van 6% tot 9% bij 
vrouwen in de leeftijd 37-43 jaar. Gemeten lengte en gewicht was beschikbaar voor 
29.141 mannen en vrouwen die deelnamen aan een van de drie multicenter 
monitoringstudies van het RTVM. Deze monitoringstudies zijn uitgevoerd in 1976-
1980, 1987-1991 en 1993-1997. Voor de periode 1993-1997 waren ook gegevens 
beschikbaar voor 21.926 mannen en vrouwen in de leeftijd 20-59 j a a r - Tussen 1993 
en 1997 kwam obesitas voor bij 9% van de mannen en bij 10% van de vrouwen in 
de leeftijd van 20-59 j a a r - Gedurende deze periode steeg na correctie voor leeftijd, 
stad en opleidingsniveau het voorkomen van obesitas bij mannen met 0,54 
percentagepunten per jaar (95% betrouwbaarheidsinterval (BI): 0,13-0,96) en bij 
vrouwen met 0,35 percentagepunten per jaar (95% BI: -0,03-0,73). De stijging in het 
voorkomen van obesitas tussen 1993 en 1997 was het grootst bij mannen met een 
relatief laag opleidingsniveau en, omgekeerd, bij vrouwen met een hoog 
opleidingsniveau. Abdominale obesitas (buikomvang >i02 cm) kwam voor bij 20% 
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van de mannen en dit percentage steeg met 0,70 (95% BI: 0,15-1,24) 
percentagepunten per jaar. Bij vrouwen kwam abdominale obesitas (buikomvang 
>88 cm) voor bij 25% van de individuen. Dit percentage steeg met 1,33 (95% BI: 
0,79-0,87) percentagepunten per jaar. Seizoensvariatie (stijging in de winter en 
daling in de zomer) was duidelijker waarneembaar voor buikomvang dan voor BMI. 
De buikomvang lijkt dus beter bruikbaar dan de BMI om veranderingen in 
energiebalans en lichaamssamenstelling te detecteren. 
In hoofdstuk 4 werd de relatie tussen obesitas en sterfte beschreven met speciale 
aandacht voor oudere populaties. BMI was berekend uit gemeten gewicht en lengte 
van 7.895 Europese mannen die meededen aan de Zeven Landen Studie in de 
leeftijd 40-59 jaar. Zij werden vanaf i960 gedurende maximaal 15 jaar gevolgd. 
Gekeken werd welke mannen overleden in deze periode. Tien jaar later, toen de 
mannen de leeftijd 50-69 jaar hadden bereikt, werd de BMI nog eens gemeten en 
zijn de overlevende mannen nog eens 15 jaar gevolgd. Het relatieve risico van 
obesitas op sterfte was 1,8 (95% BI: 1,2-2,8) voor mannen die nooit rookten in de 
leeftijd 40-59 jaar en 1,4 (95% BI: 1,0-1,9) voor mannen die nooit rookten in de 
leeftijd van 50-69 jaar, met normaal gewicht (BMI: 18,5-24,9 kg/m) als 
referentlecategorie. Bij mannen die rookten was obesitas niet gerelateerd aan een 
sterftetoename, mogelijk door het hoge sterfterisico dat rokers sowieso hebben door 
het roken zelf. Overgewicht (BMI 25,0-29,9 kg/m2) was niet gerelateerd aan sterfte. 
In de Erasmus Rotterdam Gezondheid en Ouderen (ERGO) studie werden de BMI, 
de buikomvang en de ratio van buikomvang en heupomvang (buik-heup ratio) 
vergeleken als indicator voor verhoogde sterftecijfers. Het ERGO onderzoek omvat 
gegevens van 6,296 mannen en vrouwen in de leeftijd van 55 tot 102 jaar. De 
gemiddelde periode dat deelnemers zijn gevolgd was 5,4 jaar. Bij de 424 mannen die 
nooit rookten was de buikomvang meer continu en sterker gerelateerd aan de kans 
op overlijden dan de BMI. De buik-heup ratio was niet duidelijk gerelateerd aan de 
kans op overlijden. Het deel van de sterfte dat was toe te schrijven aan een grote 
buikomvang was driemaal zo groot als het deel van de sterfte dat was toe te 
schrijven aan een hoge BMI. 
In hoofdstuk 5 werd het verband van obesitas met aandoeningen van het 
bewegingsapparaat en lichamelijke beperkingen in het Mini-Finland 
gezondheidsonderzoek behandeld. Deze Finse populatiestudie omvatte gegevens 
van 5.625 mannen en vrouwen in de leeftijd van 30-64 jaar die zijn gemeten in 1978-
1980. Het hebben van lichamelijke beperkingen was gedefinieerd als het ontvangen 
van een werkloosheidsuitkering tijdens het 15-jarige vervolgonderzoek of het moeite 
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hebben met algemeen dagelijkse levensverrichtingen bij de start van het onderzoek. 
Gegevens over arbeidsongeschiktheid werden verzameld door het koppelen van 
gegevens aan het Finse nationaal register voor arbeidsongeschiktheidsuitkeringen. 
Het verband tussen obesitas en artrose in de knie was sterker dan het verband 
tussen obesitas en artrose in de heup. Artrose was gerelateerd aan lichamelijke 
beperkingen. Obesitas was ook onafhankelijk van artrose gerelateerd aan 
lichamelijke beperkingen. Het verband van obesitas met werkloosheid en 
moeilijkheden in algemeen dagelijkse levensverrichtingen werd zowel bij de groep 
mensen met artrose als bij de groep mensen zonder artrose gevonden. De groep 
mensen met zowel obesitas als artrose had 7,9 (95% BI: 4,4-13,9) zo vaak 
moeilijkheden met algemeen dagelijkse levensverrichtingen dan de groep mensen 
zonder obesitas en zonder artrose. In de groep Finnen met obesitas en artrose trad 
arbeidsongeschiktheid 2,4 (95% BI: 1,3-4,3) keer vaker op dan in de groep Finnen 
die geen obesitas en geen artrose hadden. Verder was obesitas gerelateerd aan 
chronische lagerugpijn, chronische pijn in het schoudergewricht en chronische 
nekpijn bij de start van het onderzoek in de groep vrouwen. In de groep mannen 
was overgewicht (BMI 25,0-29,9 kg/m2) wel en obesitas (BMI >30 ,O kg/m) niet 
gerelateerd aan deze aandoeningen van het bewegingsapparaat. 
Verder werden in hoofdstuk 5 de potentiele effecten beschreven van een gewichts-
beheersingsprogramma op het optreden van artrose en arbeidsongeschiktheid in de 
Nederlandse bevolking. Voor het berekenen hiervan is gebruik gemaakt van het 
chronische ziektenmodel. Het was berekend dat preventie van een gewichtsstijging 
(minder dan 0,5 kg per jaar) een toename in obesitas van 3,5 percentagepunten zou 
voorkomen. Hierdoor zouden 26.000 nieuwe gevallen van artrose en 19.000 nieuwe 
gevallen van arbeidsongeschiktheid worden voorkomen in de gehele Nederlandse 
bevolking van werkbare leeftijd door preventie van gewichtsstijging op 
populatieniveau gedurende een periode van tien jaar. 
Tenslotte, werden relatieve risico's op en ongezonde levensjaren door 
arbeidsongeschiktheid, coronaire hartziekte en medicatiegebruik voor chronische 
aandoeningen gepresenteerd per BMI categoric Hiervoor is data gebruikt van een 
tweede Finse populatiestudie, de Mobiele Kliniek Studie van het Finse sociale 
verzekeringsinstituut. In deze studie is lichaamsgewicht en lengte gemeten bij 
ongeveer 17.000 mannen en vrouwen in de leeftijd van 20-64 j a a r bij de start van 
het onderzoek in 1973-1978. Deelnemers aan de studie zijn gedurende maximaal 15 
jaar, tot leeftijd 65 jaar, gevolgd voor wat betreft het optreden van 
arbeidsongeschiktheid, ziekenhuisopname voor coronaire hartziekte, en ziekten die 
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leiden tot langdurig medicijngebrek. Relatieve risico's voor obesitas ten opzichte 
van normaal gewicht op het optreden van arbeidsongeschiktheid, coronaire 
hartziekte, en ziekten die leiden tot chronisch medicijngebruik waren groter dan de 
relatieve risico's op sterfte. Relatieve risico's waren het hoogst in de jongste 
leeftijdscategorieen. Tijdens het vervolgonderzoek van maximaal 15 jaar leefden 
obese mannen respectievelijk 0,5 0,4 en 1,7 meer jaren met arbeidsongeschiktheid, 
coronaire hartziekte, en ziekte leidend tot langdurig medicijngebruik dan mensen 
met een normaal gewicht. Obese vrouwen leefden respectievelijk 0,5 0,4 en 1,3 jaren 
meer met deze aandoeningen dan vrouwen met een normaal gewicht. 
In hoofdstuk 6 werden de resultaten van dit proefschrift samengevat en 
bediscussieerd binnen de context van de literatuur. Het voorkomen van obesitas is 
recentelijk gestegen in Nederlandse volwassenen. De resultaten van cohort studies 
die in dit proefschrift worden gerapporteerd, bevestigen dat obesitas is gerelateerd 
aan het optreden van sterfte, ziekte en lichamelijke beperkingen. Relatieve risico's 
van obesitas voor het optreden van ziekte en lichamelijke beperkingen waren groter 
dan het relatieve risico van obesitas op sterfte. Volgens de hypothese die is gesteld in 
hoofdstuk 2, is met behulp van empirische gegevens aangetoond dat personen met 
obesitas niet alleen korter leven, maar 00k meer ongezonde levensjaren doormaken 
door arbeidsongeschiktheid, coronaire hartziekte, en ziekte die leidt tot langdurig 
medicijngebruik. 
In het laatste deel van hoofdstuk 6 werd ingegaan op het potentiele belang van 
nieuwe, innovatieve gewichtsbeheersingsprogramma's. Preventieprogramma's zijn 
theoretisch efficienter dan afvalprogramma's in het terugdringen van de stijging in 
het voorkomen van obesitas. Er zijn slechts enkele grote populatiestudies uitgevoerd 
die waren gericht op de preventie van gewichtsstijging. Het is recentelijk geopperd 
dat obesitas het gevolg is van een normale reactie op een pathologische omgeving, 
de zogenaamde 'obesogene omgeving', in plaats van een pathologische reactie op 
een normale omgeving. Daarom zouden nieuwe gewichtsbeheersingsprogramma's 
als doel moeten hebben om meer te weten te komen over de omgevingsfactoren die 
het gedrag van mensen beinvloeden. Het veranderen van de 'obesogene omgeving' 
is waarschijnlijk van groot belang voor het succes van gewichtsbeheersings-
programma's. 
Obesitas, gemeten met de BMI, heeft een grote invloed op de volksgezondheid, op 
alle leeftijden. De gezondheidsinvloed van obesitas bij ouderen is waarschijnlijk 
beter te bestuderen door het gebruik van de buikomvang dan door het gebruik van 
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de BMI. De epidemiologische populatiestudies en rekenkundige modellen die 
beschreven zijn in dit proefschrift, suggereren dat de verwachte toename in het 
voorkomen van obesitas zal lijden tot een toename in sterfte, maar ook tot een 
toename in het aantal jaren van ziekte en lichamelijke beperkingen in de bevolking. 
De nieuwe gegevens in dit proefschrift tonen aan dat gewichtsbeheersings-
programma's hoge prioriteit verdienen op zowel de wetenschappelijke als op de 
politieke agenda. 
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List of abbreviations 
AF 
P 
BI 
BMI 
CHD 
CI 
CVD 
ERGO 
HR 
MONICA 
MORGEN 
NC 
NHANES 
OA 
OR 
REF 
RR 
WCRF 
WHO 
WHR 
Population Attributable Fraction 
Betrouwbaarheidsinterval 
Body Mass Index 
Coronary Heart Disease 
Confidence Interval 
Cardiovascular Diseases 
Erasmus Rotterdam Gezondheid en Ouderen 
Hazard Ratio 
Monitoring trends and determinants in cardiovascular disease 
Monitoring project on risk factors for chronic diseases 
Not Calculated 
National Health and Nutrition Examination Survey 
Osteoarthritis 
Odds Ratio 
Reference category 
Relative Risk 
World Cancer Research Fund 
World Health Organization 
Waist-Hip Ratio 
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